0000792935
false
--12-31
2023
Q3
0000792935
2023-01-01
2023-09-30
0000792935
2023-11-20
0000792935
2023-09-30
0000792935
2022-12-31
0000792935
us-gaap:RedeemablePreferredStockMember
2023-09-30
0000792935
us-gaap:RedeemablePreferredStockMember
2022-12-31
0000792935
2023-07-01
2023-09-30
0000792935
2022-07-01
2022-09-30
0000792935
2022-01-01
2022-09-30
0000792935
us-gaap:SeriesAPreferredStockMember
2022-12-31
0000792935
us-gaap:CommonStockMember
2022-12-31
0000792935
us-gaap:AdditionalPaidInCapitalMember
2022-12-31
0000792935
grst:DiscountToParValueMember
2022-12-31
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-12-31
0000792935
us-gaap:RetainedEarningsMember
2022-12-31
0000792935
us-gaap:NoncontrollingInterestMember
2022-12-31
0000792935
us-gaap:SeriesAPreferredStockMember
2023-03-31
0000792935
us-gaap:CommonStockMember
2023-03-31
0000792935
us-gaap:AdditionalPaidInCapitalMember
2023-03-31
0000792935
grst:DiscountToParValueMember
2023-03-31
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-03-31
0000792935
us-gaap:RetainedEarningsMember
2023-03-31
0000792935
us-gaap:NoncontrollingInterestMember
2023-03-31
0000792935
2023-03-31
0000792935
us-gaap:SeriesAPreferredStockMember
2023-06-30
0000792935
us-gaap:CommonStockMember
2023-06-30
0000792935
us-gaap:AdditionalPaidInCapitalMember
2023-06-30
0000792935
grst:DiscountToParValueMember
2023-06-30
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-06-30
0000792935
us-gaap:RetainedEarningsMember
2023-06-30
0000792935
us-gaap:NoncontrollingInterestMember
2023-06-30
0000792935
2023-06-30
0000792935
us-gaap:SeriesAPreferredStockMember
2021-12-31
0000792935
us-gaap:CommonStockMember
2021-12-31
0000792935
us-gaap:AdditionalPaidInCapitalMember
2021-12-31
0000792935
grst:DiscountToParValueMember
2021-12-31
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2021-12-31
0000792935
us-gaap:RetainedEarningsMember
2021-12-31
0000792935
us-gaap:NoncontrollingInterestMember
2021-12-31
0000792935
2021-12-31
0000792935
us-gaap:SeriesAPreferredStockMember
2022-03-31
0000792935
us-gaap:CommonStockMember
2022-03-31
0000792935
us-gaap:AdditionalPaidInCapitalMember
2022-03-31
0000792935
grst:DiscountToParValueMember
2022-03-31
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-03-31
0000792935
us-gaap:RetainedEarningsMember
2022-03-31
0000792935
us-gaap:NoncontrollingInterestMember
2022-03-31
0000792935
2022-03-31
0000792935
us-gaap:SeriesAPreferredStockMember
2022-06-30
0000792935
us-gaap:CommonStockMember
2022-06-30
0000792935
us-gaap:AdditionalPaidInCapitalMember
2022-06-30
0000792935
grst:DiscountToParValueMember
2022-06-30
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-06-30
0000792935
us-gaap:RetainedEarningsMember
2022-06-30
0000792935
us-gaap:NoncontrollingInterestMember
2022-06-30
0000792935
2022-06-30
0000792935
us-gaap:SeriesAPreferredStockMember
2023-01-01
2023-03-31
0000792935
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0000792935
us-gaap:AdditionalPaidInCapitalMember
2023-01-01
2023-03-31
0000792935
grst:DiscountToParValueMember
2023-01-01
2023-03-31
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-03-31
0000792935
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0000792935
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-03-31
0000792935
2023-01-01
2023-03-31
0000792935
us-gaap:SeriesAPreferredStockMember
2023-04-01
2023-06-30
0000792935
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0000792935
us-gaap:AdditionalPaidInCapitalMember
2023-04-01
2023-06-30
0000792935
grst:DiscountToParValueMember
2023-04-01
2023-06-30
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-04-01
2023-06-30
0000792935
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0000792935
us-gaap:NoncontrollingInterestMember
2023-04-01
2023-06-30
0000792935
2023-04-01
2023-06-30
0000792935
us-gaap:SeriesAPreferredStockMember
2023-07-01
2023-09-30
0000792935
us-gaap:CommonStockMember
2023-07-01
2023-09-30
0000792935
us-gaap:AdditionalPaidInCapitalMember
2023-07-01
2023-09-30
0000792935
grst:DiscountToParValueMember
2023-07-01
2023-09-30
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-07-01
2023-09-30
0000792935
us-gaap:RetainedEarningsMember
2023-07-01
2023-09-30
0000792935
us-gaap:NoncontrollingInterestMember
2023-07-01
2023-09-30
0000792935
us-gaap:SeriesAPreferredStockMember
2022-01-01
2022-03-31
0000792935
us-gaap:CommonStockMember
2022-01-01
2022-03-31
0000792935
us-gaap:AdditionalPaidInCapitalMember
2022-01-01
2022-03-31
0000792935
grst:DiscountToParValueMember
2022-01-01
2022-03-31
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-01-01
2022-03-31
0000792935
us-gaap:RetainedEarningsMember
2022-01-01
2022-03-31
0000792935
us-gaap:NoncontrollingInterestMember
2022-01-01
2022-03-31
0000792935
2022-01-01
2022-03-31
0000792935
us-gaap:SeriesAPreferredStockMember
2022-04-01
2022-06-30
0000792935
us-gaap:CommonStockMember
2022-04-01
2022-06-30
0000792935
us-gaap:AdditionalPaidInCapitalMember
2022-04-01
2022-06-30
0000792935
grst:DiscountToParValueMember
2022-04-01
2022-06-30
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-04-01
2022-06-30
0000792935
us-gaap:RetainedEarningsMember
2022-04-01
2022-06-30
0000792935
us-gaap:NoncontrollingInterestMember
2022-04-01
2022-06-30
0000792935
2022-04-01
2022-06-30
0000792935
us-gaap:SeriesAPreferredStockMember
2022-07-01
2022-09-30
0000792935
us-gaap:CommonStockMember
2022-07-01
2022-09-30
0000792935
us-gaap:AdditionalPaidInCapitalMember
2022-07-01
2022-09-30
0000792935
grst:DiscountToParValueMember
2022-07-01
2022-09-30
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-07-01
2022-09-30
0000792935
us-gaap:RetainedEarningsMember
2022-07-01
2022-09-30
0000792935
us-gaap:NoncontrollingInterestMember
2022-07-01
2022-09-30
0000792935
us-gaap:SeriesAPreferredStockMember
2023-09-30
0000792935
us-gaap:CommonStockMember
2023-09-30
0000792935
us-gaap:AdditionalPaidInCapitalMember
2023-09-30
0000792935
grst:DiscountToParValueMember
2023-09-30
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-09-30
0000792935
us-gaap:RetainedEarningsMember
2023-09-30
0000792935
us-gaap:NoncontrollingInterestMember
2023-09-30
0000792935
us-gaap:SeriesAPreferredStockMember
2022-09-30
0000792935
us-gaap:CommonStockMember
2022-09-30
0000792935
us-gaap:AdditionalPaidInCapitalMember
2022-09-30
0000792935
grst:DiscountToParValueMember
2022-09-30
0000792935
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-09-30
0000792935
us-gaap:RetainedEarningsMember
2022-09-30
0000792935
us-gaap:NoncontrollingInterestMember
2022-09-30
0000792935
2022-09-30
0000792935
us-gaap:LandMember
2023-01-01
2023-09-30
0000792935
us-gaap:LandMember
2023-09-30
0000792935
us-gaap:LandMember
2022-12-31
0000792935
us-gaap:PropertyPlantAndEquipmentMember
2023-01-01
2023-09-30
0000792935
us-gaap:PropertyPlantAndEquipmentMember
2023-09-30
0000792935
us-gaap:PropertyPlantAndEquipmentMember
2022-12-31
0000792935
us-gaap:LeaseholdImprovementsMember
2023-01-01
2023-09-30
0000792935
us-gaap:LeaseholdImprovementsMember
2023-09-30
0000792935
us-gaap:LeaseholdImprovementsMember
2022-12-31
0000792935
us-gaap:FurnitureAndFixturesMember
2023-01-01
2023-09-30
0000792935
us-gaap:FurnitureAndFixturesMember
2023-09-30
0000792935
us-gaap:FurnitureAndFixturesMember
2022-12-31
0000792935
us-gaap:VehiclesMember
2023-01-01
2023-09-30
0000792935
us-gaap:VehiclesMember
2023-09-30
0000792935
us-gaap:VehiclesMember
2022-12-31
0000792935
us-gaap:ComputerEquipmentMember
2023-01-01
2023-09-30
0000792935
us-gaap:ComputerEquipmentMember
2023-09-30
0000792935
us-gaap:ComputerEquipmentMember
2022-12-31
0000792935
2023-08-04
0000792935
grst:LeoniteCapitalLLCMember
2023-01-01
2023-09-30
0000792935
grst:LeoniteCapitalLLCMember
2022-01-01
2022-12-31
0000792935
grst:LeoniteFundILPMember
2023-01-01
2023-09-30
0000792935
grst:LeoniteFundILPMember
2022-01-01
2022-12-31
0000792935
grst:AuctusFundLLCMember
2023-01-01
2023-09-30
0000792935
grst:AuctusFundLLCMember
2022-01-01
2022-12-31
0000792935
grst:LabrysFundLPMember
2023-01-01
2023-09-30
0000792935
grst:LabrysFundLPMember
2022-01-01
2022-12-31
0000792935
grst:EdBlasiakMember
2023-01-01
2023-09-30
0000792935
grst:EdBlasiakMember
2022-01-01
2022-12-31
0000792935
grst:JoshuaBaumanMember
2023-01-01
2023-09-30
0000792935
grst:JoshuaBaumanMember
2022-01-01
2022-12-31
0000792935
grst:ConvertibleNotesMember
2023-01-01
2023-09-30
0000792935
grst:ConvertibleNotesMember
2022-01-01
2022-12-31
0000792935
grst:SeriesNConvertibleNotesMember
2023-01-01
2023-09-30
0000792935
grst:SeriesNConvertibleMember
2023-01-01
2023-09-30
0000792935
grst:SeriesNConvertibleNotesMember
2022-01-01
2022-12-31
0000792935
2022-01-01
2022-12-31
0000792935
grst:CranberryCoveHoldingsLtdMember
2023-09-30
0000792935
grst:CranberryCoveHoldingsLtdMember
2022-12-31
0000792935
grst:ShawanELeonMember
2023-01-01
2023-09-30
0000792935
grst:ShawanELeonMember
2022-01-01
2022-12-31
0000792935
grst:LeonDevelopmentsLtdMember
2023-01-01
2023-09-30
0000792935
grst:LeonDevelopmentsLtdMember
2022-01-01
2022-12-31
0000792935
grst:EileenGreeneMember
2023-01-01
2023-09-30
0000792935
grst:EileenGreeneMember
2022-01-01
2022-12-31
0000792935
grst:Excercise1Member
2023-01-01
2023-09-30
0000792935
grst:Excercise2Member
2023-01-01
2023-09-30
0000792935
grst:Excercise2Member
2023-01-01
2023-09-30
0000792935
grst:RentalOperationsMember
2023-01-01
2023-09-30
0000792935
grst:InPatientServicesMember
2023-01-01
2023-09-30
0000792935
grst:RentalInPatientServicesMember
2023-01-01
2023-09-30
0000792935
grst:RentalOperationsMember
2022-01-01
2022-09-30
0000792935
grst:InPatientServicesMember
2022-01-01
2022-09-30
0000792935
grst:RentalInPatientServicesMember
2022-01-01
2022-09-30
0000792935
grst:RentalOperationsMember
2023-09-30
0000792935
grst:InPatientServicesMember
2023-09-30
0000792935
grst:RentalInPatientServicesMember
2023-09-30
0000792935
grst:RentalOperationsMember
2022-09-30
0000792935
grst:InPatientServicesMember
2022-09-30
0000792935
grst:RentalInPatientServicesMember
2022-09-30
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 10-Q
(Mark
One)
☒ QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the quarterly period ended September 30, 2023
or
☐ TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the transition period from to
Commission
File Number 000-54748
ETHEMA
HEALTH CORPORATION.
(Exact
Name of Registrant as Specified in its Charter)
Colorado |
|
84-1227328 |
(State or other jurisdiction
of
incorporation or organization) |
|
(I.R.S. employer
Identification No.) |
|
|
|
950
Evernia Street
West Palm Beach, Florida |
|
33401 |
Address of Principal Executive
Offices |
|
Zip Code |
(416) 500-0020
Registrant’s
Telephone Number, Including Area Code
Former
Name, Former Address and Former Fiscal Year, if Changed Since Last Report
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐ |
Accelerated filer ☐ |
Non-accelerated filer ☒ |
Smaller reporting company ☒ |
|
Emerging growth company ☐ |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common shares |
|
GRST |
|
OTC Pink |
|
|
|
|
|
|
Indicate
the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: Number of
shares of common stock outstanding as of November 20, 2023 was 3,729,053,805.
NOTE
REGARDING FORWARD-LOOKING STATEMENTS
This
Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act
of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In
particular, statements contained in this Quarterly Report on Form 10-Q, including but not limited to, statements regarding the sufficiency
of our cash, our ability to finance our operations and business initiatives and obtain funding for such activities; our future results
of operations and financial position, business strategy and plan prospects, or costs and objectives of management for future acquisitions,
are forward looking statements. These forward-looking statements relate to our future plans, objectives, expectations and intentions
and may be identified by words such as “may,” “will,” “should,” “expects,”
“plans,” “anticipates,” “intends,” “targets,” “projects,” “contemplates,”
“believes,” “seeks,” “goals,” “estimates,” “predicts,” “potential”
and “continue” or similar words. Readers are cautioned that these forward-looking statements are based on our current
beliefs, expectations and assumptions and are subject to risks, uncertainties, and assumptions that are difficult to predict.
Therefore, actual results may differ materially and adversely from those expressed, projected or implied in any forward-looking statements. We undertake
no obligation to revise or update any forward-looking statements for any reason.
NOTE
REGARDING COMPANY REFERENCES
Throughout
this Quarterly Report on Form 10-Q, “Ethema,” the “Company,” “we,” “us” and “our”
refer to Ethema Health Corporation.
FORM
10-Q
ETHEMA
HEALTH CORPORATION
TABLE
OF CONTENTS
|
|
Page |
|
PART I - FINANCIAL INFORMATION |
|
Item l. |
Financial Statements |
1 |
|
Condensed Consolidated
Balance Sheets as of September 30, 2023 (Unaudited) and December 31, 2022 |
1 |
|
Unaudited Condensed Consolidated
Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2023 and 2022 |
2 |
|
Unaudited Condensed Consolidated
Statements of Stockholders’ Deficit for the nine months ended September 30, 2023 and 2022 |
3 |
|
Unaudited Condensed Consolidated
Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 |
5 |
|
Notes to the Unaudited Condensed Consolidated Financial
Statements |
6 |
Item 2. |
Management’s Discussion
and Analysis of Financial Condition and Results of Operations |
31 |
Item 3. |
Quantitative and Qualitative Disclosures About Market
Risk |
36 |
Item 4. |
Controls and Procedures |
36 |
|
|
|
|
PART II - OTHER INFORMATION |
|
Item 1. |
Legal Proceedings |
37 |
Item 1A. |
Risk Factors |
37 |
Item 2. |
Unregistered Sales of Equity Securities and Use of
Proceeds |
37 |
Item 3. |
Defaults Upon Senior Securities |
37 |
Item 4. |
Mine Safety Disclosures |
37 |
Item 5. |
Other Information |
37 |
Item 6. |
Exhibits |
37 |
SIGNATURES |
38 |
ETHEMA
HEALTH CORPORATION
CONDENSED CONSOLIDATED
BALANCE SHEETS
| |
September
30, 2023 | |
December
31, 2022 |
ASSETS | |
| (Unaudited) | | |
| | |
| |
| | | |
| | |
Current
assets | |
| | | |
| | |
Cash | |
$ | 11,728 | | |
$ | 140,757 | |
Accounts
receivable, net | |
| 681,072 | | |
| 337,074 | |
Prepaid
expenses | |
| 39,069 | | |
| 44,718 | |
Other
current assets | |
| 62,652 | | |
| 20,347 | |
Total
current assets | |
| 794,521 | | |
| 542,896 | |
Non-current
assets | |
| | | |
| | |
Property
and equipment, net | |
| 523,699 | | |
| 2,974,395 | |
Intangible
assets, net | |
| 984,447 | | |
| 1,252,932 | |
Right
of use assets | |
| 9,331,261 | | |
| 1,393,071 | |
Deposits | |
| 374,000 | | |
| 400,000 | |
Total
non-current assets | |
| 11,213,407 | | |
| 6,020,398 | |
Total
assets | |
$ | 12,007,928 | | |
$ | 6,563,294 | |
| |
| | | |
| | |
LIABILITIES
AND STOCKHOLDERS’ DEFICIT | |
| | | |
| | |
| |
| | | |
| | |
Current
liabilities | |
| | | |
| | |
Accounts
payable and accrued liabilities | |
$ | 129,415 | | |
$ | 170,934 | |
Taxes
payable | |
| — | | |
| 248,644 | |
Convertible
notes, net of discounts | |
| 4,408,209 | | |
| 5,269,250 | |
Short-term
notes | |
| 124,886 | | |
| 460,534 | |
Mortgage
loans | |
| — | | |
| 3,504,605 | |
Receivables
funding | |
| 324,704 | | |
| 416,731 | |
Government
assistance loans | |
| 14,925 | | |
| 14,818 | |
Operating
lease liability | |
| 32,753 | | |
| 287,017 | |
Finance
lease liability | |
| 8,289 | | |
| 7,891 | |
Accrued
dividends | |
| — | | |
| 194,829 | |
Related
party payables | |
| 2,670,008 | | |
| 2,713,878 | |
Total
current liabilities | |
| 7,713,189 | | |
| 13,289,131 | |
Non-current
liabilities | |
| | | |
| | |
Government
assistance loans | |
| 24,282 | | |
| 79,555 | |
Deferred
taxes | |
| 170,855 | | |
| 217,451 | |
Third
party loans | |
| 248,757 | | |
| 578,335 | |
Operating
lease liability | |
| 9,339,227 | | |
| 1,206,413 | |
Finance
lease liability | |
| 18,648 | | |
| 24,952 | |
Total
non-current liabilities | |
| 9,801,769 | | |
| 2,106,706 | |
Total
liabilities | |
| 17,514,958 | | |
| 15,395,837 | |
| |
| | | |
| | |
Redeemable
Preferred stock - Series B; $1.00 par value, 10,000,000 shares authorized; 0 and 400,000 shares outstanding
as of September 30, 2023 and December 31, 2022, respectively. | |
| — | | |
| 400,000 | |
| |
| | | |
| | |
Stockholders’
deficit | |
| | | |
| | |
Preferred
stock - Series A; $0.01 par value, 10,000,000 shares authorized 4,000,000 shares outstanding as of September
30, 2023 and December 31, 2022, respectively. | |
| 40,000 | | |
| 40,000 | |
Common
stock - $0.01 par value, 10,000,000,000 shares authorized; 3,729,053,805 shares issued and outstanding as
of September 30, 2023 and December 31, 2022, respectively. | |
| 37,290,539 | | |
| 37,290,539 | |
Additional
paid-in capital | |
| 26,187,925 | | |
| 23,419,917 | |
Discount
for shares issued below par value | |
| (27,363,367 | ) | |
| (27,363,367 | ) |
Accumulated
other comprehensive loss | |
| — | | |
| (5,065 | ) |
Accumulated
deficit | |
| (41,960,217 | ) | |
| (43,484,751 | ) |
Stockholders’
deficit attributable to Ethema Health Corporation stockholders’ | |
| (5,805,120 | ) | |
| (10,102,727 | ) |
Non-controlling
interest | |
| 298,090 | | |
| 870,184 | |
Total
stockholders’ deficit | |
| (5,507,030 | ) | |
| (9,232,543 | ) |
Total
liabilities and stockholders’ deficit | |
$ | 12,007,928 | | |
$ | 6,563,294 | |
The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements
ETHEMA
HEALTH CORPORATION
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
AND
COMPREHENSIVE INCOME (LOSS)
| |
Three
months ended September 30, 2023 | |
Three
months ended September 30, 2022 | |
Nine
months ended September 30, 2023 | |
Nine
months ended September 30, 2022 |
| |
| |
| |
| |
|
Revenues | |
$ | 1,353,899 | | |
$ | 1,424,943 | | |
$ | 4,219,904 | | |
$ | 3,586,290 | |
| |
| | | |
| | | |
| | | |
| | |
Operating
expenses | |
| | | |
| | | |
| | | |
| | |
General
and administrative | |
| 249,283 | | |
| 289,073 | | |
| 755,685 | | |
| 760,533 | |
Rent
expense | |
| 107,707 | | |
| 114,717 | | |
| 328,204 | | |
| 314,256 | |
Management
fees | |
| 30,000 | | |
| 30,000 | | |
| 273,003 | | |
| 90,000 | |
Professional
fees | |
| 171,659 | | |
| 19,131 | | |
| 460,773 | | |
| 180,867 | |
Salaries
and wages | |
| 651,537 | | |
| 580,432 | | |
| 1,873,280 | | |
| 1,456,099 | |
Depreciation
and amortization | |
| 110,185 | | |
| 136,608 | | |
| 388,259 | | |
| 402,851 | |
Total
operating expenses | |
| 1,320,371 | | |
| 1,169,961 | | |
| 4,079,204 | | |
| 3,204,606 | |
| |
| | | |
| | | |
| | | |
| | |
Operating
Income | |
| 33,528 | | |
| 254,982 | | |
| 140,700 | | |
| 381,684 | |
| |
| | | |
| | | |
| | | |
| | |
Other
Income (expense) | |
| | | |
| | | |
| | | |
| | |
Other
income | |
| 110 | | |
| (1,045 | ) | |
| 449 | | |
| 10,018 | |
Forgiveness
of government assistance loan | |
| — | | |
| 104,368 | | |
| — | | |
| 104,368 | |
Penalty
on convertible debt | |
| — | | |
| — | | |
| (34,688 | ) | |
| — | |
Extension
fee on property purchase | |
| — | | |
| — | | |
| (130,000 | ) | |
| — | |
Gain
on disposal of property | |
| 2,484,172 | | |
| | | |
| 2,484,172 | | |
| | |
Loss
on debt extinguishment | |
| (277,175 | ) | |
| — | | |
| (277,175 | ) | |
| — | |
Interest
expense | |
| (81,371 | ) | |
| (163,561 | ) | |
| (382,448 | ) | |
| (367,177 | ) |
Amortization
of debt discount | |
| (73,857 | ) | |
| (87,704 | ) | |
| (238,304 | ) | |
| (551,738 | ) |
Derivative
liability movement | |
| — | | |
| 45,156 | | |
| — | | |
| 175,593 | |
Foreign
exchange movements | |
| 6,598 | | |
| 404,538 | | |
| (84,148 | ) | |
| 502,350 | |
Benefit
from (provision for) Income taxes | |
| 15,532 | | |
| (44,652 | ) | |
| 221,107 | | |
| (87,615 | ) |
Net
income | |
| 2,107,537 | | |
| 512,082 | | |
| 1,699,665 | | |
| 167,483 | |
Net
income attributable to non-controlling interest | |
| (31,058 | ) | |
| (28,787 | ) | |
| (127,906 | ) | |
| (52,425 | ) |
Net
income allocable to Ethema Health Corporation Stockholders | |
| 2,076,479 | | |
| 483,295 | | |
| 1,571,759 | | |
| 115,058 | |
Preferred
stock dividend | |
| — | | |
| (24,582 | ) | |
| (47,225 | ) | |
| (73,923 | ) |
Net
income available to common shareholders of Ethema Health Corporation | |
| 2,076,479 | | |
| 458,713 | | |
| 1,524,534 | | |
| 41,135 | |
Accumulated
other comprehensive loss | |
| | | |
| | | |
| | | |
| | |
Foreign
currency translation adjustment | |
| — | | |
| (169,965 | ) | |
| 5,065 | | |
| (208,317 | ) |
| |
| | | |
| | | |
| | | |
| | |
Total
comprehensive income (loss) | |
$ | 2,076,479 | | |
$ | 288,748 | | |
$ | 1,529,599 | | |
$ | (167,182 | ) |
Income
per share | |
| | | |
| | | |
| | | |
| | |
Basic | |
$ | 0.00 | | |
$ | 0.00 | | |
$ | 0.00 | | |
$ | 0.00 | |
Diluted | |
$ | 0.00 | | |
$ | 0.00 | | |
$ | 0.00 | | |
$ | 0.00 | |
Weighted
average common shares outstanding | |
| | | |
| | | |
| | | |
| | |
Basic | |
| 3,729,053,805 | | |
| 3,729,053,805 | | |
| 3,729,053,805 | | |
| 3,696,636,223 | |
Diluted | |
| 3,931,379,775 | | |
| 4,276,544,380 | | |
| 3,931,379,775 | | |
| 4,244,126,798 | |
The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements
ETHEMA
HEALTH CORPORATION
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
| |
|
|
|
| |
|
|
|
| |
| |
| |
| |
| |
| |
|
| |
Series
A Preferred | |
Common | |
Additional paid-in | |
Discount
to | |
Accumulated
other Comprehensive | |
Accumulated | |
Non-controlling shareholders | |
|
| |
Shares | |
Amount | |
Shares | |
Amount | |
Capital | |
par
value | |
Income | |
Deficit | |
interest | |
Total |
Balance
as of December 31, 2022 | |
| 4,000,000 | | |
$ | 40,000 | | |
| 3,729,053,805 | | |
$ | 37,290,539 | | |
$ | 23,419,917 | | |
$ | (27,363,367 | ) | |
$ | (5,065 | ) | |
$ | (43,484,751 | ) | |
$ | 870,184 | | |
$ | (9,232,543 | ) |
Foreign
currency translation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (1,504 | ) | |
| — | | |
| — | | |
| (1,504 | ) |
Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| | | |
| — | | |
| (178,685 | ) | |
| 2,968 | | |
| (175,717 | ) |
Dividends
accrued | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (23,419 | ) | |
| — | | |
| (23,419 | ) |
Balance
as of March 31, 2023 | |
| 4,000,000 | | |
$ | 40,000 | | |
| 3,729,053,805 | | |
$ | 37,290,539 | | |
$ | 23,419,917 | | |
$ | (27,363,367 | ) | |
$ | (6,569 | ) | |
$ | (43,686,855 | ) | |
$ | 873,152 | | |
$ | (9,433,183 | ) |
Disposal
of subsidiary to related party | |
| — | | |
| — | | |
| — | | |
| — | | |
| 2,034,885 | | |
| — | | |
| — | | |
| — | | |
| (700,000 | ) | |
| 1,334,885 | |
Deemed
extinguishment of debt by related party | |
| — | | |
| — | | |
| — | | |
| — | | |
| 461,184 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 461,184 | |
Foreign
currency translation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 6,569 | | |
| — | | |
| — | | |
| 6,569 | |
Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (326,035 | ) | |
| 93,880 | | |
| 232,155 | |
Dividends
accrued | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (23,806 | ) | |
| — | | |
| (23,806 | ) |
Balance
as of June 30, 2023 | |
| 4,000,000 | | |
$ | 40,000 | | |
| 3,729,053,805 | | |
$ | 37,290,539 | | |
$ | 25,915,986 | | |
$ | (27,363,367 | ) | |
$ | — | | |
$ | (44,036,696 | ) | |
$ | 267,032 | | |
$ | (7,886,506 | ) |
Fair
value of warrants issued for debt extinguishment | |
| — | | |
| — | | |
| — | | |
| — | | |
| 271,939 | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 271,939 | |
Net
income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 2,076,479 | | |
| 31,058 | | |
| 2,107,537 | |
Balance
as of September 30, 2023 | |
| 4,000,000 | | |
$ | 40,000 | | |
| 3,729,053,805 | | |
$ | 37,290,539 | | |
$ | 26,187,925 | | |
$ | (27,363,367 | ) | |
$ | — | | |
$ | (41,960,217 | ) | |
$ | 298,090 | | |
$ | (5,507,030 | ) |
| |
Series
A Preferred | |
Common | |
Additional paid-in | |
Discount
to | |
Accumulated
other Comprehensive | |
Accumulated | |
Non-controlling shareholders | |
|
| |
Shares | |
Amount | |
Shares | |
Amount | |
Capital | |
par
value | |
Income | |
Deficit | |
interest | |
Total |
Balance
as of December 31, 2021 | |
| 4,000,000 | | |
$ | 40,000 | | |
| 3,579,053,805 | | |
$ | 35,790,539 | | |
$ | 22,791,350 | | |
$ | (26,013,367 | ) | |
$ | 816,532 | | |
$ | (44,103,311 | ) | |
$ | 822,876 | | |
$ | (9,855,381 | ) |
Conversion
of convertible notes | |
| — | | |
| — | | |
| 150,000,000 | | |
| 1,500,000 | | |
| — | | |
| (1,350,000 | ) | |
| — | | |
| — | | |
| — | | |
| 150,000 | |
Foreign
currency translation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 34,517 | | |
| — | | |
| — | | |
| 34,517 | |
Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| | | |
| — | | |
| (174,447 | ) | |
| 9,462 | | |
| (164,985 | ) |
Dividends
accrued | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (24,613 | ) | |
| — | | |
| (24,613 | ) |
Balance
as of March 31, 2022 | |
| 4,000,000 | | |
$ | 40,000 | | |
| 3,729,053,805 | | |
$ | 37,290,539 | | |
$ | 22,791,350 | | |
$ | (27,363,367 | ) | |
$ | 851,049 | | |
$ | (44,302,371 | ) | |
$ | 832,338 | | |
$ | (9,860,462 | ) |
Foreign
currency translation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (72,869 | ) | |
| — | | |
| — | | |
| (72,869 | ) |
Net
loss | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (193,790 | ) | |
| 14,176 | | |
| (179,614 | ) |
Dividends
accrued | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (24,728 | ) | |
| — | | |
| (24,728 | ) |
Balance
as of June 30, 2022 | |
| 4,000,000 | | |
$ | 40,000 | | |
| 3,729,053,805 | | |
$ | 37,290,539 | | |
$ | 22,791,350 | | |
$ | (27,363,367 | ) | |
$ | 778,180 | | |
$ | (44,520,889 | ) | |
$ | 846,514 | | |
$ | (10,137,673 | ) |
Foreign
currency translation | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (169,965 | ) | |
| — | | |
| — | | |
| (169,965 | ) |
Net
income | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| 483,294 | | |
| 28,787 | | |
| 512,082 | |
Dividends
accrued | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| — | | |
| (24,582 | ) | |
| — | | |
| (24,582 | ) |
Balance
as of September 30, 2022 | |
| 4,000,000 | | |
$ | 40,000 | | |
| 3,729,053,805 | | |
$ | 37,290,539 | | |
$ | 22,791,350 | | |
$ | (27,363,367 | ) | |
$ | 608,215 | | |
$ | (44,062,177 | ) | |
$ | 875,301 | | |
$ | (9,820,139 | ) |
The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements
ETHEMA
HEALTH CORPORATION
UNAUDITED
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
| |
Nine
months ended September 30, 2023 | |
Nine
months ended September 30, 2022 |
Operating
activities | |
| | | |
| | |
Net
income | |
$ | 1,699,665 | | |
$ | 167,483 | |
Adjustment
to reconcile net income to net cash (used in) provided by operating activities: | |
| | | |
| | |
Depreciation
and amortization | |
| 388,259 | | |
| 402,851 | |
Forgiveness
of government assistance loan | |
| — | | |
| (104,368 | ) |
Non-cash
interest accrual on escrow deposit | |
| — | | |
| 758 | |
Gain
on disposal of property | |
| (2,484,172 | ) | |
| — | |
Loss
on debt extinguishment | |
| 277,175 | | |
| — | |
Penalty
on convertible notes | |
| 34,688 | | |
| — | |
Amortization
of debt discount | |
| 238,304 | | |
| 564,006 | |
Derivative
liability movements | |
| — | | |
| (175,593 | ) |
Non-cash
deferred tax movements | |
| (46,597 | ) | |
| (56,382 | ) |
Amortization
of right of use asset | |
| 169,682 | | |
| 194,086 | |
Changes
in operating assets and liabilities (net of assets acquired and liabilities assumed) | |
| | | |
| | |
Accounts
receivable | |
| (289,697 | ) | |
| (145,833 | ) |
Prepaid
expenses and other current assets | |
| (48,457 | ) | |
| (14,891 | ) |
Accounts
payable and accrued liabilities | |
| (110,110 | ) | |
| 211,771 | |
Operating
lease liability | |
| (167,319 | ) | |
| (179,009 | ) |
Taxes
payable | |
| (237,211 | ) | |
| 154,234 | |
Net
cash (used in) provided by operating activities | |
| (575,790 | ) | |
| 1,019,113 | |
| |
| | | |
| | |
Investing
activities | |
| | | |
| | |
Acquisition
of property, plant and equipment | |
| (5,244,011 | ) | |
| (285,103 | ) |
Proceeds
on disposal of property | |
| 8,093,448 | | |
| — | |
Deposit
paid | |
| (374,000 | ) | |
| (50,000 | ) |
Net
cash provided by (used in) investing activities | |
| 2,475,437 | | |
| (335,103 | ) |
| |
| | | |
| | |
Financing
activities | |
| | | |
| | |
Repayment
of mortgage loans | |
| (58,320 | ) | |
| (88,586 | ) |
Proceeds
from convertible loans | |
| 150,000 | | |
| — | |
Repayment
of convertible loans | |
| (1,124,442 | ) | |
| — | |
Repayment
of federal assistance loans | |
| (10,855 | ) | |
| — | |
Proceeds
from short term loans | |
| 223,500 | | |
| 160,000 | |
Repayment
of short term loans | |
| (568,325 | ) | |
| (289,044 | ) |
Repayment
of third party loans | |
| (361,260 | ) | |
| (77,953 | ) |
Repayment
of finance leases | |
| (5,907 | ) | |
| (5,531 | ) |
Proceeds
from receivables funding | |
| 580,646 | | |
| 440,000 | |
Repayment
of receivables funding | |
| (848,417 | ) | |
| (80,000 | ) |
Proceeds
from related party notes | |
| — | | |
| 334,299 | |
Repayment
of related party notes | |
| (76,296 | ) | |
| — | |
Net
cash (used in) provided by financing activities | |
| (2,099,676 | ) | |
| 393,185 | |
| |
| | | |
| | |
Effect
of exchange rate on cash | |
| 71,000 | | |
| (564,934 | ) |
| |
| | | |
| | |
Net
change in cash | |
| (129,029 | ) | |
| 512,261 | |
Beginning
cash balance | |
| 140,757 | | |
| 48,822 | |
Ending
cash balance | |
$ | 11,728 | | |
$ | 561,083 | |
| |
| | | |
| | |
Supplemental
cash flow information | |
| | | |
| | |
Cash
paid for interest | |
$ | 334,735 | | |
$ | 158,511 | |
Cash
paid for income taxes | |
$ | — | | |
$ | — | |
| |
| | | |
| | |
Non-cash
investing and financing activities | |
| | | |
| | |
Conversion
of convertible notes | |
$ | — | | |
$ | 150,000 | |
The
accompanying notes are an integral part of the unaudited condensed consolidated financial statements
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Nature
of business
Since
2010, the Company has operated addiction treatment centers. Initially the Company operated an addiction treatment center in Ontario Canada
under its Greenestone Muskoka clinic, which was sold on February 14, 2017. Simultaneously with this sale the Company purchased buildings
and operated an addiction treatment center in Delray Beach, Florida under its Addiction Recovery Institute of America subsidiary with
a license obtained in December 2016, initially through owned properties in Delray Beach and subsequently though leased properties in
West Palm Beach, Florida. Since June 30, 2020, the Company has been actively involved in the management of a treatment center operated
by Evernia in West Palm Beach, Florida. On July 1, 2021, the Company closed on the acquisition of 75% of ATHI, which owns 100% of Evernia,
once the probationary approval of a license was obtained from the Department of Children and Family Services of Florida. Evernia is the
only active treatment center operated by the Company.
The
Company also owned the real estate on which its Greenstone Muskoka clinic operated. The current tenant operates an addiction treatment
center on these premises. The Company collected rent on this property, which is treated as a separate business segment. On
June 30, 2023, the Company sold Cranberry Cove Holdings, in which the real estate was registered to Leonite Capital, in exchange for
the cancellation of preferred shares and the accrued dividend liability owed on the preferred shares.
2. Summary
of significant accounting policies
Financial
Reporting
The
(a) unaudited condensed consolidated balance sheets as of September 30, 2023, and as of December 31, 2022, which has been derived from
audited consolidated financial statements, and (b) the unaudited condensed consolidated statements of operations, stockholders’
deficit and cash flows of the Company, have been prepared in accordance with accounting principles generally accepted in the
United States (“US GAAP”) for interim financial information and the instructions to Form 10-Q and Rule 8-03 of Regulation
S-X. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements. In
the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have
been included. Operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of results that
may be expected for the year ending December 31, 2023. These unaudited condensed consolidated financial statements should be read in
conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Form 10-K for the year
ended December 31, 2022, filed with the Securities and Exchange Commission (“SEC”) on March 31, 2023.
All
amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless
stated otherwise.
a) Use
of Estimates
The
preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting
periods. Actual results could differ from those estimates.
b) Principles
of consolidation and foreign translation
The
accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all of its subsidiaries. All
intercompany transactions and balances have been eliminated on consolidation.
Certain
of the Company’s subsidiaries functional currency is the Canadian dollar, while the Company’s reporting currency is the U.S.
dollar. All transactions initiated in Canadian dollars are translated into US dollars in accordance with ASC 830, “Foreign Currency
Translation” as follows:
|
● |
Monetary
assets and liabilities at the rate of exchange in effect at the balance sheet date. |
|
● |
Certain
non-monetary assets and liabilities and equity at historical rates. |
|
● |
Revenue
and expense items and cash flows at the average rate of exchange prevailing during the year. |
Adjustments
arising from such translations are deferred until realization and are included as a separate component of stockholders’ deficit
as a component of accumulated other comprehensive income or loss. Therefore, translation adjustments are not included in determining
net income (loss) but reported as other comprehensive income (loss).
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
2.
Summary of significant accounting policies (continued)
b) Principles
of consolidation and foreign translation (continued)
For
foreign currency transactions, the Company translates these amounts to the Company’s functional currency at the exchange rate effective
on the invoice date. If the exchange rate changes between the time of purchase and the time actual payment is made, a foreign exchange
transaction gain or loss results which is included in determining net income for the year.
On
June 30, 2023, the Company disposed on Cranberry Cove Holdings whose functional currency was Canadian Dollars, all remaining subsidiaries
have the U.S. dollar as a functional currency.
The
relevant translation rates are as follows: The Company disposed of Cranberry cove Holdings on June 30, 2023, the exchange rates used
for the six months in which it had control over Cranberry cove holdings was as follows; for the six months ended June 30, 2023, a closing
rate of CDN$1 equals US$0.7553 and an average exchange rate of CDN$1 equals US$0.7420, and for the year ended December 31, 2022, a closing
rate of CDN$1.0000 equals US$0.7383 and an average exchange rate of CDN$1.0000 equals US$0.7686.
c) Cash
and cash equivalents
For
purposes of the statements of cash flows, the Company considers all highly liquid instruments purchased with a maturity of three months
or less and money market accounts to be cash equivalents. The Company maintains cash and cash equivalents with several financial institutions
in the USA and Canada. There were no cash equivalents at September 30, 2023 and December 31, 2022.
The
Company primarily places cash balances in the USA with high-credit quality financial institutions located in the United States which
are insured by the Federal Deposit Insurance Corporation up to a limit of $250,000 per institution, in Canada which are insured
by the Canadian Deposit Insurance Corporation up to a limit of CDN$100,000 per institution.
d) Accounts
receivable
Accounts
receivable primarily consists of amounts due from third-party payors (non-governmental) and private pay patients and is recorded net
of allowances for doubtful accounts and contractual discounts. The Company’s ability to collect outstanding receivables is critical
to its results of operations and cash flows. Accordingly, accounts receivable reported in the Company’s unaudited condensed consolidated
financial statements is recorded at the net amount expected to be received. The Company’s primary collection risks are (i) the
risk of overestimating net revenues at the time of billing that may result in the Company receiving less than the recorded receivable,
(ii) the risk of non-payment as a result of commercial insurance companies denying claims, (iii) the risk that patients will
fail to remit insurance payments to the Company when the commercial insurance company pays out-of-network claims directly to the patient,
(iv) resource and capacity constraints that may prevent the Company from handling the volume of billing and collection issues in
a timely manner, (v) the risk that patients do not pay the Company for their self-pay balances (including co-pays, deductibles and
any portion of the claim not covered by insurance) and (vi) the risk of non-payment from uninsured patients.
e) Allowance
for Doubtful Accounts, Contractual and Other Discounts
The
Company derives the majority of its revenues from commercial payors at in-network rates. The Company recognizes revenue based on historical
collections received from healthcare providers, recognizing only a percentage of revenues actually billed. Effectively recognizing revenue
net of any expected billing differentials. Based on the Company’s collection experience, the percentage of revenue recognized is
adjusted on a periodic basis, thereby taking into account expected credit losses in the revenue recognition process. The revenue we recognize
is already net of expected credit losses, therefore management does not maintain a separate allowance for doubtful accounts, contractual
and other discounts.
Management
also takes into consideration the age of accounts, creditworthiness and current economic trends when evaluating the percentage of revenue
to be recognized.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
2.
Summary of significant accounting policies (continued)
f) Property
and equipment
Property
and equipment is recorded at cost. Depreciation is calculated on the straight line basis over the estimated life of the asset.
g) Intangible
assets
Intangible
assets are stated at acquisition cost less accumulated amortization, if applicable, less any adjustments for impairment losses.
Amortization
is charged on a straight-line basis over the estimated remaining useful lives of the individual intangibles. Where intangibles are deemed
to be impaired the Company recognizes an impairment loss measured as the difference between the estimated fair value of the intangible
and its book value.
Licenses
to provide substance abuse rehabilitation services are amortized over the expected life of the contract, including any anticipated renewals.
The Company expects its licenses to remain in operation for a period of five years.
h) Leases
The
Company accounts for leases in terms of AC 842 whereby leases are classified as either finance or operating leases. Leases that transfer
substantially all of the benefits and inherent risks of ownership of property to the Company are accounted for as finance leases. At
the time a finance lease is entered into, an asset is recorded together with its related long-term obligation to reflect the acquisition
and financing. Property and equipment recorded under finance leases is amortized on the same basis as described above. Operating leases
are recognized on the balance sheet as a lease liability with a corresponding right of use asset for all leases with a term that is more
than twelve months. Payments under operating leases are expensed as incurred.
i) Derivatives
The
Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine
whether the embedded conversion feature should be bifurcated from the host instrument and accounted for as a derivative at fair value
with changes in fair value recorded in earnings. The Company previously used a Black Scholes Option Pricing model to estimate the fair
value of convertible debt conversion features at the end of each applicable reporting period. Changes in the fair value of these derivatives
during each reporting period were included in the statements of operations. Inputs into the Black Scholes Option Pricing model require
estimates, including such items as estimated volatility of the Company’s stock, risk free interest rate and the estimated life
of the financial instruments being fair valued.
j) Financial
instruments
The
Company initially measures its financial assets and liabilities at fair value. The Company subsequently measures all its financial assets
and financial liabilities at amortized cost.
Financial
assets measured at amortized cost include cash and accounts receivable.
Financial
liabilities measured at amortized cost include bank indebtedness, accounts payable and accrued liabilities, harmonized sales tax payable,
withholding taxes payable, convertible notes payable, loans payable and related party notes.
Financial
assets measured at cost are tested for impairment when there are indicators of impairment. The amount of the write-down is recognized
in net income. The previously recognized impairment loss may be reversed to the extent of the improvement, directly or by adjusting the
allowance account, provided it is no greater than the amount that would have been reported at the date of the reversal had the impairment
not been recognized previously. The amount of the reversal is recognized in net income. The Company recognizes its transaction costs
in net income in the period incurred. However, financial instruments that will not be subsequently measured at fair value are adjusted
by the transaction costs that are directly attributable to their origination, issuance or assumption.
FASB
ASC 820 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles,
and expands disclosures about fair value measurements. ASC 820 establishes a three tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value as follows:
|
· |
Level 1. Observable
inputs such as quoted prices in active markets; |
|
· |
Level 2. Inputs,
other than the quoted prices in active markets, that are observable either directly or indirectly; and |
|
· |
Level 3. Unobservable
inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions. |
The
Company measures its convertible debt and derivative liabilities associated therewith at fair value. These liabilities are revalued periodically
and the resultant gain or loss is realized through the consolidated Statement of Operations and Comprehensive Loss
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
2.
Summary of significant accounting policies (continued)
k) Related
parties
Parties
are considered to be related to the Company if the parties directly or indirectly, through one or more intermediaries, control, are controlled
by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members
of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if
one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting
parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All
transactions are recorded at fair value of the goods or services exchanged.
l) Revenue
recognition
ASC
606 requires companies to exercise more judgment and recognize revenue using a five-step process.
The
Company’s provision for doubtful accounts are recorded as a direct reduction to revenue instead of being presented as a separate
line item on the consolidated statements of operations and comprehensive loss.
As
our performance obligations relate to contracts with a duration of one year or less, the Company elected the optional exemption in ASC
606-10-50-14(a). Therefore, the Company is not required to disclose the transaction price for the remaining performance obligations at
the end of the reporting period or when the Company expects to recognize the revenue. The Company has minimal unsatisfied performance
obligations at the end of the reporting period as our patients typically are under no obligation to remain admitted in our facilities.
The
Company receives payments from the following sources for services rendered in our U.S. Facility: (i) commercial insurers; and (ii) individual
patients and clients. As the period between the time of service and time of payment is typically one year or less, the Company elected
the practical expedient under ASC 606-10-32-18 and does not adjust for the effects of a significant financing component.
The
Company derives a significant portion of its revenue from other payors that receive discounts from established billing rates. The various
managed care contracts under which these discounts must be calculated are complex, subject to interpretation and adjustment, and may
include multiple reimbursement mechanisms for different types of services provided in the Company’s inpatient facilities and cost
settlement provisions. Management estimates the transaction price on a payor-specific basis given its interpretation of the applicable
regulations or contract terms. The services authorized and provided and related reimbursement are often subject to interpretation that
could result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract renegotiations
occur frequently, necessitating regular review and assessment of the estimation process by management.
Settlements
with third-party payors are estimated and recorded in the period in which the related services are rendered and are adjusted in future
periods as final settlements are determined. In the opinion of management, adequate provision has been made for any adjustments and final
settlements. However, there can be no assurance that any such adjustments and final settlements will not have a material effect on the
Company’s financial condition or results of operations. The Company’s receivables were $681,072, $337,074 and $176,011 at
September 30, 2023, December 31, 2022 and December 31, 2021, respectively. Management believes that these receivables are properly stated
and are not likely to be settled for a significantly different amount.
The
Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that
reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from
the sale of its services. The Company applies the following five steps in order to determine the appropriate amount of revenue to
be recognized as it fulfills its obligations under each of its revenue transactions:
|
i. |
identify the
contract with a customer; |
|
ii. |
identify the
performance obligations in the contract; |
|
iii. |
determine the
transaction price; |
|
iv. |
allocate the
transaction price to performance obligations in the contract; and |
|
v. |
recognize revenue
as the performance obligation is satisfied. |
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
2.
Summary of significant accounting policies (continued)
m) Income
taxes
The
Company accounts for income taxes under the provisions of ASC Topic 740, “Income Taxes”. Under ASC Topic
740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated
financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred income taxes are provided
using the liability method. Under this method, deferred income taxes are recognized for the tax consequences of temporary differences
by applying enacted statutory rates applicable to future years to differences between the financial statement carrying amounts and the
tax bases of existing assets and liabilities. The tax basis of an asset or liability is the amount attributed to that asset or liability
for tax purposes. The effect on deferred taxes of a change in tax rates is recognized in income in the period of change. A valuation
allowance is provided to reduce the amount of deferred tax assets if it is considered more likely than not that some portion of, or all
of, the deferred tax assets will not be realized.
ASC Topic
740 contains a two-step approach to recognizing and measuring uncertain tax positions taken or expected to be taken in a tax return.
The first step is to determine if the weight of available evidence indicates that it is more likely than not that the tax position will
be sustained in an audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax
benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company recognizes interest and
penalties accrued on unrecognized tax benefits within general and administrative expense. To the extent that accrued interest and penalties
do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction in general and administrative expenses
in the period that such determination is made. The tax returns for fiscal 2019, through 2022 are subject to audit or review by the US
tax authorities, whereas fiscal 2011 through 2022 are subject to audit or review by the Canadian tax authority.
n) Net
income per Share
Basic
net income per share is computed on the basis of the weighted average number of common stock outstanding during the year.
Diluted
net income per share is computed on the basis of the weighted average number of common stock and common stock equivalents outstanding.
Dilutive securities having an anti-dilutive effect on diluted net income per share are excluded from the calculation.
Dilution
is computed by applying the treasury stock method for options and warrants. Under this method, “in-the money” options and
warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained
thereby were used to purchase common stock at the average market price during the period. Dilution is computed by applying the if-converted
method for convertible preferred stocks. Under this method, convertible preferred stock is assumed to be converted at the beginning of
the period (or at the time of issuance, if later), and preferred dividends (if any) will be added back to determine income applicable
to common stock. The shares issuable upon conversion will be added to weighted average number of common stock outstanding. Conversion
will be assumed only if it reduces earnings per share (or increases loss per share).
o) Stock
based compensation
Stock
based compensation cost is measured at the grant date, based on the estimated fair value of the award and is recognized as expense over
the employee’s requisite service period or vesting period on a straight-line basis. Share-based compensation expense recognized
in the consolidated statements of operations for the nine months ended September 30, 2023 and 2022 is based on awards ultimately expected
to vest and has been reduced for estimated forfeitures. This estimate will be revised in subsequent periods if actual forfeitures differ
from those estimates. We have no awards with performance conditions and no awards dependent on market conditions.
There
were no stock -based compensation awards that vested during the nine months ended September 30, 2023 and 2022 and there was no stock based
compensation recorded in the unaudited condensed consolidated financial statements.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
2.
Summary of significant accounting policies (continued)
p) Financial
instruments risks
The
Company is exposed to various risks through its financial instruments. The following analysis provides a measure of the Company’s
risk exposure and concentrations at the balance sheet dates, September 30, 2023 and December 31, 2022.
Credit
risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an
obligation. Financial instruments that subject the Company to credit risk consist primarily of accounts receivable.
Credit
risk associated with accounts receivable is mitigated as only a percentage of the revenue billed to health insurance companies is recognized
as income until such time as the actual funds are collected. The revenue is concentrated amongst several health insurance companies located
in the US.
In
the opinion of management, credit risk with respect to accounts receivable is assessed as low.
Liquidity
risk is the risk the Company will not be able to meet its financial obligations as they fall due. The Company is exposed to liquidity
risk through its working capital deficiency of approximately $6.9 million, and an accumulated deficit of approximately $42.0 million.
The Company is dependent upon the raising of additional capital in order to implement its business plan. There is no assurance that the
Company will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect
on the Company’s financial condition. In the opinion of management, liquidity risk is assessed as high, material and remains unchanged
from that of the prior year.
Market
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices.
Market risk comprises of three types of risk: interest rate risk, currency risk, and other price risk. The Company is exposed to interest
rate risk.
Interest
rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
interest rates. The Company is exposed to interest rate risk on its convertible debt, short term loans, third party loans and government
assistance loans as of September 30, 2023. In the opinion of management, interest rate risk is assessed as moderate.
Currency
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange
rates. The Company is no longer subject to currency risk as it has disposed of its subsidiaries that operated in Canada.
Other
price risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
prices (other than those arising from interest rate risk or currency risk), whether those changes are caused by factors specific to the
individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market. In the opinion
of management, the Company is not exposed to this risk and remains unchanged from the prior year.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
2.
Summary of significant accounting policies (continued)
q) Allowance
for credit losses
The
Company recognizes revenue based on historical collections received from healthcare providers, recognizing only a percentage of revenues
actually billed. Effectively recognizing revenue net of any expected billing differentials. Based on the Company’s collection experience,
the percentage of revenue recognized is adjusted on a periodic basis, thereby taking into account expected credit losses in the revenue
recognition process. The revenue we recognize is already net of expected credit losses.
We
constantly evaluate our collections experience and consider the market conditions and current economic developments facing the Company’s
operations . We have not experienced significantly different collections to revenues we have recognized and we have not seen any deterioration
in the payment patterns from the healthcare providers that the Company works with, we cannot predict with any certainty that the payment
patterns the Company experiences may change and we may be required to adjust the percentage of revenue recognized.
r) Recent
accounting pronouncements
The
Financial Accounting Standards Board (“FASB”) issued additional updates during the nine months ended September 30, 2023.
None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material
impact on the Company’s consolidated financial statements upon adoption.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
3. Going
concern
The
Company’s unaudited condensed consolidated financial statements have been prepared in accordance with US GAAP applicable to a going
concern, which assumes that the Company will be able to meet its obligations and continue its operations in the normal course of business.
At September 30, 2023 the Company has a working capital deficiency of $6.9 million, and total liabilities in excess of assets in
the amount of $5.5 million. Management believes that current available resources will not be sufficient to fund the Company’s
planned expenditures over the next 12 months. These factors, individually and collectively indicate that a material uncertainty exists
that raises substantial doubt about the Company's ability to continue as a going concern for one year from the date of issuance of these
condensed interim consolidated financial statements.
The
Company will be dependent upon the raising of additional capital through placement of common shares, and/or debt financing in order to
implement its business plan and generating sufficient revenue in excess of costs. If the Company raises additional capital through the
issuance of equity securities or securities convertible into equity, stockholders will experience dilution, and such securities may have
rights, preferences or privileges senior to those of the holders of common stock or convertible senior notes. If the Company raises additional
funds by issuing debt, the Company may be subject to limitations on its operations, through debt covenants or other restrictions. If
the Company obtains additional funds through arrangements with collaborators or strategic partners, the Company may be required to relinquish
its rights to certain geographical areas, or techniques that it might otherwise seek to retain. There is no assurance that the Company
will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect on the
Company’s financial condition. These unaudited condensed consolidated financial statements do not include any adjustments to the
amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.
4. Disposal
of subsidiary
On
June 30, 2023, the Company entered into an exchange agreement with Leonite Capital, LLC, whereby it exchanged the 400,000 Series B shares
with a value of $400,000 plus accrued dividends thereon of $61,184 for its entire shareholding in its property owning subsidiary, Cranberry
Cove Holdings. The Series B shares were cancelled upon consummation of the transaction.
Immediately
prior to the disposal of Cranberry Cove Holdings, the Company assumed the loan owed to a third party of $779,005 and the loan owing to
Leon Developments of $1,973,837, Leon developments, a related party, owned by the Company’s CEO, Shawn Leon. In addition, the Company
forgave the intercompany debt owing by Cranberry Cove Holdings of $4,566,848.
The
assets and liabilities disposed of were as follows:
Schedule of Other Assets and Liabilities Disposed
| |
Net
book value |
Assets | |
| | |
Other
receivable | |
$ | 12,015 | |
Property
and equipment | |
| 2,420,499 | |
| |
| 2,432,514 | |
Liabilities | |
| | |
Accounts
payable and accrued liabilities | |
| (196,859 | ) |
Government
assistance loans | |
| (45,317 | ) |
Mortgage
loan | |
| (3,525,223 | ) |
| |
| (3,767,399 | ) |
| |
| | |
Disposal
of subsidiary to related party – recorded as additional paid in capital | |
$ | (1,334,885 | ) |
The
minority shareholders interest related to the Series A preferred stock in Cranberry Cove Holdings was recorded as a deemed contribution
to the Company and credited to additional paid in capital, resulting in a total credit to additional paid in capital of $2,034,885.
The
cancellation of the Series B shares, were owned by Leonite Capital, a related party, was deemed to be an extinguishment of debt by a related
party and recorded as a credit to additional paid in capital of $461,184.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
5. Property
and equipment
Acquisition
and simultaneous disposition of property
On
October 3, 2022 the Company entered into a purchase and sale agreement with Evernia Station Limited Partnership for the purchase of 950
Evernia Street, West Palm Beach, Florida (“950”), the property in which it operates its treatment center, for gross proceeds
of $5,500,000. (“Purchase Agreement”). The closing was originally scheduled for February 1, 2023, however through a series
of 6 addendums to the Purchase Agreement requiring the payment of a total $180,000 in extension fees, the Closing was extended to August
3, 2023.
On
February 27, 2023 the Company signed a listing agreement with Stream Capital Partners listing 950 for sale at a price of $9,568,000 with
the intention of identifying a buyer that would purchase and then potentially enter into a lease agreement with the Company.
On
May 4, 2023 the Company signed a Letter of Intent with Pontus Net Lease Advisers, LLC to sell 950 for $8,500,000 and lease the property
to the Company for a term of twenty years with two ten year extensions. On May 19, 2023, the Company signed a purchase and sale agreement
with Pontus Net Lease Advisors to sell 950 for $8,500,000. On August 4, 2023, the Company completed both the purchase of 950 from Evernia
Station Limited Partnership and the subsequent sale of 950 to Pontus Net Lease Advisors, LLC.
Simultaneously
with the closing of the purchase and sale agreements, on August 4, 2023, the Company entered into a long term lease for 950 with an initial
term of twenty years, and two ten year extension options. The lessor is Pontus EHC Palm Beach, LLC , a Delaware limited liability company
and a portfolio company of Pontus Net Lease Advisors, LLC. The lease is absolutely net and the lease cost for the initial year is $748,000
paid monthly. The lease increases at a rate of 2.75% per year for a total term lease obligation of $19,595,653 over the initial twenty-year
term. The Lease is personally guaranteed by the Company President and the guarantee may be released after 5 years based on certain financial
and performance metrics being met.
The
Company paid gross proceeds of $1,449,000 to Leonite Capital and Leonite Fund I, LP in settlement of all amounts outstanding to both
entities, disclosed in notes 8 and 9 above. In addition, $65,450 was paid to Ed Blasiak to settle the convertible promissory note disclosed
in note 8 above, $179,474 was paid to Joshua Bauman to settle the convertible promissory note disclosed in note 8 above, and $260,548
was paid to Mirage Realty, LLC to settle the senior secured promissory note, disclosed in note 9 above.
The
details of the property purchase and subsequent sale are as follows:
Property purchase and subsequent
| |
Amount |
Purchase
of 950 Evernia Street property | |
| | |
Purchase
price | |
$ | 5,500,000 | |
Fees
and expenses related to property purchase | |
| 109,276 | |
Total
acquisition cost | |
| 5,609,276 | |
| |
| | |
Proceeds
on sale | |
| 8,500,000 | |
Fees
and expenses related to disposal of the property | |
| (406,552 | ) |
Net
proceeds on disposal of property | |
| 8,093,448 | |
| |
| | |
Gain
on sale of property | |
$ | 2,484,172 | |
Property
and equipment consists of the following:
Schedule of sale of property
| |
| |
September
30, 2023 | |
December
31, 2022 |
| |
Useful lives | |
Cost | |
Accumulated
depreciation | |
Net
book value | |
Net
book value |
Land | |
Indefinite | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | 158,742 | |
Property | |
25 years | |
| — | | |
| — | | |
| — | | |
| 2,310,448 | |
Leasehold
improvements | |
Life of
lease | |
| 456,547 | | |
| (76,676 | ) | |
| 379,871 | | |
| 373,320 | |
Furniture
and fittings | |
6 years | |
| 149,260 | | |
| (41,234 | ) | |
| 108,026 | | |
| 92,941 | |
Vehicles | |
5 years | |
| 55,949 | | |
| (26,263 | ) | |
| 29,686 | | |
| 38,079 | |
Computer
equipment | |
3
years | |
| 7,525 | | |
| (1,409 | ) | |
| 6,116 | | |
| 865 | |
| |
| |
$ | 669,281 | | |
$ | (145,582 | ) | |
$ | 523,699 | | |
$ | 2,974,395 | |
Depreciation
expense for the three months ended September 30, 2023 and 2022 was $20,690 and $47,113, respectively, and for the nine months ended September
30, 2023 and 2022 was $119,773 and $134,366, respectively.
On
June 30, 2023, the Company sold its interest in Cranberry Cove Holdings to Leonite Capital, which includes the land and property and
the associated mortgage loan as disclosed in Note 10. Refer Note 4 above.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
6. Intangibles
Intangible
assets consist of the following:
Schedule of Intangible assets
|
|
Useful
lives |
|
September
30,
2023 |
|
December
31, 2022 |
|
|
|
|
Cost |
|
Accumulated
amortization |
|
Net
book value |
|
Net
book value |
Health care
Provider license |
|
5
years |
|
$ |
1,789,903 |
|
|
$ |
(805,456 |
) |
|
$ |
984,447 |
|
|
$ |
1,252,932 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
Company evaluates intangible assets for impairment on an annual basis during the last month of each year and at an interim date if indications
of impairment exist. Intangible asset impairment is determined by comparing the fair value of the asset to its carrying amount with an
impairment being recognized only when the fair value is less than carrying value and the impairment is deemed to be permanent in nature.
The
Company recorded $89,495 in amortization expense for finite-lived assets for each of the three months ended September 30, 2023 and
2022 and $268,485 for each of the nine months ended September 30, 2023 and 2022.
7. Leases
The
Company acquired ATHI on July 1, 2021, ATHI’s wholly owned subsidiary had entered into an operating lease agreement for certain
real property located at 950 Evernia Street, West Palm Beach, Florida, with effect from February 1, 2019 for a period
of three years, expiring on 1 February 2022. Under the terms of the lease agreement, the lease was extended during October 2021 for a
further 5 year period until 1 February 2027.
As
described in note 4 above, on October 3, 2022 the Company entered into a purchase and sale agreement with Evernia Station Limited Partnership
for the purchase of 950 Evernia Street, West Palm Beach, Florida, the property in which it operates its treatment center, for gross proceeds
of $5,500,000. On August 3, 2023, after 6 addendums to the agreement, the Company closed on the acquisition of the property. This resulted
in the termination of the lease with Evernia station, resulting in the reversal of the remaining right-of-use asset of $1,226,080 and
the associated operating lease liability of $1,328,803, which liability included $102,723 of accrued rental, which was offset against
the rental expense.
On
August 4, 2023, the Company entered into a long term lease for 950 Evernia Street, West Palm Beach, Florida with an initial term of twenty
years, and two ten year extension options. The lessor is Pontus EHC Palm Beach, LLC , a Delaware limited liability company and a portfolio
company of Pontus Net Lease Advisors, LLC. The lease is absolutely net and the lease cost for the initial year is $748,000 paid monthly.
The lease increases at a rate of 2.75% per year for a total term lease obligation of $19,595,653 over the initial twenty-year term. The
Lease is personally guaranteed by the Company President and the guarantee may be released after 5 years based on certain financial and
performance metrics being met. Due to the initial lease term of twenty years, the Company is not certain that the extension periods will
be exercised at this point in time and accordingly, these have been excluded from the present value of the minimum future lease payments.
To determine the
present value of minimum future lease payments for operating leases at August 4, 2023, the Company was required to estimate a rate of
interest that we would have to pay to borrow on a collateralized basis over a similar term in a similar economic environment (the "incremental
borrowing rate" or "IBR").
The Company determined
the appropriate IBR by identifying a reference rate and making adjustments that take into consideration financing options and certain
lease-specific circumstances. For the reference rate, the Company used the Fannie Mae, in excess of $3,000,000 rate based on an 80% value
to loan ratio, averaging the 15 and 30 year indicative rates, resulting in a rate of 7.70%. The Company determined that 7.70% per
annum was an appropriate incremental borrowing rate to apply to its real-estate operating lease.
The
present value of the future minimum lease payments was valued at $9,333,953 on August 4, 2023.
Right of use assets are included in the consolidated balance sheet are as follows:
Schedule of Right of use assets
| |
September
30, 2023 | |
December
31, 2022 |
Non-current
assets | |
| | | |
| | |
Right-of-use
assets – finance leases, net of depreciation, included in Property and equipment | |
$ | 26,937 | | |
$ | 38,079 | |
Right-of-use
assets - operating leases, net of amortization | |
$ | 9,331,261 | | |
$ | 1,393,071 | |
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
7.
Leases (continued)
Lease
costs consists of the following:
Schedule of finance and operating lease
| |
| |
|
| |
Nine
months ended September 30, |
| |
2023 | |
2022 |
Finance lease cost: | |
| | | |
| | |
Amortization of
right-of-use assets | |
$ | 8,392 | | |
$ | 8,392 | |
Interest
expense on finance lease liabilities | |
| 1,504 | | |
| 1,880 | |
| |
| 9,896 | | |
| 10,272 | |
| |
| | | |
| | |
Operating
lease cost | |
$ | 446,189 | | |
$ | 194,086 | |
Lease
cost | |
$ | 456,085 | | |
$ | 204,358 | |
Other
lease information:
Schedule of Other lease
| |
|
|
|
|
|
|
| |
Nine
months ended September 30, |
| |
2023 | |
2022 |
Cash paid for amounts included
in the measurement of lease liabilities | |
| |
|
Operating cash
flows from finance leases | |
$ | (1,504 | ) | |
$ | (1,880 | ) |
Operating cash flows from
operating leases | |
| (446,189 | ) | |
| (199,539 | ) |
Financing
cash flows from finance leases | |
| (5,868 | ) | |
| (5,492 | ) |
Cash
paid for amounts included in the measurement of lease liabilities | |
$ | (453,361 | ) | |
$ | (204,479 | ) |
| |
| | | |
| | |
Weighted average lease term
– finance leases | |
| 3
years and 2 months | | |
| 4
years and 1 months | |
Weighted average remaining
lease term – operating leases | |
| 19
years and 11 months | | |
| 4
years and 4 months | |
| |
| | | |
| | |
Discount rate – finance
leases | |
| 6.60 | % | |
| 6.61 | % |
Discount rate – operating
leases | |
| 7.70 | % | |
| 4.64 | % |
Maturity
of Leases
Finance
lease liability
The
amount of future minimum lease payments under finance leases as of September 30, 2023 is as follows:
Schedule of Finance lease liability
| |
Amount |
Remainder of 2023 | |
$ | 2,457 | |
2024 | |
| 9,829 | |
2025 | |
| 9,829 | |
2026 | |
| 6,195 | |
2027 | |
| 1,707 | |
| |
| 30,017 | |
Imputed interest | |
| (3,080 | ) |
Total finance lease liability | |
$ | 26,937 | |
Disclosed as: | |
| | |
Current portion | |
$ | 8,289 | |
Non-Current portion | |
| 18,648 | |
Lease liability | |
$ | 26,937 | |
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
7.
Leases (continued)
Operating
lease liability
The
amount of future minimum lease payments under operating leases are as follows:
Schedule of Operating lease liability
| |
Amount |
| |
|
Remainder of 2023 | |
$ | 249,333 | |
2024 | |
| 754,857 | |
2025 | |
| 775,615 | |
2026 | |
| 796,945 | |
2027 | |
| 818,861 | |
| |
| 16,200,042 | |
Total undiscounted minimum future lease payments | |
| 19,595,653 | |
Imputed interest | |
| (10,223,673 | ) |
Total operating lease liability | |
$ | 9,371,980 | |
| |
| | |
Disclosed as: | |
| | |
Current portion | |
$ | 32,753 | |
Non-Current portion | |
| 9,339,227 | |
Lease liability | |
$ | 9,371,980 | |
Lessor
Property
Prior
to the disposal of the Company’s wholly owned subsidiary CCH on June 30, 2023, the company owned a property located at 3571
Muskoka Road, #169, Bala, on which the operations of the Canadian Rehab Clinic were located prior to disposal on February 14, 2017. The
property was leased to the purchasers of the business of the Canadian Rehab Clinic, initially for a period of 5 years, which was renewed
for an additional 5 years, with a further two 5 year renewal periods available to the lessee.
The
Lease was considered in terms of ASC 842, Leases and determined to be an operating lease as the criteria for the lease to be a sales-type
lease or a direct financing lease were not met, including the possibility of the lessee exercising the option to purchase the property
being considered as remote.
The
Company derived rental income of CDN$243,288 ($180,522) for the six months ended June 30, 2023, the date of disposal of CCH and the property,
see Note 4 above.
8. Short-term
Convertible Notes
The
short-term convertible notes consist of the following:
Schedule of short-term convertible notes
|
|
Interest
rate |
|
Maturity
Date |
|
Principal |
|
Interest |
|
September
30, 2023 |
|
December
31, 2022 |
Leonite Capital, LLC |
|
|
12.0 |
% |
|
On Demand |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
184,749 |
|
Leonite Fund I, LP |
|
|
Variable |
|
|
On Demand |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
720,830 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auctus Fund, LLC |
|
|
0.0 |
% |
|
On Demand |
|
|
70,000 |
|
|
|
— |
|
|
|
70,000 |
|
|
|
80,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Labrys Fund, LP |
|
|
12.0 |
% |
|
On Demand |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
8,826 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ed Blasiak |
|
|
6.5 |
% |
|
On Demand |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
63,322 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joshua Bauman |
|
|
11.0 |
% |
|
October 21, 2022 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
169,710 |
|
|
|
|
10.0 |
% |
|
August 9, 2023 |
|
|
150,000 |
|
|
|
2,131 |
|
|
|
152,131 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series N convertible notes |
|
|
6.0 |
% |
|
On Demand |
|
|
3,229,000 |
|
|
|
957,078 |
|
|
|
4,186,078 |
|
|
|
4,041,813 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3,449,000 |
|
|
$ |
959,209 |
|
|
$ |
4,408,209 |
|
|
$ |
5,269,250 |
|
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
8.
Short-term Convertible Notes (continued)
Leonite
Capital, LLC
On
July 12, 2020, the Company entered into a Senior Secured Convertible Note agreement with Leonite for $440,000 with an original issue
discount of $40,000 for gross proceeds of $400,000, the initial tranche advanced will be for cash of $200,000 plus the OID
of $20,000, the remaining advances will be at the discretion of the Leonite. The loan bears interest at 6.5% per annum and matures
on June 12, 2021. The Company is required to make monthly payments of the accrued interest on the advances made. The note is convertible
into common shares at the option of the holder at $0.10 per share, or 80% multiplied by the price per share paid in subsequent financings
or after a six month period from the effective date at 60% of the lowest trading price during the preceding 21 consecutive trading days.
The note has both conversion price protection and anti-dilution protection provisions.
On
February 28, 2022, in terms of a conversion notice, Leonite converted the principal sum of $149,250 of the Leonite Note into 150,000,000 shares
of common stock at a conversion price of $0.0010 per share.
On
March 1, 2023, the Company entered into a forbearance agreement with Leonite whereby the parties agreed to extend the maturity date of
the note to June 8, 2023, the Company will continue to pay interest on the note, until repaid. On August 4, 2023, the Company settled
all outstanding liabilities owing to Leonite Capital and Leonite fund I, L.P. for gross proceeds of $1,449,000.
Leonite
Fund I, LP
Effective
June 1, 2022, the Company entered into a Note Exchange Agreement whereby the convertible promissory notes entered into with Labrys Fund
LP on May 7, 2021, with an outstanding principal balance of $341,000, and on June 2, 2021, with an outstanding principal balance of $230,000
and accrued interest thereon of $25,300, were exchanged for a new Senior Secured Convertible Promissory note in the principal amount
of $745,375, including an OID of $149,075. The Note matured on March 1, 2023, and bore interest at the minimum of 10% per annum or the
Wall Street Journal quoted prime rate plus 5.75%.
Interest
is payable monthly and the note may be prepaid with a prepayment penalty of 10%. The note is convertible into common stock
at a fixed conversion price of $0.01 per share, subject to anti-dilution adjustments and a fundamental transaction clause allowing the
note holder to receive the same consideration as common stockholders would receive.
The
convertible note is secured by all of the assets of Ethema Health Corporation and Addiction Recovery Institute of America, LLC.
On
March 1, 2023, the Company entered into a forbearance agreement with Leonite whereby the parties agreed to extend the maturity date of
the note to June 8, 2023, the Company will continue to pay interest on the note, until repaid. On August 4, 2023, the Company
settled all outstanding liabilities owing to Leonite Capital and Leonite fund I, L.P. for gross proceeds of $1,449,000.
Auctus
Fund, LLC
On
August 7, 2019, the Company, entered into a Securities Purchase Agreement with Auctus Fund, LLC, pursuant to which the Company issued
a Convertible Promissory Note in the aggregate principal amount of $225,000. The Note had a maturity date of May 7, 2020 and
bore interest at the rate of ten percent per annum from the date on which the Note was issued until the same became due and payable,
whether at maturity or upon acceleration or by prepayment or otherwise. The Company had the right to prepay the Note in terms of agreement.
The outstanding principal amount of the Note is convertible at any time and from time to time at the election of Auctus Fund, LLC during
the period beginning on the date that is 180 days following the issue date into shares of the Company’s common stock at a conversion
price equal to 60% of the lowest closing bid price of the Company’s common stock for the thirty trading days prior to conversion.
On
June 15, 2020, The Company entered into an amended agreement with Auctus whereby the Company agreed to discharge the principal amount
of the note by nine equal monthly installments of $25,000 commencing in October 2020. During the year ended December 31, 2021, the
Company repaid Auctus the principal sum of $50,000.
During
March 2022, the Company paid $20,000 of principal on the convertible note, thereby reducing the principal outstanding to $80,000. The
note matured May 7, 2020, Auctus Fund LLC has not declared a default and we are in discussion with the lender on settling the note.
During
February 2023, the Company paid $10,000 of principal on the convertible note, thereby reducing the principal outstanding to $70,000.
The note matured May 7, 2020, Auctus Fund LLC has not declared a default and we are in constant in constant discussion with the lender
on settling the note.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
8.
Short-term Convertible Notes (continued)
Ed
Blasiak
On
September 14, 2020, the Company entered into a Securities Purchase Agreement with Ed Blasiak (“Blasiak”), pursuant to which
the Company issued a senior secured convertible promissory note in the aggregate principal amount of $55,000, including an original issue
discount of $5,000. The note bears interest at 6.5% per annum and matured on September 14, 2021. The note is senior to any
future borrowings and commencing on October 1, 2020 the Company will make monthly payments of the accrued interest under the note. The
note may be prepaid at certain prepayment penalties and is convertible into shares of common stock at a conversion price at the option
of the holder at $0.001 per share, adjusted for anti-dilution provisions; or 80% of the price per share of subsequent equity financings
or; after six months 60% of the lowest trading price during the preceding six month period.
The
note had matured and was in default, Ed Blasiak has not declared a default under the note. On August 4, 2023, the Company settled
the senior secured convertible promissory note owing to Ed Blasiak for proceeds of $65,450.
Joshua
Bauman
On
October 21, 2021, the Company entered into a Securities Purchase Agreement with Bauman, pursuant to which the Company issued a senior
secured convertible promissory note in the aggregate principal amount of $150,000, including an original issue discount of $16,250. The
note bears interest at 11.0% per annum, which is guaranteed and earned in full on issue date and matured on October 21, 2022.
The note is convertible into shares of common stock at a conversion price at the option of the holder at $0.001 per share, adjusted for
anti-dilution provisions.
The
note had matured and was in default, Mr. Bauman has not declared a default under the note. On August 4, 2023, the Company settled
the senior secured convertible promissory note owing to Mr. Bauman for proceeds of $179,474.
On
August 9, 2023, the Company issued a convertible promissory note to Bauman, in the aggregate principal amount of $150,000. The note bears
interest at 10.0% per annum and matures on August 9, 2024. The note is convertible into shares of common stock at a conversion price
at the option of the holder at $0.001 per share, adjusted for anti-dilution provisions. The note is convertible into common stock at
the option of the holder after the expiration of six months from the issuance date, in addition, should the note reach its maturity date,
August 9, 2024, the note will automatically convert into shares of common stock at the conversion price, subject to anti-dilution provisions.
Series
N convertible notes
Between
January 28, 2019 and June 11, 2020, the Company closed several tranches of Series N Convertible notes in which it raised $3,229,000 in
principal from accredited investors through the issuance to the investors of the Company’s Series N convertible notes, in the total
original principal amount of $3,229,000, which Notes are convertible into the Company’s common stock at a conversion price of $0.08 per
share together with three year warrants to purchase up to a total of 52,237,500 shares of the Company’s common stock
at an exercise price of $0.12 per share. Both the conversion price under the Notes and the exercise price under the warrants are
subject to standard adjustment mechanisms. The notes matured one year from the date of issuance.
The
series N convertible notes matured and are in default. The Company is considering its options to settle these notes.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
9. Short-term
Notes
Leonite
Capital, LLC
Secured
Promissory Notes
On
March 1, 2022, the Company entered into a secured Promissory Note in the aggregate principal amount of $124,000 for net proceeds
of $100,000 after an original issue discount of $24,000. Due to the failure to repay the note by due date, a penalty of $37,200
was added to the principal outstanding and the Company incurs a monthly monitoring fee of $2,000 per month. In addition the note earns
interest at a default rate of 24% per annum on the total balance outstanding, including the monthly monitoring fee and accrued interest.
The
Note had a maturity date of April 1, 2022. On August 4, 2023, the Company settled all outstanding liabilities owing to Leonite Capital
and Leonite fund I, L.P. for gross proceeds of $1,449,000.
On
May 3, 2022, the Company, entered into a secured Promissory Note in the aggregate principal amount of $76,250 for net proceeds of
$61,000 after an original issue discount of $15,250. Due to the failure to repay the note by due date, a penalty of $22,875 was
added to the principal outstanding and the Company incurs a monthly monitoring fee of $2,000 per month. In addition the note earns interest
at a default rate of 24% per annum on the total balance outstanding, including the monthly monitoring fee and accrued interest.
The
Note had a maturity date of June 17, 2022. On August 4, 2023, the Company settled all outstanding liabilities owing to Leonite
Capital and Leonite fund I, L.P. for gross proceeds of $1,449,000.
Mirage
Realty, LLC
On
March 15, 2023, the Company, entered into a senior secured Promissory Note in the aggregate principal amount of $250,000 for net
proceeds of $223,500 after an original issue discount and fees of $26,500. The note earns interest at 10% per annum and matures on July
15, 2023
On
August 4, 2023, the Company settled the senior secured promissory note owing to Mirage Realty for gross proceeds of $260,548.
LXR
Biotech
On
April 12, 2019, the Company, entered into a secured Promissory Note in the aggregate principal amount of CDN$133,130. The Note had a
maturity date of April 11, 2020 and bears interest at the rate of six percent per annum from the date on which the Note was
issued.
This
note has not been repaid, is in default and remains outstanding. The balance outstanding at September 30, 2023 was $124,886 (CDN$168,845).
10. Mortgage
loans
Mortgage
loans is disclosed as follows:
Schedule of mortgage loans
|
|
Interest
rate |
|
|
Maturity
date |
|
Principal
Outstanding |
|
|
Accrued
interest |
|
|
September
30,
2023 |
|
|
December
31,
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cranberry Cove Holdings, Ltd. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pace Mortgage |
|
|
4.2 |
% |
|
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,504,605 |
Disclosed as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term portion |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
— |
|
|
$ |
3,504,605 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cranberry
Cove Holdings, Ltd. (“CCH”)
On July 19, 2017, CCH, a wholly owned subsidiary, closed on a loan agreement in the principal amount of CDN$5,500,000. The loan is secured
by a first mortgage on the premises owned by CCH located at 3571 Muskoka Road 169, Bala, Ontario.
The
loan bears interest at the fixed rate of 4.2% with a 5-year primary term and a 25-year amortization. The Company has guaranteed
the loan and the Company’s chief executive officer and controlling shareholder also has personally guaranteed the Loan. CCH and
the Company have granted the Lender a general security interest in its assets to secure repayment of the Loan. The loan is amortized
with monthly installments of CDN $29,531.
On
June 30, 2023, the Company sold its interest in CCH to Leonite Capital, which includes the real property as disclosed in Note 5 and the
associated mortgage loan. Refer to Note 4 above.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
11. Government
assistance loans
On
December 1, 2020, CCH was granted a Covid-19 related government assistance loan in the aggregate principal amount of CDN$ 40,000 (Approximately
$31,000). The grant is interest free and CDN$ 10,000 is forgivable if the loan is repaid in full by December 31, 2022. The maturity
date of this loan was extended by an additional year to December 31, 2023.
On
January 12, 2021, CCH received a further CDN$ 20,000 Covid-19 related government assistance loan. The loan is interest free
and if repaid by December 31, 2022, CDN$ 10,000 is forgivable. This loan was not repaid by December 31, 2022.
On
June 30, 2023, the Company sold its interest in CCH to Leonite Capital, which includes the Canadian government assistance loan. Refer
to Note 4 above.
On
May 3, 2021, ARIA was granted a government assistance loan in the aggregate principal amount of $157,367. The loan is forgivable if the
Company demonstrates that the proceeds were used for expenses such as employee costs during the pandemic. Should the loan not be forgiven,
interest is payable on the loan at the rate of 1% per annum and the principal is repayable and interest is payable over an 18 month period.
On
September 21, 2022, ARIA received partial forgiveness of the government assistance loan of $104,368, the balance of the loan plus accrued
interest is due and payable. On December 30, 2022, the Company sold ARIA to its Chairman and CEO and agreed to assume the repayment of
the government assistance loan. As of September 30, 2023, the balance outstanding, including interest thereon was $39,207.
12. Receivables
funding
September
26, 2022 Funding
On
September 26, 2022, the Company, through its 75% held subsidiary, Evernia Health Center, LLC, entered into a Receivables Sale Agreement
with Itria Ventures LLC (“Itria”), whereby $310,000 of the Receivables of Evernia were sold to Itria, for gross proceeds
of $250,000. The Company also incurred fees of $5,500, resulting in net proceeds of $244,500. The Company is obliged to pay 7.41% of
the receivables until the amount of $310,000 is paid in full, with periodic repayments of $6,458 per week. The guarantor of the funding
is a minority shareholder in ATHI.
The
Company made weekly cash payments of $6,458 totaling $310,000 on the September 26, 2022 funding, thereby settling the receivables funding.
December
13, 2022 Funding
On
December 13, 2022, the Company, through its 75% held subsidiary, Evernia Health Center, LLC entered into a Receivables Sale Agreement
with Itria Ventures LLC (“Itria”), whereby $305,000 of the Receivables of Evernia were sold to Itria, for gross proceeds
of $250,000. The Company also incurred fees of $2,500, resulting in net proceeds of $247,500. The Company is obliged to pay 6.08% of
the receivables until the amount of $305,000 is paid in full, with periodic repayments of $6,354 per week. The guarantor of the funding
is a minority shareholder in ATHI.
The
Company made weekly cash payments of $6,354 totaling $241,458 on the December 13, 2022 funding. On September 15, 2023, the Company repaid
the remaining principal outstanding of $63,542 out of the proceeds received from the September 15, 2023 receivables funding with Itria.
January
19, 2023 Funding
On
January 19, 2023, the Company, through its 75% held subsidiary, Evernia Health Center, LLC, entered into a Receivables Sales Agreement
with Bizfund.com (“Bizfund)”), whereby $132,000 of the Receivables of Evernia were sold to Bizfund, for gross proceeds of
$100,000. The Company is obliged to pay 15.0% of the receivables until the amount of $132,000 is paid in full, with periodic repayments
of $2,750 per week. The guarantor of the funding is a minority shareholder in ATHI.
The
Company made weekly cash payments of $2,750 totaling $49,500 on the January 19, 2023 funding. On June 2, 2023 the Company entered into
another receivables funding agreement with Bizfund, whereby Bizfund forgave $8,250 of the premium due on the January 19, 2023 funding
and transferred the remaining principal balance of $74,250 to the June 2, 2023 funding. The unamortized balance of the debt discount
of $12,616 was expensed on June 2, 2023, thereby extinguishing the receivables funding.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
12.
Receivables funding (continued)
February
14, 2023 Funding
On
February 14, 2023, the Company, through its 75% held subsidiary, Evernia Health Center, LLC, entered into a Receivables Sale Agreement
with Fox Business Funding (“Fox”), whereby $118,800 of the Receivables of Evernia were sold to Fox, for gross proceeds of
$90,000. The Company is obligated to pay 8.0% of the receivables until the amount of $118,800 is paid in full, with periodic repayments
of $2,970 per week. The guarantor of the funding is a minority shareholder in ATHI.
The
Company made weekly cash payments of $2,970 totaling $86,130 on the February 14, 2023 funding. on September 15, 2023, the Company repaid
the remaining principal outstanding of $32,670 out of the proceeds received from the September 15, 2023 receivables funding with Itria.
June
2, 2023 Funding
On
June 2, 2023, the Company received funding from an agreement entered into through its 75% held subsidiary, Evernia Health Center, LLC
entered into a Receivables Sale Agreement with Bizfund.com (“Bizfund)”), whereby $198,000 of the Receivables of Evernia were
sold to Bizfund, for gross proceeds of $150,000, made up of a cash payment to the Company of $75,750 and the transfer of $74,250 of the
January 19, 2023, outstanding principal to the June 2, 2023 funding agreement.. The Company is obliged to pay 15.0% of the receivables
until the amount of $198,000 is paid in full, with periodic repayments of $4,950 per week. The guarantor of the funding is a minority
shareholder in ATHI.
The
Company made weekly cash payments of $4,950 totaling $79,200 on the June 2, 2023 funding. The balance outstanding at September 30, 2023
was $118,800, less unamortized discount of $30,687.
September
15, 2022 Funding
On
September 15, 2023, the Company, through its 75% held subsidiary, Evernia Health Center, LLC entered into a Receivables Sale Agreement
with Itria Ventures LLC (“Itria”), whereby $320,000 of the Receivables of Evernia were sold to Itria, for gross proceeds
of $250,000. The Company also incurred fees of $3,000, resulting in net proceeds of $247,500. The Company is obliged to pay $6,666.67
per week until the amount of $320,000 is paid in full. The guarantor of the funding is a minority shareholder in ATHI.
The
Company made weekly cash payments of $6,667 totaling $13,333 on the September 15, 2022 funding. The balance outstanding at September
30, 2023 was $306,667, less unamortized discount of $70,076.
13. Third
Party loans
On
April 12, 2019, Eileen Greene, a related party, assigned CDN$1,000,000 of the amount owed by the Company to her, to a third party.
The loan bears interest at 12% per annum which the Company agreed to pay. This loan was assumed by the Company on the disposal of CCH
to Leonite Capital as disclosed in note 4 above.
During
April and May 2023, the Company made ad-hoc repayments of CDN$25,000 (approximately $25,970) on the third party loan. Between August 9
and August 10, 2023, the Company made principal repayment of CDN$450,000 ($335,290) As of September 30, 2023 the balance of principal
and interest outstanding on third party loans was CDN$336,320 ($248,757).
14. Related
party payables
Schedule
of Related party payable
| |
September
30, | |
December
31, |
| |
2023 | |
2022 |
Due
to related parties | |
| | | |
| | |
Shawn
E. Leon | |
$ | 124,445 | | |
$ | 411,611 | |
Leon
Developments Ltd. | |
| 1,092,701 | | |
| 850,657 | |
Eileen
Greene | |
| 1,452,862 | | |
| 1,451,610 | |
Total
related party payables | |
$ | 2,670,008 | | |
$ | 2,713,878 | |
Shawn
E. Leon
As
of September 30, 2023 and December 31, 2022, the Company had a payable to Shawn Leon of $124,445 and $411,611, respectively. Mr. Leon
is a director and CEO of the Company. The balances payable are non-interest bearing and have no fixed repayment terms.
On
December 30, 2022, the Company sold its wholly-owned subsidiaries, Greenestone Muskoka and ARIA, to Mr. Leon for gross proceeds of $0.
The Company realized a gain on disposal of $628,567 which was recorded as an increase in Additional Paid in Capital due to the related
party nature of the transaction.
Due
to the current financial position of the Group, Mr. Leon forfeited the management fees due to him for the nine months ended September
30, 2023 and the year ended December 31, 2022.
Leon
Developments, Ltd.
Leon
Developments is owned by Shawn Leon, the Company’s CEO and director. As of September 30, 2023 and December 31, 2022, the Company
owed Leon Developments, Ltd., $1,092,701 and $850,607, respectively.
The
Company paid Leon Developments a management fee of CDN$250,000 (approximately $185,503) and $0 for the nine months ended September 30,
2023 and 2022, respectively.
On
June 30, 2023, the Company assumed the liability owing to Leon developments of CDN$1,974,012 (approximately $1,490,946) from its subsidiary,
CCH, immediately prior to the disposal of CCH to a related party, Leonite Capital LLC.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
|
14. |
Related
party transactions (continued) |
Eileen
Greene
As
of September 30, 2023 and December 31, 2022, the Company owed Eileen Greene, the spouse of our CEO, Shawn Leon, $1,452,862 and $1,451,610,
respectively. The amount owed to Ms. Greene is non-interest bearing and has no fixed repayment terms.
Leonite
Capital, LLC and Leonite Fund I, LLP
Leonite
Capital is considered a related party due to its Series A Preferred stock interest in CCH, which was previously a wholly-owned subsidiary
of the Company, of $700,000, and its Series B Preferred stock interest in the Company of $400,000, as of December 31, 2022.
The
Series A Preferred stock interest in CCH of $700,000 was recorded as a minority shareholder interest as of December 31, 2022.
Accrued
dividends on the CCH Series A Preferred shares of $145,547 and accrued dividends on the Series B Preferred shares of $49,282 was owed
to Leonite Capital as of December 31, 2022. Prior to the disposal of CCH to Leonite Capital on June 30, 2023, and the simultaneous cancellation
of the Series B Preferred stock as discussed below, the accrued dividends on the CCH Series A Preferred shares was $184,545 and the accrued
dividends on the Series B Preferred shares was $61,184.
On
June 30, 2023, the Company entered into an exchange agreement with Leonite Capital whereby it exchanged the 400,000 Series B shares with
a value of $400,000 plus accrued dividends thereon of $61,184 for its entire shareholding in its property owning subsidiary, Cranberry
Cove Holdings. The Series B shares and the accrued dividends thereon were extinguished and cancelled upon consummation of the transaction.
Due
to the related party nature of the transaction, the net result of the disposal of $1,334,885 and the $700,000 of the CCH Series A Preferred
shares, totaling $2,034,885, was recorded as a credit to additional paid-in-capital.
In
addition, due to the related party nature of the transaction, the cancellation of the Series B Preferred stock, of $400,000 and the dividends
thereon of $61,184, totaling $461,184, was recorded as an extinguishment of debt reflected in additional paid-in-capital.
On
August 4, 2023, the company repaid Leonite Capital $1,449,000 consisting of repayments of short-term convertible notes of $995,257, promissory
notes of $420,069, additional penalty on settlement of $5,236 and a personal loan by Leonite to Shawn Leon of $28,438, which repayment
reduced the related party payable to Shawn Leon, as disclosed above.
As
disclosed in note 8 above, the Company owed Leonite Capital and Leonite Funds I, LP, an entity under common control with Leonite Capital,
short-term convertible notes, including principal and interest thereon of $0 and $905,579 as of September 30, 2023 and December 31, 2022,
respectively.
In
addition, as disclosed in note 9 above, the Company owed Leonite capital, secured promissory notes, including principal, monitoring fees
and interest thereon totaling $0 and $340,281 as of September 30, 2023 and December 31, 2022, respectively.
All
related party transactions occur in the normal course of operations and in terms of agreements entered into between the parties.
15. Stockholder’s
deficit
Authorized
and outstanding
The
Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued 3,729,053,805
shares of common stock at September 30, 2023 and December 31, 2022.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
15. Stockholder’s
deficit (continued)
|
b. |
Series
A Preferred shares |
Authorized,
issued and outstanding
The
Company has authorized 10,000,000 Series A preferred shares with a par value of $0.01 per share. The Company has
issued and outstanding 4,000,000 Series A Preferred shares at September 30, 2023 and December 31, 2022.
|
c. |
Series
B preferred shares |
Authorized
and outstanding
The
Company has authorized 400,000 Series B preferred shares with a par value of $1.00 per share. The company has issued and outstanding 0
and 400,000 Series B Preferred shares at September 30, 2023 and December 31, 2022, respectively.
The
Series B preferred shares are senior secured and were mandatorily redeemable by the Company on July 1, 2021, and were originally classified
as mezzanine debt. These Series B preferred shares meet the definition of liabilities in terms of ASC 480- debt and are no longer contingently
convertible, due to the fact that the redemption date has passed.
On
June 30, 2023, the Company entered into an exchange agreement with Leonite Capital whereby it exchanged the shares in its wholly owned
subsidiary, CCH for the return and cancellation of the Series B preferred shares, together with the dividends accrued thereon. Refer
to note 4 above.
Our
board of directors adopted the Greenstone Healthcare Corporation 2013 Stock Option Plan (the “Plan”) to promote our long-term
growth and profitability by (i) providing our key directors, officers and employees with incentives to improve stockholder value and
contribute to our growth and financial success and (ii) enable us to attract, retain and reward the best available persons for positions
of substantial responsibility. A total of 10,000,000 shares of our common stock have been reserved for issuance upon exercise
of options granted pursuant to the Plan. The Plan allows us to grant options to our employees, officers and directors and those of our
subsidiaries; provided that only our employees and those of our subsidiaries may receive incentive stock options under the Plan. We have
no issued options at September 30, 2023 under the Plan.
All
of the warrants have cashless exercise terms whereby in-the-money warrants may be exercised by reducing the number of shares issued in
terms of the warrant exercise to offset the proceeds due on the exercise.
All
of the warrants have price protection features whereby any securities issued subsequent to the date of the warrant issuance date, were
issued at a lower price, or have conversion features that are lower than the current exercise price, or were converted at a lower price,
or are exercisable at a lower price, to the current warrant exercise price, will result in the exercise price of the warrant being set
to the lower issue, conversion or exercise price.
Warrant
exchange agreement
On June
28, 2023 the Company entered into a Warrant Exchange Agreement with Leonite that exchanged a Warrant outstanding to Leonite originally
issued on June 12, 2020 for a new Warrant dated June 30, 2023. The substantial changes to the warrant affect the number of shares in
the warrant, the exercise price and the term. The original warrant provided for Leonite to have a continuing right to purchase a 20%
share of the outstanding common shares until it expired on June 12, 2025 which was originally set at 326,286,847 shares. The new warrant
is exercisable for 745,810,761 shares, 20% of the current number of common shares outstanding, with no allowance for adjustment, except
normal adjustments due to splits or consolidations, until the new expiry date of June 30, 2027. The exercise price in the original warrant
was $0.10, with allowance for adjustments, which when applied resulted in an exercise price of $0.0004 per share. The exercise price
on the new warrant is $0.001 and is only adjustable if the Company issues any shares at a price less than the exercise price during the
warrant period except for any issuance of shares to the Company’s president or related parties on any debt outstanding to those
parties as of June 30, 2023, and limited to a conversion price of $0.0005 per share. The Warrant Exchange agreement was conditional on
Leonite receiving a full payment of all of its outstanding loans originally set as by July 20, 223. This date was extended and all of
the notes were repaid on August 4, 2023. Leonite held several notes at June 30, 2023, some of which were convertible into shares at variable
rates, see notes 9 and 10 above. The total amount repaid to settle all of the outstanding liabilities was $1,449,000.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
15.
Stockholder’s deficit (continued)
The
replacement warrants were valued effective June 30, 2023, the effective date of issuance of the warrants, as the difference between the
fair value of the original warrant exercisable for 326,286,847 shares of common stock and the fair value of the replacement four-year
warrant exercisable for 745,810,861 shares of common stock at an exercise price of $0.001 per share.
The
warrants were valued using a Black-Scholes valuation model. The following assumptions were used in the valuation model:
Share-Based
Payment Arrangement, Performance Shares, Activity
|
|
Nine
months ended
September 30,
2023 |
Exercise price |
|
$ |
0.001 |
|
Risk free interest rate |
|
|
4.31 to 4.87 |
% |
Expected life of options |
|
|
2 to 4 years |
Expected volatility of underlying stock |
|
|
205.5 to 243.0 |
% |
Expected dividend rate |
|
|
0 |
% |
A
summary of the Company’s warrant activity during the period from January 1, 2022 to September 30, 2023 is as follows:
Schedule of warrants outstanding
|
|
No.
of shares |
|
Exercise
price
per share |
|
Weighted
average exercise
price |
|
|
|
|
|
|
|
Outstanding
as of January 1, 2022 |
|
|
623,777,506 |
|
|
|
$0.000675
to $0.12 |
|
|
$ |
0.0052875 |
|
Granted |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Forfeited/cancelled |
|
|
(20,925,000 |
) |
|
|
$0.12 |
|
|
|
0.12 |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Outstanding
as of December 31, 2022 |
|
|
602,852,506 |
|
|
|
$0.000675 to $0.00205 |
|
|
$ |
0.001306 |
|
Granted |
|
|
745,810,761 |
|
|
|
$0.001 |
|
|
|
0.001 |
|
Forfeited/cancelled |
|
|
(326,286,847 |
) |
|
|
$0.000675 |
|
|
|
0.000675 |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Outstanding
as of September 30, 2023 |
|
|
1,022,376,420 |
|
|
|
$0.001
to $0.00205 |
|
|
$ |
0.0012840 |
|
The
following table summarizes information about warrants outstanding at September 30, 2023:
Schedule of assumption
|
|
|
Warrants
outstanding |
|
|
Warrants
exercisable |
|
Exercise
price |
|
|
No.
of shares |
|
|
Weighted
average
remaining years |
|
|
Weighted
average
exercise price |
|
|
No.
of shares |
|
|
Weighted
average
exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$0.001 |
|
|
|
745,810,761 |
|
|
|
3.75 |
|
|
|
|
|
|
|
745,810,761 |
|
|
|
|
|
$0.002050 |
|
|
|
276,565,659 |
|
|
|
2.27 |
|
|
|
|
|
|
|
276,565,659 |
|
|
|
|
|
|
|
|
|
1,022,376,420 |
|
|
|
3.35 |
|
|
$ |
0.001284 |
|
|
|
1,022,376,420 |
|
|
$ |
0.001284 |
|
All
of the warrants outstanding at September 30, 2023 are vested. The warrants outstanding at September 30, 2023 have an intrinsic value
of $0.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
16. Segment
information
The
Company had two reportable operating segments:
|
a. |
Rental income
from the property owned by CCH subsidiary located at 3571 Muskoka Road, #169, Bala, on which the operations of the Canadian Rehab
Clinic were located prior to disposal on February 14, 2017 and subsequently leased to the purchasers of the business of the Canadian
Rehab Clinic, for a period of 5 years renewable for a further three five-year periods and with an option to acquire the property
at a fixed price. In terms of an exchange agreement entered into with Leonite Capital effective June 30, 2023, the property owning
subsidiary CCH was exchanged for the Series B preferred shares issued to Leonite Capital. Refer note 4 above. |
|
b. |
Rehabilitation
Services provided to customers, these services were provided to customers at our Evernia, Addiction Recovery Institute of America
and Seastone of Delray operations. |
The
segment operating results of the reportable segments is disclosed as follows:
Schedule of segment information
| |
|
|
|
|
|
|
|
|
|
|
| |
Nine
months ended September 30, 2023 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Revenue | |
$ | 180,522 | | |
$ | 4,039,382 | | |
$ | 4,219,904 | |
Operating expenses | |
| 245,528 | | |
| 3,833,676 | | |
| 4,079,204 | |
| |
| | | |
| | | |
| | |
Operating (loss) income | |
| (65,006 | ) | |
| 205,706 | | |
| 140,700 | |
| |
| | | |
| | | |
| | |
Other (expense)
income | |
| | | |
| | | |
| | |
Forgiveness
of intercompany loan | |
| 3,481,332 | | |
| (3,481,332 | ) | |
| — | |
Other
income | |
| — | | |
| 449 | | |
| 449 | |
Penalty
on convertible notes | |
| — | | |
| (34,688 | ) | |
| (34,688 | ) |
Extension
fee on property purchase | |
| — | | |
| (130,000 | ) | |
| (130,000 | ) |
Gain
on disposal of property | |
| — | | |
| 2,484,172 | | |
| 2,484,172 | |
Loss
on debt extinguishment | |
| — | | |
| (277,175 | ) | |
| (277,175 | ) |
Interest
expense | |
| (95,464 | ) | |
| (286,984 | ) | |
| (382,448 | ) |
Amortization
of debt discount | |
| — | | |
| (238,304 | ) | |
| (238,304 | ) |
Foreign
exchange movements | |
| (81,033 | ) | |
| (3,115 | ) | |
| (84,148 | ) |
Net income
(loss) before taxes | |
| 3,239,829 | | |
| (1,761,271 | ) | |
| 1,478,558 | |
Taxes | |
| — | | |
| 221,107 | | |
| 221,107 | |
Net
income (loss) | |
$ | 3,239,829 | | |
$ | (1,540,164 | ) | |
$ | 1,699,665 | |
The
operating assets and liabilities of the reportable segments is as follows:
| |
|
|
|
|
|
|
|
|
|
|
| |
September
30, 2023 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Purchase
of fixed assets | |
$ | (43,611 | ) | |
$ | 5,287,622 | | |
$ | 5,244,011 | |
Assets | |
| | | |
| | | |
| | |
Current assets | |
| — | | |
| 794,521 | | |
| 794,521 | |
Non-current assets | |
| — | | |
| 11,213,407 | | |
| 11,213,407 | |
Liabilities | |
| | | |
| | | |
| | |
Current liabilities | |
| — | | |
| (7,713,189 | ) | |
| (7,713,189 | ) |
Non-current liabilities | |
| — | | |
| (9,801,769 | ) | |
| (9,801,769 | ) |
Net
liability position | |
$ | — | | |
$ | (5,507,030 | ) | |
$ | (5,507,030 | ) |
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
16.
Segment information (continued)
The
segment operating results of the reportable segments is disclosed as follows:
| |
|
|
|
|
|
|
|
|
|
|
|
| |
Nine
months ended September 30, 2022 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Revenue | |
$ | 292,303 | | |
$ | 3,297,387 | | |
$ | 3,586,290 | |
Operating expenses | |
| (99,515 | ) | |
| (3,105,091 | ) | |
| (3,204,606 | ) |
| |
| | | |
| | | |
| | |
Operating
income | |
| 192,788 | | |
| 188,896 | | |
| 381,684 | |
| |
| | | |
| | | |
| | |
Other (expense)
income | |
| | | |
| | | |
| | |
Other
income | |
| — | | |
| 10,018 | | |
| 10,018 | |
Forgiveness
of government assistance loan | |
| — | | |
| 104,368 | | |
| 104,368 | |
Interest
expense | |
| (156,297 | ) | |
| (210,880 | ) | |
| (367,177 | ) |
Amortization
of debt discount | |
| — | | |
| (551,738 | ) | |
| (551,738 | ) |
Derivative
liability movement | |
| — | | |
| 175,593 | | |
| 175,593 | |
Foreign
exchange movements | |
| 116,635 | | |
| 385,715 | | |
| 502,350 | |
Net income
before taxes | |
| 153,126 | | |
| 101,972 | | |
| 255,098 | |
Taxes | |
| — | | |
| (87,615 | ) | |
| (87,615 | ) |
Net
Income | |
$ | 153,126 | | |
$ | 14,357 | | |
$ | 167,483 | |
The
operating assets and liabilities of the reportable segments is as follows:
| |
|
|
|
|
|
|
|
|
|
|
| |
September
30, 2022 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Purchase
of fixed assets | |
$ | — | | |
$ | 285,103 | | |
$ | 285,103 | |
Assets | |
| | | |
| | | |
| | |
Current assets | |
| 7,972 | | |
| 952,223 | | |
| 960,195 | |
Non-current assets | |
| 2,469,499 | | |
| 3,299,226 | | |
| 5,768,725 | |
Liabilities | |
| | | |
| | | |
| | |
Current liabilities | |
| (4,974,475 | ) | |
| (9,047,232 | ) | |
| (14,021,707 | ) |
Non-current liabilities | |
| (603,557 | ) | |
| (1,523,795 | ) | |
| (2,127,352 | ) |
Mandatory redeemable preferred
shares | |
| — | | |
| (400,000 | ) | |
| (400,000 | ) |
Intercompany
balances | |
| (1,263,485 | ) | |
| 1,263,485 | | |
| — | |
Net
liability position | |
$ | (4,364,046 | ) | |
$ | (8,131,754 | ) | |
$ | (9,820,139 | ) |
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
17. Net
income per common share
For the three months ended September 30, 2023, the computation of basic and diluted earnings per share is calculated as follows:
Schedule of Earnings Per Share, Basic and Diluted
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings per share | |
| | | |
| | | |
| | |
Net income per
share available for common stockholders | |
$ | 2,076,479 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible debt | |
| 50,964 | | |
| 202,325,970 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 2,127,443 | | |
| 3,931,379,775 | | |
$ | 0.00 | |
For
the three months ended September 30, 2022, the computation of basic and diluted earnings per share is calculated as follows:
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings per share | |
| | | |
| | | |
| | |
Net income per
share available for common stockholders | |
$ | 458,713 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible debt | |
| 163,565 | | |
| 547,490,575 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 622,278 | | |
| 4,276,544,380 | | |
$ | 0.00 | |
For
the nine months ended September 30, 2023, the computation of basic and diluted earnings per share is calculated as follows:
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings
per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 1,524,534 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible
debt | |
| 146,395 | | |
| 202,325,970 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 1,670,929 | | |
| 3,931,379,775 | | |
$ | 0.00 | |
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
17. Net
income per common share (continued)
For the nine months ended September 30, 2022, the computation of basic and diluted earnings per share is calculated as follows:
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings per share | |
| | | |
| | | |
| | |
Net income per
share available for common stockholders | |
$ | 41,135 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible debt | |
| 230,724 | | |
| 547,490,575 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 271,859 | | |
| 4,244,126,798 | | |
$ | 0.00 | |
18. Commitments
and contingencies
a. Options
granted to purchase shares in ATHI
On
July 12, 2020, the Company entered into a five year option agreement with Leonite Capital LLC (“Leonite”) and other investors
(collectively the “Transferees”). The Company agreed to sell to Leonite a portion of the total outstanding shares of ATHI
from the shares of ATHI held by the company. The Company provided Leonite an option to purchase 4,000,000 shares of ATHI from the Company
for a purchase consideration of $0.0001 per share (a total consideration of $400), based on the advances that Leonite made to the Company
totaling $396,000. Leonite shall share in all distributions by ATHI to the Company, on an as exercised basis, equal to the advances made
by Leonite to the Company, thereafter the option will be reduced to 50% of the shares exercisable under the option.
On
September 14, 2020, the Company entered into a five year option agreement with Ed Blasiak (“Blasiak”) whereby the Company
agreed to sell to Blasiak a portion of the total outstanding shares of ATHI. The Company provided Blasiak an option to purchase 571,428
shares of ATHI from the Company for a purchase consideration of $0.0001 per share (a total consideration of $57), based on the advances
that Blasiak made to the Company totaling $50,000. Blasiak shall share in all distributions by ATHI to the Company, on an as exercised
basis, equal to the advances made by Blasiak to the Company, thereafter the option will be reduced to 50% of the shares exercisable under
the option.
On
October 29, 2020, the Company entered into a five year option agreement with First Fire whereby the Company agreed to sell to First Fire
a portion of the total outstanding shares of ATHI. The Company provided First Fire an option to purchase 1,428,571 shares of ATHI from
the Company for a purchase consideration of $0.0001 per share (a total consideration of $143), based on the advances that First Fire
made to the Company totaling $120,000. First Fire shall share in all distributions by ATHI to the Company, on an as exercised basis,
equal to the advances made by First Fire to the Company, thereafter the option will be reduced to 50% of the shares exercisable under
the option.
On October
29, 2020, the Company entered into a five year option agreement entered into with Bauman, so that the Company agreed to sell to Bauman
a portion of the total outstanding shares of ATHI. The Company provided Bauman an option to purchase 1,428,571 shares of ATHI from the
Company for a purchase consideration of $0.0001 per share (a total consideration of $143), based on the advances that Bauman made to
the Company totaling $120,000. Bauman shall share in all distributions by ATHI to the Company, on an as exercised basis, equal to the
advances made by Bauman to the Company, thereafter the option will be reduced to 50% of the shares exercisable under the option.
From
time to time, the Company and its subsidiaries enter into legal disputes in the ordinary course of business. The Company believes there
are no material legal or administrative matters pending that are likely to have, individually or in the aggregate, a material adverse
effect on its business or results of operations.
ETHEMA
HEALTH CORPORATION
NOTES
TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
19. Subsequent
events
On
November 15, 2023, the Company, entered into a senior secured Promissory Note in the aggregate principal amount of $250,000 for net
proceeds of $223,500 after an original issue discount and fees of $26,500. The note earns interest at 10% per annum and matures on March
15, 2024.
Other
than disclosed above, the Company has evaluated subsequent events through the date of the condensed consolidated financial statements
were issued, we did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
Item
2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The
following discussion and analysis is intended as a review of significant factors affecting our financial condition and results of operations
for the periods indicated. The discussion should be read in conjunction with our condensed consolidated financial statements and the
notes presented herein and the consolidated financial statements and the other information set forth in our Annual Report on Form 10-
K for the year ended December 31, 2022 filed with the Securities and Exchange Commission on March 31, 2023. In addition to historical
information, the following Management’s Discussion and Analysis of Financial Condition and Results of Operations contains
forward-looking statements that involve risks and uncertainties. Our actual results could differ significantly from those anticipated
in these forward-looking statements as a result of certain factors discussed herein and any other periodic reports filed and to
be filed with the Securities and Exchange Commission.
Plan
of Operation
During
the next twelve months, the Company plans to continue to grow the Evernia business organically or through acquisitions, should any
opportunities present themselves. On August 4,
2023, we completed both the purchase of the property in which the Evernia operates for gross proceeds of $5,500,000 and the subsequent
sale of the property to Pontus Net Lease Advisors, LLC for gross proceeds of $8,500,000. Net proceeds on the two transactions after the
payment of convertible and short-term notes and fees and expenses related to the transactions above was $571,784. The proceeds were used
to repay certain indebtedness and to provide some working capital to organically grow the operations. We are still pursuing a Regulation
A financing to further reduce debt and allow us to pursue future acquisitions.
Results of
operations for the three months ended September 30, 2023 and 2022.
Revenues
Revenues
were $1,353,899 and $1,424,943 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $71,044 or 5.0%.
The revenue from in-patient services related to Evernia was S1,353,899 and $1,316,425 for the three months ended September 30, 2023 and
2022, respectively. The increase is attributable to the increase in the number of patients at the facility and increasing our in-network
provider status to a second insurance provider.
The
revenue from rental properties was $0 and $108,518 for the three months ended September 30, 2023 and 2022. The subsidiary owning the
rental property, CCH was sold on June 30, 2023.
Operating
Expenses
Operating
expenses were $1,320,371 and $1,169,961 for the three months ended September 30, 2023 and 2022, respectively, an increase of $150,410
or 12.9%. The increase is primarily due to the following:
|
● |
Professional
fees were $171,659 and $19,131 for the three months ended September 30, 2023 and 2022, respectively, an increase of $152,528 or 797.3%.
The increase is primarily due to the level of corporate activity as the company prepares for a regulation A filing and an increase
in outside contractors used to operate the business during the current year. |
|
● |
Salaries and
wages were $651,537 and $580,432 for the three months ended September 30, 2023 and 2022, respectively, an increase of $71,105 or
12.3%. the increase is primarily due to the increase in headcount to service the increase in our patient headcount and the growth
of the facility over the prior year and is directly correlated to the increase in revenue. |
|
● |
Depreciation
and amortization was $110,185 and $136,608 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $26,423
or 19.3%. The decrease is primarily due to the depreciation associated with the assets of CCH which was disposed of in the prior
quarter. |
|
● |
Rent expense
was $107,707 and $114,717 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $7,010 or 6.1%. This
is primarily due to a credit of $102,723 related to a rental accrual made on the cancellation of the previous property lease, offset
by an increase in rental expense of $74,300 in terms of the new lease agreement entered into, in addition additional property was
leased on a short term basis as the patient base expands. |
|
● |
General and
administrative expenses was $249,283, and $289,073 for the three months ended September 30, 2023 and 2022, respectively, a decrease
of $39,970. The decrease consists of numerous individually insignificant expense items. |
Operating
income
Operating
income was $33,528 and $254,982 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $221,454 or 86.9%.
The decrease is due to the decrease in revenues and the increase in operating expenses as discussed in detail above.
Other
income
Other
income was $110 and $(1,045) for the three months ended September 30, 2023 and 2022, respectively. The amounts are immaterial.
Forgiveness
of government assistance loan
Forgiveness
of federal assistance loan was $0 and $104,368 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $104,368.
The Company received partial forgiveness of the Government assistance loan in the prior year.
Gain on
disposal of property
Gain on disposal
of property was $2,484,172 and $0 for the three months ended September 30, 2023 and 2022, respectively, an increase of $2,484,172 or
100.0%. The Company exercised its option to acquire the property located at 950 Evernia Street, West Palm Beach, Florida, in which its
treatment center operations, and subsequently disposed of the property to a third party, realizing a gross profit of $2,484,172, after
transaction costs.
Loss
on debt extinguishment
Loss
on debt extinguishment was $277,175 and $0 for the three months ended September 30, 2023 and 2022, respectively, an increase of $277,175
or 100.0%. The loss on debt extinguishment is related primarily to replacement warrants issued to Leonite Capital as part of the settlement
reached with Leonite, whereby all indebtedness to Leonite.
Interest
expense
Interest
expense was $81,371 and $163,651 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $82,280 or 50.3%.
The decrease is primarily due to the disposal of CCH to Leonite on June 30, 2023, which included the disposal of the mortgage loan associated
with the property, in addition, the Company settled principal of $1,124,442 of convertible notes on August 4, 2023, resulting in a reduced
interest charge for the current quarter.
Amortization
of debt discount
Amortization
of debt discount was $73,857 and 87,704 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $13,847 or
15.8%. The decrease is primarily due to the overall decrease in receivables funding over the prior year.
Derivative
liability movement
The
derivative liability movement was $0 and $45,156 for the three months ended September 30, 2023 and 2022, respectively. The derivative
liability movement represents the mark to market movements of variably priced convertible notes and warrants issued during the prior
comparative period. The derivative liability was eliminated in the prior year as the underlying liabilities no longer qualified for derivative
liability treatment under ASU2020-06.
Foreign
exchange movements
Foreign
exchange movements were $6,598 and $404,538 for the three months ended September 30, 2023 and 2022, respectively, a decrease of $397,940
or 98.4%. The foreign exchange movement consists of realized exchange gains and (losses) on monetary assets and liabilities settled during
the current year as well as mark to market adjustments on monetary assets and liabilities reflected on the balance sheet and denominated
in Canadian Dollars. In the prior year, the Company had subsidiaries denominated in Canadian Dollars, most of the prior year movement
consisted of mark-to market movements on intercompany balances, these Canadian denominated subsidiaries were disposed of in December
2022 and June 30, 2022, thereby reducing the Company’s exposure to fluctuations in the Canadian dollar exchange rate.
Net income
before income taxes
Net
income before income taxes was $2,092,005 and $556,734 for the three months ended September 30, 2023 and 2022, respectively, an increase
of $1,535,271 or 275.8%. The increase is primarily due to the gain on disposal of property realized in the current year, offset by a
reduction in operating income and the loss on debt extinguishment, discussed in detail above.
Income
Taxes
Income
taxes credit was $15,532 and $(44,652) for the three months ended September 30, 2023 and 2022, a decrease of $60,184 or 134.8%. The Company
has sufficient net operating losses to offset any taxable income during the current period, the current income tax credit related to
a deferred tax credit on intangible assets.
Net income
Net
income was $2,107,537 and $512,082 for the three months ended September 30, 2023 and 2022, respectively, an increase of $1,595,455 or
311.6%, primarily due to the increase in net income before taxation and the movement in income taxes, discussed above.
For the nine
months ended September 30, 2023 and September 30, 2022.
Revenues
Revenues
were $4,219,904 and $3,586,290 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $633,614 or 17.7%.
The revenue from in-patient services related to Evernia was S4,034,607 and $3,289,727 for the nine months ended September 30, 2023 and
2022, respectively, an increase of $744,880 or 22.6%. The increase is attributable to the increase in the number of beds available at
the facility and increasing our in-network provider status to a second insurance provider.
The
revenue from rental properties was $180,522 and $296,533 for the nine months ended September 30, 2023 and 2022, a decrease of $116,011
or 39.1%. The company sold CCH on June 30, 2023, its rental property owning subsidiary.
Operating
Expenses
Operating
expenses were $4,079,204 and $3,204,606 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $874,598
or 27.3%. The increase is primarily due to the following:
|
● |
Management
fees was $273,003 and $90,000 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $183,003 or 203.3%.
The increase is due to management fees paid to Leon developments from CCH prior to the disposal of CCH to a third party on September
30, 2023. This is a once off management fee. |
|
● |
Professional
fees were $460,773 and $180,867 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $279,906 or 154.8%.
The increase is primarily due to the level of corporate activity for fund raising and the disposal of the CCH operation and contractor
fees related to the increase of the number of patients treated at the facility. |
|
● |
Salaries and
wages were $1,873,280 and $1,456,099 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $417,181
or 28.7%. the increase is primarily due to the increase in patients and the growth of the facility over the prior year and is directly
correlated to the increase in revenue. |
|
● |
The remaining
decrease in operating expenses of $5,492 consists of several individually immaterial expenses. |
Operating
income
The
operating income was $140,700 and $381,684 for the nine months ended September 30, 2023 and 2022, respectively, a decrease of $240,984
or 63.1%. The decrease is due to the increase in operating expenses, offset by the increase in revenue as discussed in detail above.
Other
income
Other
income was $449 and $10,018 for the nine months ended September 30, 2023 and 2022, respectively. The amounts are immaterial.
Penalty
on convertible debt
The
penalty on convertible notes was $34,688 and $0 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $34,688
or 100%. The penalty on convertible note was agreed upon with one of our lenders whose note was in default and was subsequently settled
after June 30, 2023.
Extension
fee on property purchase
The
extension fee on the property purchase was $130,000 and $0 for the six months ended June 30, 2023 and 2022, respectively, an increase
of $130,000 or 100%. The extension fee was levied by the landlord of our West Palm Beach facility to afford us additional time to structure
the acquisition of the facility, which we will in turn dispose of to a third party lender.
Gain on
disposal of property
Gain on disposal
of property was $2,484,172 and $0 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $2,484,172 or 100.0%.
The Company exercised its option to acquire the property located at 950 Evernia Street, West Palm Beach, Florida, in which its treatment
center operations, and subsequently disposed of the property to a third party, realizing a gross profit of $2,484,172, after transaction
costs.
Loss
on debt extinguishment
Loss
on debt extinguishment was $277,175 and $0 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $277,175
or 100.0%. The loss on debt extinguishment is related primarily to replacement warrants issued to Leonite Capital as part of the settlement
reached with Leonite, whereby all indebtedness to Leonite.
Interest
expense
Interest
expense was $382,448 and $367,177 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $15,271 or 4.2%.
The increase is primarily due to monitoring fees incurred on two short term notes which are currently in default and default interest
incurred on those borrowings, offset by a decrease in mortgage interest due to the disposal of CCH, our property owning subsidiary on
June 30, 2023.
Amortization
of debt discount
Amortization
of debt discount was $238,304 and $551,738 for the nine months ended September 30, 2023 and 2022, respectively, a decrease of $313,434
or 56.8%. The decrease is primarily due to the full amortization of debt discount on convertible notes in the prior periods, these convertible
notes are expected to be settled in the short term out of proceeds of the simultaneous property acquisition and disposal. The current
period amortization is primarily the amortization of discount on receivables funding.
Derivative
liability movement
The
derivative liability movement was $0 and $175,593 for the nine months ended September 30, 2023 and 2022, respectively. The derivative
liability movement represents the mark to market movements of variably priced convertible notes and warrants issued during the prior
comparative period. The derivative liability was eliminated in the prior year as the underlying liabilities no longer qualified for derivative
liability treatment under ASU2020-06.
Foreign
exchange movements
Foreign
exchange movements were $(84,148) and $502,350 for the nine months ended September 30, 2023 and 2022, respectively, representing the
realized exchange gains and (losses) on monetary assets and liabilities settled during the current year as well as mark to market adjustments
on monetary assets and liabilities reflected on the balance sheet and denominated in Canadian Dollars. In the prior year, the Company
had subsidiaries denominated in Canadian Dollars, most of the prior year movement consisted of mark-to market movements on intercompany
balances, these Canadian denominated subsidiaries were disposed of in December 2022 and June 30, 2022, thereby reducing the Company’s
exposure to fluctuations in the Canadian dollar exchange rate.
Net income
before income taxes
Net
income before income taxes was $1,478,558 and $255,098 for the nine months ended September 30, 2023 and 2022, respectively, an increase
of $1,223,460 or 479.6%. The increase is primarily due to the gain on sale of property, offset by the loss on debt extinguishment, the
extension fee paid on the property purchase and the foreign exchange movements, all discussed in detail above.
Income
taxes
Income
taxes was a Tax credit was $221,107 and taxation charge was $(87,615) for the nine months ended September 30, 2023 and 2022, an increase
in credit of $308,722 or 352.4%. The increase is due to the completion of tax returns for our operating subsidiaries during the current
quarter, which resulted in the reversal of previously provided for income taxes, primarily related to accelerated depreciation allowances
on property and equipment.
Net inc0me
Net
income was $1,699,665 and $167,483 for the nine months ended September 30, 2023 and 2022, respectively, an increase of $1,532,182 or
914.8%. The increase is primarily due to the increase in net income before taxation offset by the taxation credit, as discussed above.
Commitments
and contingencies
The
company has commitments under operating and finance leases as follows:
The amount of
future minimum lease payments under finance leases as of September 30, 2023 is as follows:
| |
Amount |
| Remainder
of 2023 | | |
$ | 2,457 | |
| 2024 | | |
| 9,829 | |
| 2025 | | |
| 9,829 | |
| 2026 | | |
| 6,195 | |
| 2027 | | |
| 1,707 | |
| Total
finance lease liability | | |
$ | 30,017 | |
The
amount of future minimum lease payments under operating leases are as follows:
| |
Amount |
| |
|
| Remainder
of 2023 | | |
$ | 249,333 | |
| 2024 | | |
| 754,857 | |
| 2025 | | |
| 775,615 | |
| 2026 | | |
| 796,945 | |
| 2027 | | |
| 818,861 | |
| | | |
| 16,200,042 | |
| Total
operating lease liability | | |
$ | 19,595,653 | |
The
company also has commitments under convertible loans and short term loans. If the convertible loans, as disclosed in note 11, above are
not converted they will need to be repaid.
Liquidity
and Capital Resources
We
have prepared our unaudited condensed consolidated financial statements in accordance with US GAAP applicable to a going concern, which
assumes that we will be able to meet our obligations and continue our operations in the normal course of business. At September 30, 2023
we had a working capital deficiency of $6.9 million, and total liabilities in excess of assets in the amount of $5.5 million.
We believe that current available resources will not be sufficient to fund our planned expenditures over the next 12 months. These factors,
individually and collectively indicate that a material uncertainty exists that raises substantial doubt about our ability to continue
as a going concern for one year from the date of issuance of these condensed interim consolidated financial statements.
We
are dependent on the raising additional capital through placement of common shares, and/or debt financing in order to implement our business
plan and generating sufficient revenue in excess of costs. If we raise additional capital through the issuance of equity securities or
securities convertible into equity, stockholders will experience dilution, and such securities may have rights, preferences or privileges
senior to those of the holders of common stock or convertible senior notes. If we raise additional funds by issuing debt, we may be subject
to limitations on its operations, through debt covenants or other restrictions. If we obtain additional funds through arrangements with
collaborators or strategic partners, we may be required to relinquish our rights to certain geographical areas, or techniques that we
might otherwise seek to retain. There is no assurance that we will be successful with future financing ventures, and the inability to
secure such financing may have a material adverse effect on our financial condition. These unaudited condensed consolidated financial
statements do not include any adjustments to the amounts and classifications of assets and liabilities that might be necessary should
we be unable to continue as a going concern.
Cash
(used in) generated from operating activities was $(575,790) and $1,019,112 for the nine months ended September 30, 2023 and 2022, respectively,
an increase of $1,594,902. The increase is primarily due to the following:
|
● |
An
increase in net income of $1,532,183, discussed under operations above. |
|
● |
Offset by an
increase in the movement of non-cash items of $(2,248,019), primarily due to the gain on sale of property of $2,484,172 and the movement
in the amortization of debt discount of $(325,702), offset by the movement in loss on debt extinguishment of $277,175and the prior
period derivative liability movement of $175,593. |
|
● |
The movement
in working capital increased by $(879,066), primarily due to the increase in movement in accounts receivable of $(143,864) and an
increase in the movement in accounts payable and accrued liabilities of $(321,881) and an increase in the movement of taxation payable
of $(391,445). |
Cash
provided by investing activities was $2,475,437 and cash used in investing activities was $335,103 for the nine months ended September
30, 2023 and 2022, respectively. The Company exercised its option to acquire 950 Evernia Street, where it conducts its treatment facility
for net proceeds of $5,209,276, net of deposits previously paid and subsequently sold the property for net proceeds of $8,093,448, after
fees and expenses related to the disposal. The Company paid a deposit of $374,000 for the new property lease entered into with the purchaser
of the property.
Cash
used in financing activities was $(2,099,675) and cash provided by investing activities was $393,185 for the nine months ended September
30, 2023 and 2022, respectively. In the current period the Company repaid convertible notes of $1,124,442, repaid promissory notes of
$568,325, third party loans of $361,260 and net repayment of receivables funding of $267,771, primarily out of the net proceeds of the
property disposal, offset by proceeds received on convertible notes of $150,000, proceeds from promissory notes of $223,500.
Over
the next twelve months we estimate that the company will require approximately $0.5 million in working capital as it continues to develop
the Evernia facility and it is also exploring several other treatment center options and sources of patients throughout the country.
The Company also has convertible notes, short term loans and secured promissory notes which have matured and are in default and the Company
may have to raise equity or secure debt. There is no assurance that the Company will be successful with future financing ventures, and
the inability to secure such financing may have a material adverse effect on the Company’s financial condition. In the
opinion of management, the Company’s liquidity risk is assessed as high due to this uncertainty.
We
have prepared our unaudited condensed consolidated financial statements in accordance with US GAAP applicable to a going concern, which
assumes that we will be able to meet our obligations and continue our operations in the normal course of business. At September 30, 2023
we had a working capital deficiency of $6.9 million, and total liabilities in excess of assets in the amount of $5.5 million.
We believe that current available resources will not be sufficient to fund our planned expenditures over the next 12 months. These factors,
individually and collectively indicate that a material uncertainty exists that raises substantial doubt about our ability to continue
as a going concern for one year from the date of issuance of these condensed interim consolidated financial statements.
Recently
Issued Accounting Pronouncements
The
recent Accounting Pronouncements are fully disclosed in note 2 to our unaudited condensed consolidated financial statements.
Management
does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have an effect on
the accompanying unaudited condensed consolidated financial statements.
Off
balance sheet arrangements
We
do not maintain off-balance sheet arrangements nor do we participate in non-exchange traded contracts requiring fair value accounting
treatment.
Inflation
The
effect of inflation on our revenue and operating results was not significant.
Climate
Change
We
believe that neither climate change, nor governmental regulations related to climate change, have had, or are expected to have, any material
effect on our operations.
Item
3. Quantitative and Qualitative Disclosures about Market Risk.
Not
applicable.
Item
4. Controls and Procedures.
Disclosure
Controls and Procedures
The
Company has adopted and maintains disclosure controls and procedures that are designed to provide reasonable assurance that information
required to be disclosed in the reports filed under the Exchange Act, such as this Quarterly Report on Form 10-Q, is collected, recorded,
processed, summarized and reported within the time periods specified in the rules of the Securities and Exchange Commission. The Company’s
disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to management to
allow timely decisions regarding required disclosure. As required under Exchange Act Rule 13a-15, the Company’s management, including
the Principal Executive Officer and the Principal Financial Officer, has conducted an evaluation of the effectiveness of disclosure controls
and procedures as of the end of the period covered by this report. Based upon that evaluation, the Company’s CEO and CFO concluded
that due to a lack of segregation of duties the Company’s disclosure controls and procedures are not effective to ensure that information
required to be disclosed by the Company in the reports that the Company files or submits under the Exchange Act, is recorded, processed,
summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is
accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate, to allow timely
decisions regarding required disclosure. Subject to receipt of additional financing or revenue generated from operations, the Company
intends to retain additional individuals to remedy the ineffective controls.
Changes
in Internal Control
There
has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act)
that occurred during our fiscal quarter ended September 30, 2023 that has materially affected, or is reasonably likely to materially
affect, our internal control over financial reporting.
PART
II
Item
1. Legal Proceedings.
We
are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results
of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency,
self-regulatory organization or body pending or, to the knowledge of the executive
officers of our company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries
or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could
have a material adverse effect.
Item
1A. Risk Factors.
Not
applicable because we are a smaller reporting company.
Item
2. Unregistered sales of equity securities and use of proceeds
None.
Item
3. Defaults upon senior securities
None.
Item
4. Mine Safety Disclosures.
None.
Item
5. Other Information.
Not
applicable.
Item
6. Exhibits
*
filed herewith
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.
ETHEMA
HEALTH CORPORATION
Date:
November 20, 2023
By:/s/
Shawn E. Leon
Name:
Shawn E. Leon
Title:
Chief Executive Officer and Chief Financial Officer (Principal Executive Officer and Principal Financial Officer)
Pursuant
to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
Name |
|
Position |
|
Date |
|
|
|
|
|
/s/Shawn E. Leon |
|
Chief Executive Officer
(Principal Executive Officer), |
|
November 20, 2023 |
Shawn Leon |
|
Chief Financial Officer
(Principal Financial Officer), President and Director |
|
|
|
|
|
|
|
/s/ John O’Bireck |
|
Director |
|
November 20, 2023 |
John O’Bireck |
|
|
|
|
|
|
|
|
|
/s/ Gerald T. Miller |
|
Director |
|
November 20, 2023 |
Exhibit 31.1
CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE
15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002
I, Shawn E. Leon, certify that:
I have reviewed this Quarterly Report on Form 10-Q of Ethema Health Corporation;
1. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and |
|
c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. |
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: November 20, 2023
|
/s/ Shawn E. Leon |
|
Chief Executive Officer and Chief Financial Officer
(Principal Executive Officer and Principal Financial Officer) |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002
In connection with the Quarterly Report of
Ethema Health Corporation, a Colorado corporation (the “Company”), on Form 10-Q for the quarterly period ended September
30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Shawn E. Leon,
Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to Section 18 U.S.C. 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
|
(1) |
The Report fully complies with the requirements of Section 13(a) and 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
/s/ Shawn E. Leon |
|
Chief Executive Officer and Chief Financial Officer
(Principal Executive Officer and Principal Financial Officer) |
|
November 20, 2023 |
v3.23.3
Cover - shares
|
9 Months Ended |
|
Sep. 30, 2023 |
Nov. 20, 2023 |
Cover [Abstract] |
|
|
Document Type |
10-Q
|
|
Amendment Flag |
false
|
|
Document Quarterly Report |
true
|
|
Document Transition Report |
false
|
|
Document Period End Date |
Sep. 30, 2023
|
|
Document Fiscal Period Focus |
Q3
|
|
Document Fiscal Year Focus |
2023
|
|
Current Fiscal Year End Date |
--12-31
|
|
Entity File Number |
000-54748
|
|
Entity Registrant Name |
ETHEMA
HEALTH CORPORATION.
|
|
Entity Central Index Key |
0000792935
|
|
Entity Tax Identification Number |
84-1227328
|
|
Entity Incorporation, State or Country Code |
CO
|
|
Entity Address, Address Line One |
950
Evernia Street
|
|
Entity Address, City or Town |
West Palm Beach
|
|
Entity Address, State or Province |
FL
|
|
Entity Address, Postal Zip Code |
33401
|
|
City Area Code |
(416)
|
|
Local Phone Number |
500-0020
|
|
Title of 12(b) Security |
Common shares
|
|
Trading Symbol |
GRST
|
|
Entity Current Reporting Status |
Yes
|
|
Entity Interactive Data Current |
Yes
|
|
Entity Filer Category |
Non-accelerated Filer
|
|
Entity Small Business |
true
|
|
Entity Emerging Growth Company |
false
|
|
Entity Shell Company |
false
|
|
Entity Common Stock, Shares Outstanding |
|
3,729,053,805
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEnd date of current fiscal year in the format --MM-DD.
+ References
+ Details
Name: |
dei_CurrentFiscalYearEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gMonthDayItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
+ Details
Name: |
dei_DocumentFiscalPeriodFocus |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fiscalPeriodItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThis is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
+ Details
Name: |
dei_DocumentFiscalYearFocus |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gYearItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true only for a form used as an quarterly report.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 10-Q -Number 240 -Section 308 -Subsection a
+ Details
Name: |
dei_DocumentQuarterlyReport |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true only for a form used as a transition report.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Forms 10-K, 10-Q, 20-F -Number 240 -Section 13 -Subsection a-1
+ Details
Name: |
dei_DocumentTransitionReport |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
+ Details
Name: |
dei_EntityCommonStockSharesOutstanding |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionIndicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
+ Details
Name: |
dei_EntityCurrentReportingStatus |
Namespace Prefix: |
dei_ |
Data Type: |
dei:yesNoItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityFilerCategory |
Namespace Prefix: |
dei_ |
Data Type: |
dei:filerCategoryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-T -Number 232 -Section 405
+ Details
Name: |
dei_EntityInteractiveDataCurrent |
Namespace Prefix: |
dei_ |
Data Type: |
dei:yesNoItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityShellCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicates that the company is a Smaller Reporting Company (SRC).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntitySmallBusiness |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) - USD ($)
|
Sep. 30, 2023 |
Dec. 31, 2022 |
Current assets |
|
|
Cash |
$ 11,728
|
$ 140,757
|
Accounts receivable, net |
681,072
|
337,074
|
Prepaid expenses |
39,069
|
44,718
|
Other current assets |
62,652
|
20,347
|
Total current assets |
794,521
|
542,896
|
Non-current assets |
|
|
Property and equipment, net |
523,699
|
2,974,395
|
Intangible assets, net |
984,447
|
1,252,932
|
Right of use assets |
9,331,261
|
1,393,071
|
Deposits |
374,000
|
400,000
|
Total non-current assets |
11,213,407
|
6,020,398
|
Total assets |
12,007,928
|
6,563,294
|
Current liabilities |
|
|
Accounts payable and accrued liabilities |
129,415
|
170,934
|
Taxes payable |
|
248,644
|
Convertible notes, net of discounts |
4,408,209
|
5,269,250
|
Short-term notes |
124,886
|
460,534
|
Mortgage loans |
|
3,504,605
|
Receivables funding |
324,704
|
416,731
|
Government assistance loans |
14,925
|
14,818
|
Operating lease liability |
32,753
|
287,017
|
Finance lease liability |
8,289
|
7,891
|
Accrued dividends |
|
194,829
|
Related party payables |
2,670,008
|
2,713,878
|
Total current liabilities |
7,713,189
|
13,289,131
|
Non-current liabilities |
|
|
Government assistance loans |
24,282
|
79,555
|
Deferred taxes |
170,855
|
217,451
|
Third party loans |
248,757
|
578,335
|
Operating lease liability |
9,339,227
|
1,206,413
|
Finance lease liability |
18,648
|
24,952
|
Total non-current liabilities |
9,801,769
|
2,106,706
|
Total liabilities |
17,514,958
|
15,395,837
|
Preferred stock - Series A; $0.01 par value, 10,000,000 shares authorized 4,000,000 shares outstanding as of September 30, 2023 and December 31, 2022, respectively. |
40,000
|
40,000
|
Common stock - $0.01 par value, 10,000,000,000 shares authorized; 3,729,053,805 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively. |
37,290,539
|
37,290,539
|
Additional paid-in capital |
26,187,925
|
23,419,917
|
Discount for shares issued below par value |
(27,363,367)
|
(27,363,367)
|
Accumulated other comprehensive loss |
|
(5,065)
|
Accumulated deficit |
(41,960,217)
|
(43,484,751)
|
Stockholders’ deficit attributable to Ethema Health Corporation stockholders’ |
(5,805,120)
|
(10,102,727)
|
Non-controlling interest |
298,090
|
870,184
|
Total stockholders’ deficit |
(5,507,030)
|
(9,232,543)
|
Total liabilities and stockholders’ deficit |
12,007,928
|
6,563,294
|
Redeemable Preferred Stock [Member] |
|
|
Non-current liabilities |
|
|
Preferred stock - Series A; $0.01 par value, 10,000,000 shares authorized 4,000,000 shares outstanding as of September 30, 2023 and December 31, 2022, respectively. |
|
$ 400,000
|
X |
- References
+ Details
Name: |
grst_LoansFromOtherFederalHomeLoanBanksCurrent |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
grst_LoansFromOtherFederalHomeLoanBanksNonCurrent |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
grst_StockholdersDeficitAttributableToEthemaHealthCorporationStockholders |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
grst_ThirdPartyLoans |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionSum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 45 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522
+ Details
Name: |
us-gaap_AccountsReceivableNetCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAccumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(4)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(a)(3)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 40 -Section 65 -Paragraph 2 -Subparagraph (h)(2) -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 40 -Section 65 -Paragraph 2 -Subparagraph (g)(2)(ii) -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14 -URI https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580
+ Details
Name: |
us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(1)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_AdditionalPaidInCapital |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of allowance for credit loss on financing receivable, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(4)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 326 -SubTopic 20 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446
+ Details
Name: |
us-gaap_AllowanceForNotesAndLoansReceivableCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionSum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(11)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(12)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (bb) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599
+ Details
Name: |
us-gaap_Assets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionSum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (bb) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(9)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
+ Details
Name: |
us-gaap_AssetsCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_AssetsCurrentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionSum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (bb) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
+ Details
Name: |
us-gaap_AssetsNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_AssetsNoncurrentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_CashAndCashEquivalentsAtCarryingValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionDiscount on common shares, or any unamortized balance thereof, shown separately as a deduction from the applicable account(s) as circumstances require.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.4-07) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187103-122770
+ Details
Name: |
us-gaap_CommonStockDiscountOnShares |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_CommonStockValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThe portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_ConvertibleDebtCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThe carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_DepositAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_DividendsPayableCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from finance lease, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 926 -SubTopic 20 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionSum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19-26) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (bb) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
+ Details
Name: |
us-gaap_Liabilities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(23)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(25)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(32)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
+ Details
Name: |
us-gaap_LiabilitiesAndStockholdersEquity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (bb) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765
Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_LiabilitiesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_LiabilitiesCurrentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of obligation due after one year or beyond the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 201.5-02(25)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(23)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 201.5-02(26)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 201.5-02(24)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (bb) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
+ Details
Name: |
us-gaap_LiabilitiesNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_LiabilitiesNoncurrentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTotal of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(24)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(22)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
+ Details
Name: |
us-gaap_MinorityInterest |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_OperatingLeaseLiabilityCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_OperatingLeaseLiabilityNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's right to use underlying asset under operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_OperatingLeaseRightOfUseAsset |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of current assets classified as other.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(8)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
+ Details
Name: |
us-gaap_OtherAssetsCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
+ Details
Name: |
us-gaap_PreferredStockValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 340 -SubTopic 10 -Section 05 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(7)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_PrepaidExpenseCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(8)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 360 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630
Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionThe cumulative amount of the reporting entity's undistributed earnings or deficit.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(3)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(a)(4)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 40 -Section 65 -Paragraph 2 -Subparagraph (h)(2) -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 40 -Section 65 -Paragraph 2 -Subparagraph (g)(2)(i) -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641
+ Details
Name: |
us-gaap_RetainedEarningsAccumulatedDeficit |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(16)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(16)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_SecuredDebt |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionReflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(19)(a)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(16)(a)(1)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(13)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878
+ Details
Name: |
us-gaap_ShortTermBorrowings |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionTotal of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 4.E) -URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details
Name: |
us-gaap_StockholdersEquity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEET (Unaudited) (Parenthetical) - $ / shares
|
Sep. 30, 2023 |
Dec. 31, 2022 |
Preferred Stock, Par or Stated Value Per Share |
$ 0.01
|
$ 0.01
|
Preferred Stock, Shares Authorized |
10,000,000
|
10,000,000
|
Preferred Stock, Shares Issued |
4,000,000
|
4,000,000
|
Preferred Stock, Shares Outstanding |
4,000,000
|
4,000,000
|
Common Stock, Par or Stated Value Per Share |
$ 0.01
|
$ 0.01
|
Common Stock, Shares Authorized |
10,000,000,000
|
10,000,000,000
|
Common Stock, Shares, Issued |
3,729,053,805
|
3,729,053,805
|
Common Stock, Shares, Outstanding |
3,729,053,805
|
3,729,053,805
|
Redeemable Preferred Stock [Member] |
|
|
Preferred Stock, Par or Stated Value Per Share |
$ 1.00
|
$ 1.00
|
Preferred Stock, Shares Authorized |
10,000,000
|
10,000,000
|
Preferred Stock, Shares Issued |
0
|
400,000
|
Preferred Stock, Shares Outstanding |
0
|
400,000
|
X |
- DefinitionFace amount or stated value per share of common stock.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_CommonStockParOrStatedValuePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_CommonStockSharesAuthorized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionTotal number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_CommonStockSharesIssued |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionNumber of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_CommonStockSharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionFace amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644
+ Details
Name: |
us-gaap_PreferredStockParOrStatedValuePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_PreferredStockSharesAuthorized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionTotal number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644
+ Details
Name: |
us-gaap_PreferredStockSharesIssued |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionAggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_PreferredStockSharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- Details
Name: |
us-gaap_StatementClassOfStockAxis=us-gaap_RedeemablePreferredStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)
|
3 Months Ended |
9 Months Ended |
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Income Statement [Abstract] |
|
|
|
|
Revenues |
$ 1,353,899
|
$ 1,424,943
|
$ 4,219,904
|
$ 3,586,290
|
Operating expenses |
|
|
|
|
General and administrative |
249,283
|
289,073
|
755,685
|
760,533
|
Rent expense |
107,707
|
114,717
|
328,204
|
314,256
|
Management fees |
30,000
|
30,000
|
273,003
|
90,000
|
Professional fees |
171,659
|
19,131
|
460,773
|
180,867
|
Salaries and wages |
651,537
|
580,432
|
1,873,280
|
1,456,099
|
Depreciation and amortization |
110,185
|
136,608
|
388,259
|
402,851
|
Total operating expenses |
1,320,371
|
1,169,961
|
4,079,204
|
3,204,606
|
Operating Income |
33,528
|
254,982
|
140,700
|
381,684
|
Other Income (expense) |
|
|
|
|
Other income |
110
|
(1,045)
|
449
|
10,018
|
Forgiveness of government assistance loan |
|
104,368
|
|
104,368
|
Penalty on convertible debt |
|
|
(34,688)
|
|
Extension fee on property purchase |
|
|
(130,000)
|
|
Gain on disposal of property |
2,484,172
|
|
2,484,172
|
|
Loss on debt extinguishment |
(277,175)
|
|
(277,175)
|
|
Interest expense |
(81,371)
|
(163,561)
|
(382,448)
|
(367,177)
|
Amortization of debt discount |
(73,857)
|
(87,704)
|
(238,304)
|
(551,738)
|
Derivative liability movement |
|
45,156
|
|
175,593
|
Foreign exchange movements |
6,598
|
404,538
|
(84,148)
|
502,350
|
Net income before income taxes |
2,092,005
|
556,734
|
1,478,558
|
255,098
|
Benefit from (provision for) Income taxes |
15,532
|
(44,652)
|
221,107
|
(87,615)
|
Net income |
2,107,537
|
512,082
|
1,699,665
|
167,483
|
Net income attributable to non-controlling interest |
(31,058)
|
(28,787)
|
(127,906)
|
(52,425)
|
Net income allocable to Ethema Health Corporation Stockholders |
2,076,479
|
483,295
|
1,571,759
|
115,058
|
Preferred stock dividend |
|
(24,582)
|
(47,225)
|
(73,923)
|
Net income available to common shareholders of Ethema Health Corporation |
2,076,479
|
458,713
|
1,524,534
|
41,135
|
Accumulated other comprehensive loss |
|
|
|
|
Foreign currency translation adjustment |
|
(169,965)
|
5,065
|
(208,317)
|
Total comprehensive income (loss) |
$ 2,076,479
|
$ 288,748
|
$ 1,529,599
|
$ (167,182)
|
Income per share |
|
|
|
|
Basic |
$ 0.00
|
$ 0.00
|
$ 0.00
|
$ 0.00
|
Diluted |
$ 0.00
|
$ 0.00
|
$ 0.00
|
$ 0.00
|
Weighted average common shares outstanding |
|
|
|
|
Basic |
3,729,053,805
|
3,729,053,805
|
3,729,053,805
|
3,696,636,223
|
Diluted |
3,931,379,775
|
4,276,544,380
|
3,931,379,775
|
4,244,126,798
|
X |
- References
+ Details
Name: |
grst_BasicPerShare |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_DilutedPerShare |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ExtensionFeeOnPropertyPurchase |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ForeignExchangeMovements |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NetIncomeAllocableToEthemaHealthCorporationStockholders |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NetIncomeAvailableToCommonShareholdersOfEthemaHealthCorporation |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NetIncomeLossOne |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_PenaltyOnConvertibleDebt |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_RentExpense |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_WeightedAverageCommonSharesOutstandingBasic |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_WeightedAverageCommonSharesOutstandingBasicAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_WeightedAverageCommonSharesOutstandingDiluted |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 1A -URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1F -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.8) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
+ Details
Name: |
us-gaap_AmortizationOfDebtDiscountPremium |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in deferred policy acquisition cost due to the effect of foreign currency translation gain (loss) and increase (decrease) classified as other.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 30 -Section 50 -Paragraph 2B -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124505477&loc=SL117422543-158416
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 40 -Section 65 -Paragraph 2 -Subparagraph (g)(1) -URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641
+ Details
Name: |
us-gaap_DeferredPolicyAcquisitionCostForeignCurrencyTranslationAdjustmentAndOther |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_DepreciationAndAmortization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in the fair value of derivatives recognized in the income statement.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b)(1) -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959
+ Details
Name: |
us-gaap_DerivativeGainLossOnDerivativeNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 405 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817
+ Details
Name: |
us-gaap_DividendsPreferredStock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_EarningsPerShareAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230
+ Details
Name: |
us-gaap_GainLossOnDispositionOfAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionDifference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 50 -Section 40 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 50 -Section 40 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_GainsLossesOnExtinguishmentOfDebt |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
+ Details
Name: |
us-gaap_GeneralAndAdministrativeExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of government assistance recognized.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 832 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=128342832&loc=SL128342943-244231
+ Details
Name: |
us-gaap_GovernmentAssistanceAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_IncomeStatementAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionRepresents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 55 -Paragraph 69E -URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1F -Subparagraph (b)(1) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 55 -Paragraph 69F -URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph 8 -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
+ Details
Name: |
us-gaap_InterestExpenseDebtExcludingAmortization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864
+ Details
Name: |
us-gaap_ManagementFeeExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of Net Income (Loss) attributable to noncontrolling interest.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a)(2) -URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067
+ Details
Name: |
us-gaap_NetIncomeLossAttributableToNoncontrollingInterest |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
+ Details
Name: |
us-gaap_NonoperatingIncomeExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_OperatingCostsAndExpensesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionGenerally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
+ Details
Name: |
us-gaap_OperatingExpenses |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_OperatingExpensesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe net result for the period of deducting operating expenses from operating revenues.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
+ Details
Name: |
us-gaap_OperatingIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of tax expense (benefit) allocated to other comprehensive income (loss).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 20 -Section 45 -Paragraph 11 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 45 -Paragraph 17 -URI https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 45 -Paragraph 20 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 20 -Section 45 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(23)) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(21)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901
Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 12 -URI https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(19)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263
+ Details
Name: |
us-gaap_OtherComprehensiveIncomeLossTax |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionA fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07.2(a),(b),(c),(d)) -URI https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 220 -Section 45 -Paragraph 3 -Subparagraph (k) -URI https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268
+ Details
Name: |
us-gaap_ProfessionalFees |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 235 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
+ Details
Name: |
us-gaap_Revenues |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(4)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
+ Details
Name: |
us-gaap_SalariesAndWages |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS DEFICIT (Unaudited) - USD ($)
|
Series A Preferred Stock [Member] |
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Discount To Par Value [Member] |
AOCI Attributable to Parent [Member] |
Retained Earnings [Member] |
Noncontrolling Interest [Member] |
Total |
Beginning balance, value at Dec. 31, 2021 |
$ 40,000
|
$ 35,790,539
|
$ 22,791,350
|
$ (26,013,367)
|
$ 816,532
|
$ (44,103,311)
|
$ 822,876
|
$ (9,855,381)
|
Beginning balance shares at Dec. 31, 2021 |
4,000,000
|
3,579,053,805
|
|
|
|
|
|
|
Foreign currency translation |
|
|
|
|
34,517
|
|
|
34,517
|
Net income |
|
|
|
|
|
(174,447)
|
9,462
|
(164,985)
|
Dividends accrued |
|
|
|
|
|
(24,613)
|
|
(24,613)
|
Conversion of convertible notes |
|
$ 1,500,000
|
|
(1,350,000)
|
|
|
|
150,000
|
Conversion of convertible notes |
|
150,000,000
|
|
|
|
|
|
|
Ending balance, value at Mar. 31, 2022 |
$ 40,000
|
$ 37,290,539
|
22,791,350
|
(27,363,367)
|
851,049
|
(44,302,371)
|
832,338
|
(9,860,462)
|
Ending balance at Mar. 31, 2022 |
4,000,000
|
3,729,053,805
|
|
|
|
|
|
|
Foreign currency translation |
|
|
|
|
(72,869)
|
|
|
(72,869)
|
Net income |
|
|
|
|
|
(193,790)
|
14,176
|
(179,614)
|
Dividends accrued |
|
|
|
|
|
(24,728)
|
|
(24,728)
|
Ending balance, value at Jun. 30, 2022 |
$ 40,000
|
$ 37,290,539
|
22,791,350
|
(27,363,367)
|
778,180
|
(44,520,889)
|
846,514
|
(10,137,673)
|
Ending balance at Jun. 30, 2022 |
4,000,000
|
3,729,053,805
|
|
|
|
|
|
|
Foreign currency translation |
|
|
|
|
(169,965)
|
|
|
(169,965)
|
Net income |
|
|
|
|
|
483,294
|
28,787
|
512,082
|
Dividends accrued |
|
|
|
|
|
(24,582)
|
|
(24,582)
|
Ending balance, value at Sep. 30, 2022 |
$ 40,000
|
37,290,539
|
$ 22,791,350
|
(27,363,367)
|
608,215
|
(44,062,177)
|
875,301
|
(9,820,139)
|
Ending balance at Sep. 30, 2022 |
4,000,000
|
|
3,729,053,805
|
|
|
|
|
|
Beginning balance, value at Dec. 31, 2022 |
$ 40,000
|
$ 37,290,539
|
$ 23,419,917
|
(27,363,367)
|
(5,065)
|
(43,484,751)
|
870,184
|
(9,232,543)
|
Beginning balance shares at Dec. 31, 2022 |
4,000,000
|
3,729,053,805
|
|
|
|
|
|
|
Foreign currency translation |
|
|
|
|
(1,504)
|
|
|
(1,504)
|
Net income |
|
|
|
|
|
(178,685)
|
2,968
|
(175,717)
|
Dividends accrued |
|
|
|
|
|
(23,419)
|
|
(23,419)
|
Ending balance, value at Mar. 31, 2023 |
$ 40,000
|
$ 37,290,539
|
23,419,917
|
(27,363,367)
|
(6,569)
|
(43,686,855)
|
873,152
|
(9,433,183)
|
Ending balance at Mar. 31, 2023 |
4,000,000
|
3,729,053,805
|
|
|
|
|
|
|
Foreign currency translation |
|
|
|
|
6,569
|
|
|
6,569
|
Net income |
|
|
|
|
|
(326,035)
|
93,880
|
232,155
|
Dividends accrued |
|
|
|
|
|
(23,806)
|
|
(23,806)
|
Disposal of subsidiary to related party |
|
|
2,034,885
|
|
|
|
(700,000)
|
1,334,885
|
Deemed extinguishment of debt by related party |
|
|
461,184
|
|
|
|
|
461,184
|
Ending balance, value at Jun. 30, 2023 |
$ 40,000
|
$ 37,290,539
|
25,915,986
|
(27,363,367)
|
|
(44,036,696)
|
267,032
|
(7,886,506)
|
Ending balance at Jun. 30, 2023 |
4,000,000
|
3,729,053,805
|
|
|
|
|
|
|
Net income |
|
|
|
|
|
2,076,479
|
31,058
|
2,107,537
|
Fair value of warrants issued for debt extinguishment |
|
|
271,939
|
|
|
|
|
271,939
|
Ending balance, value at Sep. 30, 2023 |
$ 40,000
|
$ 37,290,539
|
$ 26,187,925
|
$ (27,363,367)
|
|
$ (41,960,217)
|
$ 298,090
|
$ (5,507,030)
|
Ending balance at Sep. 30, 2023 |
4,000,000
|
|
3,729,053,805
|
|
|
|
|
|
X |
- References
+ Details
Name: |
grst_FairValueOfWarrantsIssuedForDebtExtinguishment |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 405 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817
+ Details
Name: |
us-gaap_Dividends |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 65 -Paragraph 1 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 60B -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580
Reference 25: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599
Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to noncontrolling interests.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (c)(3) -URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683
+ Details
Name: |
us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionNumber of shares issued which are neither cancelled nor held in the treasury.
+ References
+ Details
Name: |
us-gaap_SharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionNumber of shares issued during the period as a result of the conversion of convertible securities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-30) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1E -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe gross value of stock issued during the period upon the conversion of convertible securities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionTotal of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 4.E) -URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details
Name: |
us-gaap_StockholdersEquity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.23.3
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) - USD ($)
|
9 Months Ended |
Sep. 30, 2023 |
Sep. 30, 2022 |
Operating activities |
|
|
Net income |
$ 1,699,665
|
$ 167,483
|
Adjustment to reconcile net income to net cash (used in) provided by operating activities: |
|
|
Depreciation and amortization |
388,259
|
402,851
|
Forgiveness of government assistance loan |
|
(104,368)
|
Non-cash interest accrual on escrow deposit |
|
758
|
Gain on disposal of property |
(2,484,172)
|
|
Loss on debt extinguishment |
277,175
|
|
Penalty on convertible notes |
34,688
|
|
Amortization of debt discount |
238,304
|
564,006
|
Derivative liability movements |
|
(175,593)
|
Non-cash deferred tax movements |
(46,597)
|
(56,382)
|
Amortization of right of use asset |
169,682
|
194,086
|
Changes in operating assets and liabilities (net of assets acquired and liabilities assumed) |
|
|
Accounts receivable |
(289,697)
|
(145,833)
|
Prepaid expenses and other current assets |
(48,457)
|
(14,891)
|
Accounts payable and accrued liabilities |
(110,110)
|
211,771
|
Operating lease liability |
(167,319)
|
(179,009)
|
Taxes payable |
(237,211)
|
154,234
|
Net cash (used in) provided by operating activities |
(575,790)
|
1,019,113
|
Investing activities |
|
|
Acquisition of property, plant and equipment |
(5,244,011)
|
(285,103)
|
Proceeds on disposal of property |
8,093,448
|
|
Deposit paid |
(374,000)
|
(50,000)
|
Net cash provided by (used in) investing activities |
2,475,437
|
(335,103)
|
Financing activities |
|
|
Repayment of mortgage loans |
(58,320)
|
(88,586)
|
Proceeds from convertible loans |
150,000
|
|
Repayment of convertible loans |
(1,124,442)
|
|
Repayment of federal assistance loans |
(10,855)
|
|
Proceeds from short term loans |
223,500
|
160,000
|
Repayment of short term loans |
(568,325)
|
(289,044)
|
Repayment of third party loans |
(361,260)
|
(77,953)
|
Repayment of finance leases |
(5,907)
|
(5,531)
|
Proceeds from receivables funding |
580,646
|
440,000
|
Repayment of receivables funding |
(848,417)
|
(80,000)
|
Proceeds from related party notes |
|
334,299
|
Repayment of related party notes |
(76,296)
|
|
Net cash (used in) provided by financing activities |
(2,099,676)
|
393,185
|
Effect of exchange rate on cash |
71,000
|
(564,934)
|
Net change in cash |
(129,029)
|
512,261
|
Beginning cash balance |
140,757
|
48,822
|
Ending cash balance |
11,728
|
561,083
|
Supplemental cash flow information |
|
|
Cash paid for interest |
334,735
|
158,511
|
Cash paid for income taxes |
|
|
Non-cash investing and financing activities |
|
|
Conversion of convertible notes |
|
$ 150,000
|
X |
- References
+ Details
Name: |
grst_ConversionOfConvertibleNotes |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_DerivativeLiabilityMovements |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ForgivenessOfGovernmentAssistanceLoan |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_GainsLossesOnExtinguishmentOfDebt1 |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NoncashDeferredTaxMovements |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NoncashInterestAccrualOnEscrowDeposit |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_PenaltyOnConvertibleNotes |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ProceedsFromConvertibleLoans |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ProceedsOnDisposalOfProperty |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_RepaymentOfConvertibleLoans |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_RepaymentOfFederalAssistanceLoans |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_RepaymentOfMortgageLoans |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586
+ Details
Name: |
us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585
+ Details
Name: |
us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_DepreciationDepletionAndAmortization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906
+ Details
Name: |
us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_GainLossOnDispositionOfAssets1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_IncreaseDecreaseInAccountsReceivable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_IncreaseDecreaseInAccruedTaxesPayable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_IncreaseDecreaseInOperatingCapitalAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in obligation for operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (g)(1) -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_IncreaseDecreaseInOperatingLeaseLiability |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in prepaid expenses, and assets classified as other.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 17 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585
+ Details
Name: |
us-gaap_InterestPaidNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInFinancingActivities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInInvestingActivities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInOperatingActivities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of amortization expense for right-of-use asset from operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of amortization of other deferred costs recognized in the income statement.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
+ Details
Name: |
us-gaap_OtherAmortizationOfDeferredCharges |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe amount of cash paid for deposits on goods and services during the period; excludes time deposits and deposits with other institutions, which pertain to financial service entities.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 17 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 17 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585
+ Details
Name: |
us-gaap_PaymentsForDeposits |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585
+ Details
Name: |
us-gaap_PaymentsToAcquirePropertyPlantAndEquipment |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash inflow associated with principal collections from a borrowing supported by a written promise to pay an obligation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585
+ Details
Name: |
us-gaap_ProceedsFromCollectionOfNotesReceivable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe cash inflow from an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585
+ Details
Name: |
us-gaap_ProceedsFromSubordinatedShortTermDebt |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 65 -Paragraph 1 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 235 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884
Reference 23: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684
Reference 31: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686
Reference 32: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794
+ Details
Name: |
us-gaap_ProfitLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionRepayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585
+ Details
Name: |
us-gaap_RepaymentsOfAccountsReceivableSecuritization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (a),(b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585
+ Details
Name: |
us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash outflow for the payment of debt classified as other.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585
+ Details
Name: |
us-gaap_RepaymentsOfOtherDebt |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash outflow for an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585
+ Details
Name: |
us-gaap_RepaymentsOfSubordinatedShortTermDebt |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
v3.23.3
Disclocure - Disposal of subsidiary (Details)
|
Sep. 30, 2023
USD ($)
|
Assets |
|
Other receivable |
$ 12,015
|
Property and equipment |
2,420,499
|
|
2,432,514
|
Liabilities |
|
Accounts payable and accrued liabilities |
(196,859)
|
Government assistance loans |
(45,317)
|
Mortgage loan |
(3,525,223)
|
|
(3,767,399)
|
Disposal of subsidiary to related party – recorded as additional paid in capital |
$ (1,334,885)
|
X |
- References
+ Details
Name: |
grst_DisposalGroupIncludingDiscontinuedOperationGovernmentAssistanceLoans |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_AssetsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5B -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759
+ Details
Name: |
us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5B -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760
+ Details
Name: |
us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5B -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5C -Subparagraph (a)(2) -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759
+ Details
Name: |
us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5B -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760
+ Details
Name: |
us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5B -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759
+ Details
Name: |
us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_LiabilitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5C -Subparagraph (a)(2) -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5B -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759
+ Details
Name: |
us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.23.3
Nature of business
|
9 Months Ended |
Sep. 30, 2023 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
|
Nature of business |
1. Nature
of business
Since
2010, the Company has operated addiction treatment centers. Initially the Company operated an addiction treatment center in Ontario Canada
under its Greenestone Muskoka clinic, which was sold on February 14, 2017. Simultaneously with this sale the Company purchased buildings
and operated an addiction treatment center in Delray Beach, Florida under its Addiction Recovery Institute of America subsidiary with
a license obtained in December 2016, initially through owned properties in Delray Beach and subsequently though leased properties in
West Palm Beach, Florida. Since June 30, 2020, the Company has been actively involved in the management of a treatment center operated
by Evernia in West Palm Beach, Florida. On July 1, 2021, the Company closed on the acquisition of 75% of ATHI, which owns 100% of Evernia,
once the probationary approval of a license was obtained from the Department of Children and Family Services of Florida. Evernia is the
only active treatment center operated by the Company.
The
Company also owned the real estate on which its Greenstone Muskoka clinic operated. The current tenant operates an addiction treatment
center on these premises. The Company collected rent on this property, which is treated as a separate business segment. On
June 30, 2023, the Company sold Cranberry Cove Holdings, in which the real estate was registered to Leonite Capital, in exchange for
the cancellation of preferred shares and the accrued dividend liability owed on the preferred shares.
|
X |
- DefinitionThe entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI https://asc.fasb.org/topic&trid=2134479
+ Details
Name: |
us-gaap_NatureOfOperations |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Summary of significant accounting policies
|
9 Months Ended |
Sep. 30, 2023 |
Accounting Policies [Abstract] |
|
Summary of significant accounting policies |
2. Summary
of significant accounting policies
Financial
Reporting
The
(a) unaudited condensed consolidated balance sheets as of September 30, 2023, and as of December 31, 2022, which has been derived from
audited consolidated financial statements, and (b) the unaudited condensed consolidated statements of operations, stockholders’
deficit and cash flows of the Company, have been prepared in accordance with accounting principles generally accepted in the
United States (“US GAAP”) for interim financial information and the instructions to Form 10-Q and Rule 8-03 of Regulation
S-X. Accordingly, they do not include all of the information and footnotes required by US GAAP for complete financial statements. In
the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have
been included. Operating results for the three and nine months ended September 30, 2023 are not necessarily indicative of results that
may be expected for the year ending December 31, 2023. These unaudited condensed consolidated financial statements should be read in
conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Form 10-K for the year
ended December 31, 2022, filed with the Securities and Exchange Commission (“SEC”) on March 31, 2023.
All
amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless
stated otherwise.
a) Use
of Estimates
The
preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting
periods. Actual results could differ from those estimates.
b) Principles
of consolidation and foreign translation
The
accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all of its subsidiaries. All
intercompany transactions and balances have been eliminated on consolidation.
Certain
of the Company’s subsidiaries functional currency is the Canadian dollar, while the Company’s reporting currency is the U.S.
dollar. All transactions initiated in Canadian dollars are translated into US dollars in accordance with ASC 830, “Foreign Currency
Translation” as follows:
|
● |
Monetary
assets and liabilities at the rate of exchange in effect at the balance sheet date. |
|
● |
Certain
non-monetary assets and liabilities and equity at historical rates. |
|
● |
Revenue
and expense items and cash flows at the average rate of exchange prevailing during the year. |
Adjustments
arising from such translations are deferred until realization and are included as a separate component of stockholders’ deficit
as a component of accumulated other comprehensive income or loss. Therefore, translation adjustments are not included in determining
net income (loss) but reported as other comprehensive income (loss).
b) Principles
of consolidation and foreign translation (continued)
For
foreign currency transactions, the Company translates these amounts to the Company’s functional currency at the exchange rate effective
on the invoice date. If the exchange rate changes between the time of purchase and the time actual payment is made, a foreign exchange
transaction gain or loss results which is included in determining net income for the year.
On
June 30, 2023, the Company disposed on Cranberry Cove Holdings whose functional currency was Canadian Dollars, all remaining subsidiaries
have the U.S. dollar as a functional currency.
The
relevant translation rates are as follows: The Company disposed of Cranberry cove Holdings on June 30, 2023, the exchange rates used
for the six months in which it had control over Cranberry cove holdings was as follows; for the six months ended June 30, 2023, a closing
rate of CDN$1 equals US$0.7553 and an average exchange rate of CDN$1 equals US$0.7420, and for the year ended December 31, 2022, a closing
rate of CDN$1.0000 equals US$0.7383 and an average exchange rate of CDN$1.0000 equals US$0.7686.
c) Cash
and cash equivalents
For
purposes of the statements of cash flows, the Company considers all highly liquid instruments purchased with a maturity of three months
or less and money market accounts to be cash equivalents. The Company maintains cash and cash equivalents with several financial institutions
in the USA and Canada. There were no cash equivalents at September 30, 2023 and December 31, 2022.
The
Company primarily places cash balances in the USA with high-credit quality financial institutions located in the United States which
are insured by the Federal Deposit Insurance Corporation up to a limit of $250,000 per institution, in Canada which are insured
by the Canadian Deposit Insurance Corporation up to a limit of CDN$100,000 per institution.
d) Accounts
receivable
Accounts
receivable primarily consists of amounts due from third-party payors (non-governmental) and private pay patients and is recorded net
of allowances for doubtful accounts and contractual discounts. The Company’s ability to collect outstanding receivables is critical
to its results of operations and cash flows. Accordingly, accounts receivable reported in the Company’s unaudited condensed consolidated
financial statements is recorded at the net amount expected to be received. The Company’s primary collection risks are (i) the
risk of overestimating net revenues at the time of billing that may result in the Company receiving less than the recorded receivable,
(ii) the risk of non-payment as a result of commercial insurance companies denying claims, (iii) the risk that patients will
fail to remit insurance payments to the Company when the commercial insurance company pays out-of-network claims directly to the patient,
(iv) resource and capacity constraints that may prevent the Company from handling the volume of billing and collection issues in
a timely manner, (v) the risk that patients do not pay the Company for their self-pay balances (including co-pays, deductibles and
any portion of the claim not covered by insurance) and (vi) the risk of non-payment from uninsured patients.
e) Allowance
for Doubtful Accounts, Contractual and Other Discounts
The
Company derives the majority of its revenues from commercial payors at in-network rates. The Company recognizes revenue based on historical
collections received from healthcare providers, recognizing only a percentage of revenues actually billed. Effectively recognizing revenue
net of any expected billing differentials. Based on the Company’s collection experience, the percentage of revenue recognized is
adjusted on a periodic basis, thereby taking into account expected credit losses in the revenue recognition process. The revenue we recognize
is already net of expected credit losses, therefore management does not maintain a separate allowance for doubtful accounts, contractual
and other discounts.
Management
also takes into consideration the age of accounts, creditworthiness and current economic trends when evaluating the percentage of revenue
to be recognized.
f) Property
and equipment
Property
and equipment is recorded at cost. Depreciation is calculated on the straight line basis over the estimated life of the asset.
g) Intangible
assets
Intangible
assets are stated at acquisition cost less accumulated amortization, if applicable, less any adjustments for impairment losses.
Amortization
is charged on a straight-line basis over the estimated remaining useful lives of the individual intangibles. Where intangibles are deemed
to be impaired the Company recognizes an impairment loss measured as the difference between the estimated fair value of the intangible
and its book value.
Licenses
to provide substance abuse rehabilitation services are amortized over the expected life of the contract, including any anticipated renewals.
The Company expects its licenses to remain in operation for a period of five years.
h) Leases
The
Company accounts for leases in terms of AC 842 whereby leases are classified as either finance or operating leases. Leases that transfer
substantially all of the benefits and inherent risks of ownership of property to the Company are accounted for as finance leases. At
the time a finance lease is entered into, an asset is recorded together with its related long-term obligation to reflect the acquisition
and financing. Property and equipment recorded under finance leases is amortized on the same basis as described above. Operating leases
are recognized on the balance sheet as a lease liability with a corresponding right of use asset for all leases with a term that is more
than twelve months. Payments under operating leases are expensed as incurred.
i) Derivatives
The
Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine
whether the embedded conversion feature should be bifurcated from the host instrument and accounted for as a derivative at fair value
with changes in fair value recorded in earnings. The Company previously used a Black Scholes Option Pricing model to estimate the fair
value of convertible debt conversion features at the end of each applicable reporting period. Changes in the fair value of these derivatives
during each reporting period were included in the statements of operations. Inputs into the Black Scholes Option Pricing model require
estimates, including such items as estimated volatility of the Company’s stock, risk free interest rate and the estimated life
of the financial instruments being fair valued.
j) Financial
instruments
The
Company initially measures its financial assets and liabilities at fair value. The Company subsequently measures all its financial assets
and financial liabilities at amortized cost.
Financial
assets measured at amortized cost include cash and accounts receivable.
Financial
liabilities measured at amortized cost include bank indebtedness, accounts payable and accrued liabilities, harmonized sales tax payable,
withholding taxes payable, convertible notes payable, loans payable and related party notes.
Financial
assets measured at cost are tested for impairment when there are indicators of impairment. The amount of the write-down is recognized
in net income. The previously recognized impairment loss may be reversed to the extent of the improvement, directly or by adjusting the
allowance account, provided it is no greater than the amount that would have been reported at the date of the reversal had the impairment
not been recognized previously. The amount of the reversal is recognized in net income. The Company recognizes its transaction costs
in net income in the period incurred. However, financial instruments that will not be subsequently measured at fair value are adjusted
by the transaction costs that are directly attributable to their origination, issuance or assumption.
FASB
ASC 820 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles,
and expands disclosures about fair value measurements. ASC 820 establishes a three tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value as follows:
|
· |
Level 1. Observable
inputs such as quoted prices in active markets; |
|
· |
Level 2. Inputs,
other than the quoted prices in active markets, that are observable either directly or indirectly; and |
|
· |
Level 3. Unobservable
inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions. |
The
Company measures its convertible debt and derivative liabilities associated therewith at fair value. These liabilities are revalued periodically
and the resultant gain or loss is realized through the consolidated Statement of Operations and Comprehensive Loss
k) Related
parties
Parties
are considered to be related to the Company if the parties directly or indirectly, through one or more intermediaries, control, are controlled
by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members
of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if
one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting
parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All
transactions are recorded at fair value of the goods or services exchanged.
l) Revenue
recognition
ASC
606 requires companies to exercise more judgment and recognize revenue using a five-step process.
The
Company’s provision for doubtful accounts are recorded as a direct reduction to revenue instead of being presented as a separate
line item on the consolidated statements of operations and comprehensive loss.
As
our performance obligations relate to contracts with a duration of one year or less, the Company elected the optional exemption in ASC
606-10-50-14(a). Therefore, the Company is not required to disclose the transaction price for the remaining performance obligations at
the end of the reporting period or when the Company expects to recognize the revenue. The Company has minimal unsatisfied performance
obligations at the end of the reporting period as our patients typically are under no obligation to remain admitted in our facilities.
The
Company receives payments from the following sources for services rendered in our U.S. Facility: (i) commercial insurers; and (ii) individual
patients and clients. As the period between the time of service and time of payment is typically one year or less, the Company elected
the practical expedient under ASC 606-10-32-18 and does not adjust for the effects of a significant financing component.
The
Company derives a significant portion of its revenue from other payors that receive discounts from established billing rates. The various
managed care contracts under which these discounts must be calculated are complex, subject to interpretation and adjustment, and may
include multiple reimbursement mechanisms for different types of services provided in the Company’s inpatient facilities and cost
settlement provisions. Management estimates the transaction price on a payor-specific basis given its interpretation of the applicable
regulations or contract terms. The services authorized and provided and related reimbursement are often subject to interpretation that
could result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract renegotiations
occur frequently, necessitating regular review and assessment of the estimation process by management.
Settlements
with third-party payors are estimated and recorded in the period in which the related services are rendered and are adjusted in future
periods as final settlements are determined. In the opinion of management, adequate provision has been made for any adjustments and final
settlements. However, there can be no assurance that any such adjustments and final settlements will not have a material effect on the
Company’s financial condition or results of operations. The Company’s receivables were $681,072, $337,074 and $176,011 at
September 30, 2023, December 31, 2022 and December 31, 2021, respectively. Management believes that these receivables are properly stated
and are not likely to be settled for a significantly different amount.
The
Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that
reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from
the sale of its services. The Company applies the following five steps in order to determine the appropriate amount of revenue to
be recognized as it fulfills its obligations under each of its revenue transactions:
|
i. |
identify the
contract with a customer; |
|
ii. |
identify the
performance obligations in the contract; |
|
iii. |
determine the
transaction price; |
|
iv. |
allocate the
transaction price to performance obligations in the contract; and |
|
v. |
recognize revenue
as the performance obligation is satisfied. |
m) Income
taxes
The
Company accounts for income taxes under the provisions of ASC Topic 740, “Income Taxes”. Under ASC Topic
740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated
financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred income taxes are provided
using the liability method. Under this method, deferred income taxes are recognized for the tax consequences of temporary differences
by applying enacted statutory rates applicable to future years to differences between the financial statement carrying amounts and the
tax bases of existing assets and liabilities. The tax basis of an asset or liability is the amount attributed to that asset or liability
for tax purposes. The effect on deferred taxes of a change in tax rates is recognized in income in the period of change. A valuation
allowance is provided to reduce the amount of deferred tax assets if it is considered more likely than not that some portion of, or all
of, the deferred tax assets will not be realized.
ASC Topic
740 contains a two-step approach to recognizing and measuring uncertain tax positions taken or expected to be taken in a tax return.
The first step is to determine if the weight of available evidence indicates that it is more likely than not that the tax position will
be sustained in an audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax
benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company recognizes interest and
penalties accrued on unrecognized tax benefits within general and administrative expense. To the extent that accrued interest and penalties
do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction in general and administrative expenses
in the period that such determination is made. The tax returns for fiscal 2019, through 2022 are subject to audit or review by the US
tax authorities, whereas fiscal 2011 through 2022 are subject to audit or review by the Canadian tax authority.
n) Net
income per Share
Basic
net income per share is computed on the basis of the weighted average number of common stock outstanding during the year.
Diluted
net income per share is computed on the basis of the weighted average number of common stock and common stock equivalents outstanding.
Dilutive securities having an anti-dilutive effect on diluted net income per share are excluded from the calculation.
Dilution
is computed by applying the treasury stock method for options and warrants. Under this method, “in-the money” options and
warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained
thereby were used to purchase common stock at the average market price during the period. Dilution is computed by applying the if-converted
method for convertible preferred stocks. Under this method, convertible preferred stock is assumed to be converted at the beginning of
the period (or at the time of issuance, if later), and preferred dividends (if any) will be added back to determine income applicable
to common stock. The shares issuable upon conversion will be added to weighted average number of common stock outstanding. Conversion
will be assumed only if it reduces earnings per share (or increases loss per share).
o) Stock
based compensation
Stock
based compensation cost is measured at the grant date, based on the estimated fair value of the award and is recognized as expense over
the employee’s requisite service period or vesting period on a straight-line basis. Share-based compensation expense recognized
in the consolidated statements of operations for the nine months ended September 30, 2023 and 2022 is based on awards ultimately expected
to vest and has been reduced for estimated forfeitures. This estimate will be revised in subsequent periods if actual forfeitures differ
from those estimates. We have no awards with performance conditions and no awards dependent on market conditions.
There
were no stock -based compensation awards that vested during the nine months ended September 30, 2023 and 2022 and there was no stock based
compensation recorded in the unaudited condensed consolidated financial statements.
p) Financial
instruments risks
The
Company is exposed to various risks through its financial instruments. The following analysis provides a measure of the Company’s
risk exposure and concentrations at the balance sheet dates, September 30, 2023 and December 31, 2022.
Credit
risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an
obligation. Financial instruments that subject the Company to credit risk consist primarily of accounts receivable.
Credit
risk associated with accounts receivable is mitigated as only a percentage of the revenue billed to health insurance companies is recognized
as income until such time as the actual funds are collected. The revenue is concentrated amongst several health insurance companies located
in the US.
In
the opinion of management, credit risk with respect to accounts receivable is assessed as low.
Liquidity
risk is the risk the Company will not be able to meet its financial obligations as they fall due. The Company is exposed to liquidity
risk through its working capital deficiency of approximately $6.9 million, and an accumulated deficit of approximately $42.0 million.
The Company is dependent upon the raising of additional capital in order to implement its business plan. There is no assurance that the
Company will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect
on the Company’s financial condition. In the opinion of management, liquidity risk is assessed as high, material and remains unchanged
from that of the prior year.
Market
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices.
Market risk comprises of three types of risk: interest rate risk, currency risk, and other price risk. The Company is exposed to interest
rate risk.
Interest
rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
interest rates. The Company is exposed to interest rate risk on its convertible debt, short term loans, third party loans and government
assistance loans as of September 30, 2023. In the opinion of management, interest rate risk is assessed as moderate.
Currency
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange
rates. The Company is no longer subject to currency risk as it has disposed of its subsidiaries that operated in Canada.
Other
price risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
prices (other than those arising from interest rate risk or currency risk), whether those changes are caused by factors specific to the
individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market. In the opinion
of management, the Company is not exposed to this risk and remains unchanged from the prior year.
q) Allowance
for credit losses
The
Company recognizes revenue based on historical collections received from healthcare providers, recognizing only a percentage of revenues
actually billed. Effectively recognizing revenue net of any expected billing differentials. Based on the Company’s collection experience,
the percentage of revenue recognized is adjusted on a periodic basis, thereby taking into account expected credit losses in the revenue
recognition process. The revenue we recognize is already net of expected credit losses.
We
constantly evaluate our collections experience and consider the market conditions and current economic developments facing the Company’s
operations . We have not experienced significantly different collections to revenues we have recognized and we have not seen any deterioration
in the payment patterns from the healthcare providers that the Company works with, we cannot predict with any certainty that the payment
patterns the Company experiences may change and we may be required to adjust the percentage of revenue recognized.
r) Recent
accounting pronouncements
The
Financial Accounting Standards Board (“FASB”) issued additional updates during the nine months ended September 30, 2023.
None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material
impact on the Company’s consolidated financial statements upon adoption.
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for all significant accounting policies of the reporting entity.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -URI https://asc.fasb.org/topic&trid=2122369
+ Details
Name: |
us-gaap_SignificantAccountingPoliciesTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Going concern
|
9 Months Ended |
Sep. 30, 2023 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
|
Going concern |
3. Going
concern
The
Company’s unaudited condensed consolidated financial statements have been prepared in accordance with US GAAP applicable to a going
concern, which assumes that the Company will be able to meet its obligations and continue its operations in the normal course of business.
At September 30, 2023 the Company has a working capital deficiency of $6.9 million, and total liabilities in excess of assets in
the amount of $5.5 million. Management believes that current available resources will not be sufficient to fund the Company’s
planned expenditures over the next 12 months. These factors, individually and collectively indicate that a material uncertainty exists
that raises substantial doubt about the Company's ability to continue as a going concern for one year from the date of issuance of these
condensed interim consolidated financial statements.
The
Company will be dependent upon the raising of additional capital through placement of common shares, and/or debt financing in order to
implement its business plan and generating sufficient revenue in excess of costs. If the Company raises additional capital through the
issuance of equity securities or securities convertible into equity, stockholders will experience dilution, and such securities may have
rights, preferences or privileges senior to those of the holders of common stock or convertible senior notes. If the Company raises additional
funds by issuing debt, the Company may be subject to limitations on its operations, through debt covenants or other restrictions. If
the Company obtains additional funds through arrangements with collaborators or strategic partners, the Company may be required to relinquish
its rights to certain geographical areas, or techniques that it might otherwise seek to retain. There is no assurance that the Company
will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect on the
Company’s financial condition. These unaudited condensed consolidated financial statements do not include any adjustments to the
amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.
|
X |
- References
+ Details
Name: |
us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 40 -URI https://asc.fasb.org/subtopic&trid=51888271
+ Details
Name: |
us-gaap_SubstantialDoubtAboutGoingConcernTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Disposal of subsidiary
|
9 Months Ended |
Sep. 30, 2023 |
Discontinued Operations and Disposal Groups [Abstract] |
|
Disposal of subsidiary |
4. Disposal
of subsidiary
On
June 30, 2023, the Company entered into an exchange agreement with Leonite Capital, LLC, whereby it exchanged the 400,000 Series B shares
with a value of $400,000 plus accrued dividends thereon of $61,184 for its entire shareholding in its property owning subsidiary, Cranberry
Cove Holdings. The Series B shares were cancelled upon consummation of the transaction.
Immediately
prior to the disposal of Cranberry Cove Holdings, the Company assumed the loan owed to a third party of $779,005 and the loan owing to
Leon Developments of $1,973,837, Leon developments, a related party, owned by the Company’s CEO, Shawn Leon. In addition, the Company
forgave the intercompany debt owing by Cranberry Cove Holdings of $4,566,848.
The
assets and liabilities disposed of were as follows:
Schedule of Other Assets and Liabilities Disposed
| |
Net
book value |
Assets | |
| | |
Other
receivable | |
$ | 12,015 | |
Property
and equipment | |
| 2,420,499 | |
| |
| 2,432,514 | |
Liabilities | |
| | |
Accounts
payable and accrued liabilities | |
| (196,859 | ) |
Government
assistance loans | |
| (45,317 | ) |
Mortgage
loan | |
| (3,525,223 | ) |
| |
| (3,767,399 | ) |
| |
| | |
Disposal
of subsidiary to related party – recorded as additional paid in capital | |
$ | (1,334,885 | ) |
The
minority shareholders interest related to the Series A preferred stock in Cranberry Cove Holdings was recorded as a deemed contribution
to the Company and credited to additional paid in capital, resulting in a total credit to additional paid in capital of $2,034,885.
The
cancellation of the Series B shares, were owned by Leonite Capital, a related party, was deemed to be an extinguishment of debt by a related
party and recorded as a credit to additional paid in capital of $461,184.
|
X |
- References
+ Details
Name: |
us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -URI https://asc.fasb.org/topic&trid=2155823
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -URI https://asc.fasb.org/subtopic&trid=2122178
+ Details
Name: |
us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Property and equipment
|
9 Months Ended |
Sep. 30, 2023 |
Property, Plant and Equipment [Abstract] |
|
Property and equipment |
5. Property
and equipment
Acquisition
and simultaneous disposition of property
On
October 3, 2022 the Company entered into a purchase and sale agreement with Evernia Station Limited Partnership for the purchase of 950
Evernia Street, West Palm Beach, Florida (“950”), the property in which it operates its treatment center, for gross proceeds
of $5,500,000. (“Purchase Agreement”). The closing was originally scheduled for February 1, 2023, however through a series
of 6 addendums to the Purchase Agreement requiring the payment of a total $180,000 in extension fees, the Closing was extended to August
3, 2023.
On
February 27, 2023 the Company signed a listing agreement with Stream Capital Partners listing 950 for sale at a price of $9,568,000 with
the intention of identifying a buyer that would purchase and then potentially enter into a lease agreement with the Company.
On
May 4, 2023 the Company signed a Letter of Intent with Pontus Net Lease Advisers, LLC to sell 950 for $8,500,000 and lease the property
to the Company for a term of twenty years with two ten year extensions. On May 19, 2023, the Company signed a purchase and sale agreement
with Pontus Net Lease Advisors to sell 950 for $8,500,000. On August 4, 2023, the Company completed both the purchase of 950 from Evernia
Station Limited Partnership and the subsequent sale of 950 to Pontus Net Lease Advisors, LLC.
Simultaneously
with the closing of the purchase and sale agreements, on August 4, 2023, the Company entered into a long term lease for 950 with an initial
term of twenty years, and two ten year extension options. The lessor is Pontus EHC Palm Beach, LLC , a Delaware limited liability company
and a portfolio company of Pontus Net Lease Advisors, LLC. The lease is absolutely net and the lease cost for the initial year is $748,000
paid monthly. The lease increases at a rate of 2.75% per year for a total term lease obligation of $19,595,653 over the initial twenty-year
term. The Lease is personally guaranteed by the Company President and the guarantee may be released after 5 years based on certain financial
and performance metrics being met.
The
Company paid gross proceeds of $1,449,000 to Leonite Capital and Leonite Fund I, LP in settlement of all amounts outstanding to both
entities, disclosed in notes 8 and 9 above. In addition, $65,450 was paid to Ed Blasiak to settle the convertible promissory note disclosed
in note 8 above, $179,474 was paid to Joshua Bauman to settle the convertible promissory note disclosed in note 8 above, and $260,548
was paid to Mirage Realty, LLC to settle the senior secured promissory note, disclosed in note 9 above.
The
details of the property purchase and subsequent sale are as follows:
Property purchase and subsequent
| |
Amount |
Purchase
of 950 Evernia Street property | |
| | |
Purchase
price | |
$ | 5,500,000 | |
Fees
and expenses related to property purchase | |
| 109,276 | |
Total
acquisition cost | |
| 5,609,276 | |
| |
| | |
Proceeds
on sale | |
| 8,500,000 | |
Fees
and expenses related to disposal of the property | |
| (406,552 | ) |
Net
proceeds on disposal of property | |
| 8,093,448 | |
| |
| | |
Gain
on sale of property | |
$ | 2,484,172 | |
Property
and equipment consists of the following:
Schedule of sale of property
| |
| |
September
30, 2023 | |
December
31, 2022 |
| |
Useful lives | |
Cost | |
Accumulated
depreciation | |
Net
book value | |
Net
book value |
Land | |
Indefinite | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | 158,742 | |
Property | |
25 years | |
| — | | |
| — | | |
| — | | |
| 2,310,448 | |
Leasehold
improvements | |
Life of
lease | |
| 456,547 | | |
| (76,676 | ) | |
| 379,871 | | |
| 373,320 | |
Furniture
and fittings | |
6 years | |
| 149,260 | | |
| (41,234 | ) | |
| 108,026 | | |
| 92,941 | |
Vehicles | |
5 years | |
| 55,949 | | |
| (26,263 | ) | |
| 29,686 | | |
| 38,079 | |
Computer
equipment | |
3
years | |
| 7,525 | | |
| (1,409 | ) | |
| 6,116 | | |
| 865 | |
| |
| |
$ | 669,281 | | |
$ | (145,582 | ) | |
$ | 523,699 | | |
$ | 2,974,395 | |
Depreciation
expense for the three months ended September 30, 2023 and 2022 was $20,690 and $47,113, respectively, and for the nine months ended September
30, 2023 and 2022 was $119,773 and $134,366, respectively.
On
June 30, 2023, the Company sold its interest in Cranberry Cove Holdings to Leonite Capital, which includes the land and property and
the associated mortgage loan as disclosed in Note 10. Refer Note 4 above.
|
X |
- References
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 958 -SubTopic 360 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -URI https://asc.fasb.org/topic&trid=2155823
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 958 -SubTopic 360 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 958 -SubTopic 360 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Intangibles
|
9 Months Ended |
Sep. 30, 2023 |
Goodwill and Intangible Assets Disclosure [Abstract] |
|
Intangibles |
6. Intangibles
Intangible
assets consist of the following:
Schedule of Intangible assets
|
|
Useful
lives |
|
September
30,
2023 |
|
December
31, 2022 |
|
|
|
|
Cost |
|
Accumulated
amortization |
|
Net
book value |
|
Net
book value |
Health care
Provider license |
|
5
years |
|
$ |
1,789,903 |
|
|
$ |
(805,456 |
) |
|
$ |
984,447 |
|
|
$ |
1,252,932 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The
Company evaluates intangible assets for impairment on an annual basis during the last month of each year and at an interim date if indications
of impairment exist. Intangible asset impairment is determined by comparing the fair value of the asset to its carrying amount with an
impairment being recognized only when the fair value is less than carrying value and the impairment is deemed to be permanent in nature.
The
Company recorded $89,495 in amortization expense for finite-lived assets for each of the three months ended September 30, 2023 and
2022 and $268,485 for each of the nine months ended September 30, 2023 and 2022.
|
X |
- References
+ Details
Name: |
us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for all or part of the information related to intangible assets.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -URI https://asc.fasb.org/subtopic&trid=2144471
+ Details
Name: |
us-gaap_IntangibleAssetsDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Leases
|
9 Months Ended |
Sep. 30, 2023 |
Leases |
|
Leases |
7. Leases
The
Company acquired ATHI on July 1, 2021, ATHI’s wholly owned subsidiary had entered into an operating lease agreement for certain
real property located at 950 Evernia Street, West Palm Beach, Florida, with effect from February 1, 2019 for a period
of three years, expiring on 1 February 2022. Under the terms of the lease agreement, the lease was extended during October 2021 for a
further 5 year period until 1 February 2027.
As
described in note 4 above, on October 3, 2022 the Company entered into a purchase and sale agreement with Evernia Station Limited Partnership
for the purchase of 950 Evernia Street, West Palm Beach, Florida, the property in which it operates its treatment center, for gross proceeds
of $5,500,000. On August 3, 2023, after 6 addendums to the agreement, the Company closed on the acquisition of the property. This resulted
in the termination of the lease with Evernia station, resulting in the reversal of the remaining right-of-use asset of $1,226,080 and
the associated operating lease liability of $1,328,803, which liability included $102,723 of accrued rental, which was offset against
the rental expense.
On
August 4, 2023, the Company entered into a long term lease for 950 Evernia Street, West Palm Beach, Florida with an initial term of twenty
years, and two ten year extension options. The lessor is Pontus EHC Palm Beach, LLC , a Delaware limited liability company and a portfolio
company of Pontus Net Lease Advisors, LLC. The lease is absolutely net and the lease cost for the initial year is $748,000 paid monthly.
The lease increases at a rate of 2.75% per year for a total term lease obligation of $19,595,653 over the initial twenty-year term. The
Lease is personally guaranteed by the Company President and the guarantee may be released after 5 years based on certain financial and
performance metrics being met. Due to the initial lease term of twenty years, the Company is not certain that the extension periods will
be exercised at this point in time and accordingly, these have been excluded from the present value of the minimum future lease payments.
To determine the
present value of minimum future lease payments for operating leases at August 4, 2023, the Company was required to estimate a rate of
interest that we would have to pay to borrow on a collateralized basis over a similar term in a similar economic environment (the "incremental
borrowing rate" or "IBR").
The Company determined
the appropriate IBR by identifying a reference rate and making adjustments that take into consideration financing options and certain
lease-specific circumstances. For the reference rate, the Company used the Fannie Mae, in excess of $3,000,000 rate based on an 80% value
to loan ratio, averaging the 15 and 30 year indicative rates, resulting in a rate of 7.70%. The Company determined that 7.70% per
annum was an appropriate incremental borrowing rate to apply to its real-estate operating lease.
The
present value of the future minimum lease payments was valued at $9,333,953 on August 4, 2023.
Right of use assets are included in the consolidated balance sheet are as follows:
Schedule of Right of use assets
| |
September
30, 2023 | |
December
31, 2022 |
Non-current
assets | |
| | | |
| | |
Right-of-use
assets – finance leases, net of depreciation, included in Property and equipment | |
$ | 26,937 | | |
$ | 38,079 | |
Right-of-use
assets - operating leases, net of amortization | |
$ | 9,331,261 | | |
$ | 1,393,071 | |
Lease
costs consists of the following:
Schedule of finance and operating lease
| |
| |
|
| |
Nine
months ended September 30, |
| |
2023 | |
2022 |
Finance lease cost: | |
| | | |
| | |
Amortization of
right-of-use assets | |
$ | 8,392 | | |
$ | 8,392 | |
Interest
expense on finance lease liabilities | |
| 1,504 | | |
| 1,880 | |
| |
| 9,896 | | |
| 10,272 | |
| |
| | | |
| | |
Operating
lease cost | |
$ | 446,189 | | |
$ | 194,086 | |
Lease
cost | |
$ | 456,085 | | |
$ | 204,358 | |
Other
lease information:
Schedule of Other lease
| |
|
|
|
|
|
|
| |
Nine
months ended September 30, |
| |
2023 | |
2022 |
Cash paid for amounts included
in the measurement of lease liabilities | |
| |
|
Operating cash
flows from finance leases | |
$ | (1,504 | ) | |
$ | (1,880 | ) |
Operating cash flows from
operating leases | |
| (446,189 | ) | |
| (199,539 | ) |
Financing
cash flows from finance leases | |
| (5,868 | ) | |
| (5,492 | ) |
Cash
paid for amounts included in the measurement of lease liabilities | |
$ | (453,361 | ) | |
$ | (204,479 | ) |
| |
| | | |
| | |
Weighted average lease term
– finance leases | |
| 3
years and 2 months | | |
| 4
years and 1 months | |
Weighted average remaining
lease term – operating leases | |
| 19
years and 11 months | | |
| 4
years and 4 months | |
| |
| | | |
| | |
Discount rate – finance
leases | |
| 6.60 | % | |
| 6.61 | % |
Discount rate – operating
leases | |
| 7.70 | % | |
| 4.64 | % |
Maturity
of Leases
Finance
lease liability
The
amount of future minimum lease payments under finance leases as of September 30, 2023 is as follows:
Schedule of Finance lease liability
| |
Amount |
Remainder of 2023 | |
$ | 2,457 | |
2024 | |
| 9,829 | |
2025 | |
| 9,829 | |
2026 | |
| 6,195 | |
2027 | |
| 1,707 | |
| |
| 30,017 | |
Imputed interest | |
| (3,080 | ) |
Total finance lease liability | |
$ | 26,937 | |
Disclosed as: | |
| | |
Current portion | |
$ | 8,289 | |
Non-Current portion | |
| 18,648 | |
Lease liability | |
$ | 26,937 | |
Operating
lease liability
The
amount of future minimum lease payments under operating leases are as follows:
Schedule of Operating lease liability
| |
Amount |
| |
|
Remainder of 2023 | |
$ | 249,333 | |
2024 | |
| 754,857 | |
2025 | |
| 775,615 | |
2026 | |
| 796,945 | |
2027 | |
| 818,861 | |
| |
| 16,200,042 | |
Total undiscounted minimum future lease payments | |
| 19,595,653 | |
Imputed interest | |
| (10,223,673 | ) |
Total operating lease liability | |
$ | 9,371,980 | |
| |
| | |
Disclosed as: | |
| | |
Current portion | |
$ | 32,753 | |
Non-Current portion | |
| 9,339,227 | |
Lease liability | |
$ | 9,371,980 | |
Lessor
Property
Prior
to the disposal of the Company’s wholly owned subsidiary CCH on June 30, 2023, the company owned a property located at 3571
Muskoka Road, #169, Bala, on which the operations of the Canadian Rehab Clinic were located prior to disposal on February 14, 2017. The
property was leased to the purchasers of the business of the Canadian Rehab Clinic, initially for a period of 5 years, which was renewed
for an additional 5 years, with a further two 5 year renewal periods available to the lessee.
The
Lease was considered in terms of ASC 842, Leases and determined to be an operating lease as the criteria for the lease to be a sales-type
lease or a direct financing lease were not met, including the possibility of the lessee exercising the option to purchase the property
being considered as remote.
The
Company derived rental income of CDN$243,288 ($180,522) for the six months ended June 30, 2023, the date of disposal of CCH and the property,
see Note 4 above.
|
X |
- References
+ Details
Name: |
grst_DisclosureLeasesAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -URI https://asc.fasb.org/subtopic&trid=77888251
+ Details
Name: |
us-gaap_LesseeOperatingLeasesTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Short-term Convertible Notes
|
9 Months Ended |
Sep. 30, 2023 |
Debt Disclosure [Abstract] |
|
Short-term Convertible Notes |
8. Short-term
Convertible Notes
The
short-term convertible notes consist of the following:
Schedule of short-term convertible notes
|
|
Interest
rate |
|
Maturity
Date |
|
Principal |
|
Interest |
|
September
30, 2023 |
|
December
31, 2022 |
Leonite Capital, LLC |
|
|
12.0 |
% |
|
On Demand |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
184,749 |
|
Leonite Fund I, LP |
|
|
Variable |
|
|
On Demand |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
720,830 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auctus Fund, LLC |
|
|
0.0 |
% |
|
On Demand |
|
|
70,000 |
|
|
|
— |
|
|
|
70,000 |
|
|
|
80,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Labrys Fund, LP |
|
|
12.0 |
% |
|
On Demand |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
8,826 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ed Blasiak |
|
|
6.5 |
% |
|
On Demand |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
63,322 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joshua Bauman |
|
|
11.0 |
% |
|
October 21, 2022 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
169,710 |
|
|
|
|
10.0 |
% |
|
August 9, 2023 |
|
|
150,000 |
|
|
|
2,131 |
|
|
|
152,131 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series N convertible notes |
|
|
6.0 |
% |
|
On Demand |
|
|
3,229,000 |
|
|
|
957,078 |
|
|
|
4,186,078 |
|
|
|
4,041,813 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3,449,000 |
|
|
$ |
959,209 |
|
|
$ |
4,408,209 |
|
|
$ |
5,269,250 |
|
Leonite
Capital, LLC
On
July 12, 2020, the Company entered into a Senior Secured Convertible Note agreement with Leonite for $440,000 with an original issue
discount of $40,000 for gross proceeds of $400,000, the initial tranche advanced will be for cash of $200,000 plus the OID
of $20,000, the remaining advances will be at the discretion of the Leonite. The loan bears interest at 6.5% per annum and matures
on June 12, 2021. The Company is required to make monthly payments of the accrued interest on the advances made. The note is convertible
into common shares at the option of the holder at $0.10 per share, or 80% multiplied by the price per share paid in subsequent financings
or after a six month period from the effective date at 60% of the lowest trading price during the preceding 21 consecutive trading days.
The note has both conversion price protection and anti-dilution protection provisions.
On
February 28, 2022, in terms of a conversion notice, Leonite converted the principal sum of $149,250 of the Leonite Note into 150,000,000 shares
of common stock at a conversion price of $0.0010 per share.
On
March 1, 2023, the Company entered into a forbearance agreement with Leonite whereby the parties agreed to extend the maturity date of
the note to June 8, 2023, the Company will continue to pay interest on the note, until repaid. On August 4, 2023, the Company settled
all outstanding liabilities owing to Leonite Capital and Leonite fund I, L.P. for gross proceeds of $1,449,000.
Leonite
Fund I, LP
Effective
June 1, 2022, the Company entered into a Note Exchange Agreement whereby the convertible promissory notes entered into with Labrys Fund
LP on May 7, 2021, with an outstanding principal balance of $341,000, and on June 2, 2021, with an outstanding principal balance of $230,000
and accrued interest thereon of $25,300, were exchanged for a new Senior Secured Convertible Promissory note in the principal amount
of $745,375, including an OID of $149,075. The Note matured on March 1, 2023, and bore interest at the minimum of 10% per annum or the
Wall Street Journal quoted prime rate plus 5.75%.
Interest
is payable monthly and the note may be prepaid with a prepayment penalty of 10%. The note is convertible into common stock
at a fixed conversion price of $0.01 per share, subject to anti-dilution adjustments and a fundamental transaction clause allowing the
note holder to receive the same consideration as common stockholders would receive.
The
convertible note is secured by all of the assets of Ethema Health Corporation and Addiction Recovery Institute of America, LLC.
On
March 1, 2023, the Company entered into a forbearance agreement with Leonite whereby the parties agreed to extend the maturity date of
the note to June 8, 2023, the Company will continue to pay interest on the note, until repaid. On August 4, 2023, the Company
settled all outstanding liabilities owing to Leonite Capital and Leonite fund I, L.P. for gross proceeds of $1,449,000.
Auctus
Fund, LLC
On
August 7, 2019, the Company, entered into a Securities Purchase Agreement with Auctus Fund, LLC, pursuant to which the Company issued
a Convertible Promissory Note in the aggregate principal amount of $225,000. The Note had a maturity date of May 7, 2020 and
bore interest at the rate of ten percent per annum from the date on which the Note was issued until the same became due and payable,
whether at maturity or upon acceleration or by prepayment or otherwise. The Company had the right to prepay the Note in terms of agreement.
The outstanding principal amount of the Note is convertible at any time and from time to time at the election of Auctus Fund, LLC during
the period beginning on the date that is 180 days following the issue date into shares of the Company’s common stock at a conversion
price equal to 60% of the lowest closing bid price of the Company’s common stock for the thirty trading days prior to conversion.
On
June 15, 2020, The Company entered into an amended agreement with Auctus whereby the Company agreed to discharge the principal amount
of the note by nine equal monthly installments of $25,000 commencing in October 2020. During the year ended December 31, 2021, the
Company repaid Auctus the principal sum of $50,000.
During
March 2022, the Company paid $20,000 of principal on the convertible note, thereby reducing the principal outstanding to $80,000. The
note matured May 7, 2020, Auctus Fund LLC has not declared a default and we are in discussion with the lender on settling the note.
During
February 2023, the Company paid $10,000 of principal on the convertible note, thereby reducing the principal outstanding to $70,000.
The note matured May 7, 2020, Auctus Fund LLC has not declared a default and we are in constant in constant discussion with the lender
on settling the note.
Ed
Blasiak
On
September 14, 2020, the Company entered into a Securities Purchase Agreement with Ed Blasiak (“Blasiak”), pursuant to which
the Company issued a senior secured convertible promissory note in the aggregate principal amount of $55,000, including an original issue
discount of $5,000. The note bears interest at 6.5% per annum and matured on September 14, 2021. The note is senior to any
future borrowings and commencing on October 1, 2020 the Company will make monthly payments of the accrued interest under the note. The
note may be prepaid at certain prepayment penalties and is convertible into shares of common stock at a conversion price at the option
of the holder at $0.001 per share, adjusted for anti-dilution provisions; or 80% of the price per share of subsequent equity financings
or; after six months 60% of the lowest trading price during the preceding six month period.
The
note had matured and was in default, Ed Blasiak has not declared a default under the note. On August 4, 2023, the Company settled
the senior secured convertible promissory note owing to Ed Blasiak for proceeds of $65,450.
Joshua
Bauman
On
October 21, 2021, the Company entered into a Securities Purchase Agreement with Bauman, pursuant to which the Company issued a senior
secured convertible promissory note in the aggregate principal amount of $150,000, including an original issue discount of $16,250. The
note bears interest at 11.0% per annum, which is guaranteed and earned in full on issue date and matured on October 21, 2022.
The note is convertible into shares of common stock at a conversion price at the option of the holder at $0.001 per share, adjusted for
anti-dilution provisions.
The
note had matured and was in default, Mr. Bauman has not declared a default under the note. On August 4, 2023, the Company settled
the senior secured convertible promissory note owing to Mr. Bauman for proceeds of $179,474.
On
August 9, 2023, the Company issued a convertible promissory note to Bauman, in the aggregate principal amount of $150,000. The note bears
interest at 10.0% per annum and matures on August 9, 2024. The note is convertible into shares of common stock at a conversion price
at the option of the holder at $0.001 per share, adjusted for anti-dilution provisions. The note is convertible into common stock at
the option of the holder after the expiration of six months from the issuance date, in addition, should the note reach its maturity date,
August 9, 2024, the note will automatically convert into shares of common stock at the conversion price, subject to anti-dilution provisions.
Series
N convertible notes
Between
January 28, 2019 and June 11, 2020, the Company closed several tranches of Series N Convertible notes in which it raised $3,229,000 in
principal from accredited investors through the issuance to the investors of the Company’s Series N convertible notes, in the total
original principal amount of $3,229,000, which Notes are convertible into the Company’s common stock at a conversion price of $0.08 per
share together with three year warrants to purchase up to a total of 52,237,500 shares of the Company’s common stock
at an exercise price of $0.12 per share. Both the conversion price under the Notes and the exercise price under the warrants are
subject to standard adjustment mechanisms. The notes matured one year from the date of issuance.
The
series N convertible notes matured and are in default. The Company is considering its options to settle these notes.
|
X |
- References
+ Details
Name: |
us-gaap_DebtDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -URI https://asc.fasb.org/topic&trid=2208564
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1C -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1I -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1I -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(c)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1C -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1C -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1E -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1I -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (i) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611
+ Details
Name: |
us-gaap_DebtDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Short-term Notes
|
9 Months Ended |
Sep. 30, 2023 |
Debt Disclosure [Abstract] |
|
Short-term Notes |
9. Short-term
Notes
Leonite
Capital, LLC
Secured
Promissory Notes
On
March 1, 2022, the Company entered into a secured Promissory Note in the aggregate principal amount of $124,000 for net proceeds
of $100,000 after an original issue discount of $24,000. Due to the failure to repay the note by due date, a penalty of $37,200
was added to the principal outstanding and the Company incurs a monthly monitoring fee of $2,000 per month. In addition the note earns
interest at a default rate of 24% per annum on the total balance outstanding, including the monthly monitoring fee and accrued interest.
The
Note had a maturity date of April 1, 2022. On August 4, 2023, the Company settled all outstanding liabilities owing to Leonite Capital
and Leonite fund I, L.P. for gross proceeds of $1,449,000.
On
May 3, 2022, the Company, entered into a secured Promissory Note in the aggregate principal amount of $76,250 for net proceeds of
$61,000 after an original issue discount of $15,250. Due to the failure to repay the note by due date, a penalty of $22,875 was
added to the principal outstanding and the Company incurs a monthly monitoring fee of $2,000 per month. In addition the note earns interest
at a default rate of 24% per annum on the total balance outstanding, including the monthly monitoring fee and accrued interest.
The
Note had a maturity date of June 17, 2022. On August 4, 2023, the Company settled all outstanding liabilities owing to Leonite
Capital and Leonite fund I, L.P. for gross proceeds of $1,449,000.
Mirage
Realty, LLC
On
March 15, 2023, the Company, entered into a senior secured Promissory Note in the aggregate principal amount of $250,000 for net
proceeds of $223,500 after an original issue discount and fees of $26,500. The note earns interest at 10% per annum and matures on July
15, 2023
On
August 4, 2023, the Company settled the senior secured promissory note owing to Mirage Realty for gross proceeds of $260,548.
LXR
Biotech
On
April 12, 2019, the Company, entered into a secured Promissory Note in the aggregate principal amount of CDN$133,130. The Note had a
maturity date of April 11, 2020 and bears interest at the rate of six percent per annum from the date on which the Note was
issued.
This
note has not been repaid, is in default and remains outstanding. The balance outstanding at September 30, 2023 was $124,886 (CDN$168,845).
|
X |
- References
+ Details
Name: |
us-gaap_DebtDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for short-term debt.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -URI https://asc.fasb.org/topic&trid=2208564
+ Details
Name: |
us-gaap_ShortTermDebtTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Mortgage loans
|
9 Months Ended |
Sep. 30, 2023 |
Mortgage Loans |
|
Mortgage loans |
10. Mortgage
loans
Mortgage
loans is disclosed as follows:
Schedule of mortgage loans
|
|
Interest
rate |
|
|
Maturity
date |
|
Principal
Outstanding |
|
|
Accrued
interest |
|
|
September
30,
2023 |
|
|
December
31,
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cranberry Cove Holdings, Ltd. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pace Mortgage |
|
|
4.2 |
% |
|
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,504,605 |
Disclosed as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term portion |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
— |
|
|
$ |
3,504,605 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cranberry
Cove Holdings, Ltd. (“CCH”)
On July 19, 2017, CCH, a wholly owned subsidiary, closed on a loan agreement in the principal amount of CDN$5,500,000. The loan is secured
by a first mortgage on the premises owned by CCH located at 3571 Muskoka Road 169, Bala, Ontario.
The
loan bears interest at the fixed rate of 4.2% with a 5-year primary term and a 25-year amortization. The Company has guaranteed
the loan and the Company’s chief executive officer and controlling shareholder also has personally guaranteed the Loan. CCH and
the Company have granted the Lender a general security interest in its assets to secure repayment of the Loan. The loan is amortized
with monthly installments of CDN $29,531.
On
June 30, 2023, the Company sold its interest in CCH to Leonite Capital, which includes the real property as disclosed in Note 5 and the
associated mortgage loan. Refer to Note 4 above.
|
X |
- References
+ Details
Name: |
grst_DisclosureMortgageLoansAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_MortgageLoansTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Government assistance loans
|
9 Months Ended |
Sep. 30, 2023 |
Government Assistance Loans |
|
Government assistance loans |
11. Government
assistance loans
On
December 1, 2020, CCH was granted a Covid-19 related government assistance loan in the aggregate principal amount of CDN$ 40,000 (Approximately
$31,000). The grant is interest free and CDN$ 10,000 is forgivable if the loan is repaid in full by December 31, 2022. The maturity
date of this loan was extended by an additional year to December 31, 2023.
On
January 12, 2021, CCH received a further CDN$ 20,000 Covid-19 related government assistance loan. The loan is interest free
and if repaid by December 31, 2022, CDN$ 10,000 is forgivable. This loan was not repaid by December 31, 2022.
On
June 30, 2023, the Company sold its interest in CCH to Leonite Capital, which includes the Canadian government assistance loan. Refer
to Note 4 above.
On
May 3, 2021, ARIA was granted a government assistance loan in the aggregate principal amount of $157,367. The loan is forgivable if the
Company demonstrates that the proceeds were used for expenses such as employee costs during the pandemic. Should the loan not be forgiven,
interest is payable on the loan at the rate of 1% per annum and the principal is repayable and interest is payable over an 18 month period.
On
September 21, 2022, ARIA received partial forgiveness of the government assistance loan of $104,368, the balance of the loan plus accrued
interest is due and payable. On December 30, 2022, the Company sold ARIA to its Chairman and CEO and agreed to assume the repayment of
the government assistance loan. As of September 30, 2023, the balance outstanding, including interest thereon was $39,207.
|
X |
- References
+ Details
Name: |
grst_DisclosureGovernmentAssistanceLoansAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_GovernmentAssistanceLoansTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Receivables funding
|
9 Months Ended |
Sep. 30, 2023 |
Receivables Funding |
|
Receivables funding |
12. Receivables
funding
September
26, 2022 Funding
On
September 26, 2022, the Company, through its 75% held subsidiary, Evernia Health Center, LLC, entered into a Receivables Sale Agreement
with Itria Ventures LLC (“Itria”), whereby $310,000 of the Receivables of Evernia were sold to Itria, for gross proceeds
of $250,000. The Company also incurred fees of $5,500, resulting in net proceeds of $244,500. The Company is obliged to pay 7.41% of
the receivables until the amount of $310,000 is paid in full, with periodic repayments of $6,458 per week. The guarantor of the funding
is a minority shareholder in ATHI.
The
Company made weekly cash payments of $6,458 totaling $310,000 on the September 26, 2022 funding, thereby settling the receivables funding.
December
13, 2022 Funding
On
December 13, 2022, the Company, through its 75% held subsidiary, Evernia Health Center, LLC entered into a Receivables Sale Agreement
with Itria Ventures LLC (“Itria”), whereby $305,000 of the Receivables of Evernia were sold to Itria, for gross proceeds
of $250,000. The Company also incurred fees of $2,500, resulting in net proceeds of $247,500. The Company is obliged to pay 6.08% of
the receivables until the amount of $305,000 is paid in full, with periodic repayments of $6,354 per week. The guarantor of the funding
is a minority shareholder in ATHI.
The
Company made weekly cash payments of $6,354 totaling $241,458 on the December 13, 2022 funding. On September 15, 2023, the Company repaid
the remaining principal outstanding of $63,542 out of the proceeds received from the September 15, 2023 receivables funding with Itria.
January
19, 2023 Funding
On
January 19, 2023, the Company, through its 75% held subsidiary, Evernia Health Center, LLC, entered into a Receivables Sales Agreement
with Bizfund.com (“Bizfund)”), whereby $132,000 of the Receivables of Evernia were sold to Bizfund, for gross proceeds of
$100,000. The Company is obliged to pay 15.0% of the receivables until the amount of $132,000 is paid in full, with periodic repayments
of $2,750 per week. The guarantor of the funding is a minority shareholder in ATHI.
The
Company made weekly cash payments of $2,750 totaling $49,500 on the January 19, 2023 funding. On June 2, 2023 the Company entered into
another receivables funding agreement with Bizfund, whereby Bizfund forgave $8,250 of the premium due on the January 19, 2023 funding
and transferred the remaining principal balance of $74,250 to the June 2, 2023 funding. The unamortized balance of the debt discount
of $12,616 was expensed on June 2, 2023, thereby extinguishing the receivables funding.
February
14, 2023 Funding
On
February 14, 2023, the Company, through its 75% held subsidiary, Evernia Health Center, LLC, entered into a Receivables Sale Agreement
with Fox Business Funding (“Fox”), whereby $118,800 of the Receivables of Evernia were sold to Fox, for gross proceeds of
$90,000. The Company is obligated to pay 8.0% of the receivables until the amount of $118,800 is paid in full, with periodic repayments
of $2,970 per week. The guarantor of the funding is a minority shareholder in ATHI.
The
Company made weekly cash payments of $2,970 totaling $86,130 on the February 14, 2023 funding. on September 15, 2023, the Company repaid
the remaining principal outstanding of $32,670 out of the proceeds received from the September 15, 2023 receivables funding with Itria.
June
2, 2023 Funding
On
June 2, 2023, the Company received funding from an agreement entered into through its 75% held subsidiary, Evernia Health Center, LLC
entered into a Receivables Sale Agreement with Bizfund.com (“Bizfund)”), whereby $198,000 of the Receivables of Evernia were
sold to Bizfund, for gross proceeds of $150,000, made up of a cash payment to the Company of $75,750 and the transfer of $74,250 of the
January 19, 2023, outstanding principal to the June 2, 2023 funding agreement.. The Company is obliged to pay 15.0% of the receivables
until the amount of $198,000 is paid in full, with periodic repayments of $4,950 per week. The guarantor of the funding is a minority
shareholder in ATHI.
The
Company made weekly cash payments of $4,950 totaling $79,200 on the June 2, 2023 funding. The balance outstanding at September 30, 2023
was $118,800, less unamortized discount of $30,687.
September
15, 2022 Funding
On
September 15, 2023, the Company, through its 75% held subsidiary, Evernia Health Center, LLC entered into a Receivables Sale Agreement
with Itria Ventures LLC (“Itria”), whereby $320,000 of the Receivables of Evernia were sold to Itria, for gross proceeds
of $250,000. The Company also incurred fees of $3,000, resulting in net proceeds of $247,500. The Company is obliged to pay $6,666.67
per week until the amount of $320,000 is paid in full. The guarantor of the funding is a minority shareholder in ATHI.
The
Company made weekly cash payments of $6,667 totaling $13,333 on the September 15, 2022 funding. The balance outstanding at September
30, 2023 was $306,667, less unamortized discount of $70,076.
|
X |
- References
+ Details
Name: |
grst_DisclosureReceivablesFundingAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ReceivablesFundingTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Third Party loans
|
9 Months Ended |
Sep. 30, 2023 |
Third Party Loans |
|
Third Party loans |
13. Third
Party loans
On
April 12, 2019, Eileen Greene, a related party, assigned CDN$1,000,000 of the amount owed by the Company to her, to a third party.
The loan bears interest at 12% per annum which the Company agreed to pay. This loan was assumed by the Company on the disposal of CCH
to Leonite Capital as disclosed in note 4 above.
During
April and May 2023, the Company made ad-hoc repayments of CDN$25,000 (approximately $25,970) on the third party loan. Between August 9
and August 10, 2023, the Company made principal repayment of CDN$450,000 ($335,290) As of September 30, 2023 the balance of principal
and interest outstanding on third party loans was CDN$336,320 ($248,757).
|
X |
- References
+ Details
Name: |
grst_DisclosureThirdPartyLoansAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ThirdPartyTransactionsDisclosureTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Related party payables
|
9 Months Ended |
Sep. 30, 2023 |
Related Party Transactions [Abstract] |
|
Related party payables |
14. Related
party payables
Schedule
of Related party payable
| |
September
30, | |
December
31, |
| |
2023 | |
2022 |
Due
to related parties | |
| | | |
| | |
Shawn
E. Leon | |
$ | 124,445 | | |
$ | 411,611 | |
Leon
Developments Ltd. | |
| 1,092,701 | | |
| 850,657 | |
Eileen
Greene | |
| 1,452,862 | | |
| 1,451,610 | |
Total
related party payables | |
$ | 2,670,008 | | |
$ | 2,713,878 | |
Shawn
E. Leon
As
of September 30, 2023 and December 31, 2022, the Company had a payable to Shawn Leon of $124,445 and $411,611, respectively. Mr. Leon
is a director and CEO of the Company. The balances payable are non-interest bearing and have no fixed repayment terms.
On
December 30, 2022, the Company sold its wholly-owned subsidiaries, Greenestone Muskoka and ARIA, to Mr. Leon for gross proceeds of $0.
The Company realized a gain on disposal of $628,567 which was recorded as an increase in Additional Paid in Capital due to the related
party nature of the transaction.
Due
to the current financial position of the Group, Mr. Leon forfeited the management fees due to him for the nine months ended September
30, 2023 and the year ended December 31, 2022.
Leon
Developments, Ltd.
Leon
Developments is owned by Shawn Leon, the Company’s CEO and director. As of September 30, 2023 and December 31, 2022, the Company
owed Leon Developments, Ltd., $1,092,701 and $850,607, respectively.
The
Company paid Leon Developments a management fee of CDN$250,000 (approximately $185,503) and $0 for the nine months ended September 30,
2023 and 2022, respectively.
On
June 30, 2023, the Company assumed the liability owing to Leon developments of CDN$1,974,012 (approximately $1,490,946) from its subsidiary,
CCH, immediately prior to the disposal of CCH to a related party, Leonite Capital LLC.
Eileen
Greene
As
of September 30, 2023 and December 31, 2022, the Company owed Eileen Greene, the spouse of our CEO, Shawn Leon, $1,452,862 and $1,451,610,
respectively. The amount owed to Ms. Greene is non-interest bearing and has no fixed repayment terms.
Leonite
Capital, LLC and Leonite Fund I, LLP
Leonite
Capital is considered a related party due to its Series A Preferred stock interest in CCH, which was previously a wholly-owned subsidiary
of the Company, of $700,000, and its Series B Preferred stock interest in the Company of $400,000, as of December 31, 2022.
The
Series A Preferred stock interest in CCH of $700,000 was recorded as a minority shareholder interest as of December 31, 2022.
Accrued
dividends on the CCH Series A Preferred shares of $145,547 and accrued dividends on the Series B Preferred shares of $49,282 was owed
to Leonite Capital as of December 31, 2022. Prior to the disposal of CCH to Leonite Capital on June 30, 2023, and the simultaneous cancellation
of the Series B Preferred stock as discussed below, the accrued dividends on the CCH Series A Preferred shares was $184,545 and the accrued
dividends on the Series B Preferred shares was $61,184.
On
June 30, 2023, the Company entered into an exchange agreement with Leonite Capital whereby it exchanged the 400,000 Series B shares with
a value of $400,000 plus accrued dividends thereon of $61,184 for its entire shareholding in its property owning subsidiary, Cranberry
Cove Holdings. The Series B shares and the accrued dividends thereon were extinguished and cancelled upon consummation of the transaction.
Due
to the related party nature of the transaction, the net result of the disposal of $1,334,885 and the $700,000 of the CCH Series A Preferred
shares, totaling $2,034,885, was recorded as a credit to additional paid-in-capital.
In
addition, due to the related party nature of the transaction, the cancellation of the Series B Preferred stock, of $400,000 and the dividends
thereon of $61,184, totaling $461,184, was recorded as an extinguishment of debt reflected in additional paid-in-capital.
On
August 4, 2023, the company repaid Leonite Capital $1,449,000 consisting of repayments of short-term convertible notes of $995,257, promissory
notes of $420,069, additional penalty on settlement of $5,236 and a personal loan by Leonite to Shawn Leon of $28,438, which repayment
reduced the related party payable to Shawn Leon, as disclosed above.
As
disclosed in note 8 above, the Company owed Leonite Capital and Leonite Funds I, LP, an entity under common control with Leonite Capital,
short-term convertible notes, including principal and interest thereon of $0 and $905,579 as of September 30, 2023 and December 31, 2022,
respectively.
In
addition, as disclosed in note 9 above, the Company owed Leonite capital, secured promissory notes, including principal, monitoring fees
and interest thereon totaling $0 and $340,281 as of September 30, 2023 and December 31, 2022, respectively.
All
related party transactions occur in the normal course of operations and in terms of agreements entered into between the parties.
|
X |
- DefinitionThe entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -URI https://asc.fasb.org/topic&trid=2122745
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 850 -SubTopic 10 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864
+ Details
Name: |
us-gaap_RelatedPartyTransactionsDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Stockholder’s deficit
|
9 Months Ended |
Sep. 30, 2023 |
Equity [Abstract] |
|
Stockholder’s deficit |
15. Stockholder’s
deficit
Authorized
and outstanding
The
Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued 3,729,053,805
shares of common stock at September 30, 2023 and December 31, 2022.
|
b. |
Series
A Preferred shares |
Authorized,
issued and outstanding
The
Company has authorized 10,000,000 Series A preferred shares with a par value of $0.01 per share. The Company has
issued and outstanding 4,000,000 Series A Preferred shares at September 30, 2023 and December 31, 2022.
|
c. |
Series
B preferred shares |
Authorized
and outstanding
The
Company has authorized 400,000 Series B preferred shares with a par value of $1.00 per share. The company has issued and outstanding 0
and 400,000 Series B Preferred shares at September 30, 2023 and December 31, 2022, respectively.
The
Series B preferred shares are senior secured and were mandatorily redeemable by the Company on July 1, 2021, and were originally classified
as mezzanine debt. These Series B preferred shares meet the definition of liabilities in terms of ASC 480- debt and are no longer contingently
convertible, due to the fact that the redemption date has passed.
On
June 30, 2023, the Company entered into an exchange agreement with Leonite Capital whereby it exchanged the shares in its wholly owned
subsidiary, CCH for the return and cancellation of the Series B preferred shares, together with the dividends accrued thereon. Refer
to note 4 above.
Our
board of directors adopted the Greenstone Healthcare Corporation 2013 Stock Option Plan (the “Plan”) to promote our long-term
growth and profitability by (i) providing our key directors, officers and employees with incentives to improve stockholder value and
contribute to our growth and financial success and (ii) enable us to attract, retain and reward the best available persons for positions
of substantial responsibility. A total of 10,000,000 shares of our common stock have been reserved for issuance upon exercise
of options granted pursuant to the Plan. The Plan allows us to grant options to our employees, officers and directors and those of our
subsidiaries; provided that only our employees and those of our subsidiaries may receive incentive stock options under the Plan. We have
no issued options at September 30, 2023 under the Plan.
All
of the warrants have cashless exercise terms whereby in-the-money warrants may be exercised by reducing the number of shares issued in
terms of the warrant exercise to offset the proceeds due on the exercise.
All
of the warrants have price protection features whereby any securities issued subsequent to the date of the warrant issuance date, were
issued at a lower price, or have conversion features that are lower than the current exercise price, or were converted at a lower price,
or are exercisable at a lower price, to the current warrant exercise price, will result in the exercise price of the warrant being set
to the lower issue, conversion or exercise price.
Warrant
exchange agreement
On June
28, 2023 the Company entered into a Warrant Exchange Agreement with Leonite that exchanged a Warrant outstanding to Leonite originally
issued on June 12, 2020 for a new Warrant dated June 30, 2023. The substantial changes to the warrant affect the number of shares in
the warrant, the exercise price and the term. The original warrant provided for Leonite to have a continuing right to purchase a 20%
share of the outstanding common shares until it expired on June 12, 2025 which was originally set at 326,286,847 shares. The new warrant
is exercisable for 745,810,761 shares, 20% of the current number of common shares outstanding, with no allowance for adjustment, except
normal adjustments due to splits or consolidations, until the new expiry date of June 30, 2027. The exercise price in the original warrant
was $0.10, with allowance for adjustments, which when applied resulted in an exercise price of $0.0004 per share. The exercise price
on the new warrant is $0.001 and is only adjustable if the Company issues any shares at a price less than the exercise price during the
warrant period except for any issuance of shares to the Company’s president or related parties on any debt outstanding to those
parties as of June 30, 2023, and limited to a conversion price of $0.0005 per share. The Warrant Exchange agreement was conditional on
Leonite receiving a full payment of all of its outstanding loans originally set as by July 20, 223. This date was extended and all of
the notes were repaid on August 4, 2023. Leonite held several notes at June 30, 2023, some of which were convertible into shares at variable
rates, see notes 9 and 10 above. The total amount repaid to settle all of the outstanding liabilities was $1,449,000.
The
replacement warrants were valued effective June 30, 2023, the effective date of issuance of the warrants, as the difference between the
fair value of the original warrant exercisable for 326,286,847 shares of common stock and the fair value of the replacement four-year
warrant exercisable for 745,810,861 shares of common stock at an exercise price of $0.001 per share.
The
warrants were valued using a Black-Scholes valuation model. The following assumptions were used in the valuation model:
Share-Based
Payment Arrangement, Performance Shares, Activity
|
|
Nine
months ended
September 30,
2023 |
Exercise price |
|
$ |
0.001 |
|
Risk free interest rate |
|
|
4.31 to 4.87 |
% |
Expected life of options |
|
|
2 to 4 years |
Expected volatility of underlying stock |
|
|
205.5 to 243.0 |
% |
Expected dividend rate |
|
|
0 |
% |
A
summary of the Company’s warrant activity during the period from January 1, 2022 to September 30, 2023 is as follows:
Schedule of warrants outstanding
|
|
No.
of shares |
|
Exercise
price
per share |
|
Weighted
average exercise
price |
|
|
|
|
|
|
|
Outstanding
as of January 1, 2022 |
|
|
623,777,506 |
|
|
|
$0.000675
to $0.12 |
|
|
$ |
0.0052875 |
|
Granted |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Forfeited/cancelled |
|
|
(20,925,000 |
) |
|
|
$0.12 |
|
|
|
0.12 |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Outstanding
as of December 31, 2022 |
|
|
602,852,506 |
|
|
|
$0.000675 to $0.00205 |
|
|
$ |
0.001306 |
|
Granted |
|
|
745,810,761 |
|
|
|
$0.001 |
|
|
|
0.001 |
|
Forfeited/cancelled |
|
|
(326,286,847 |
) |
|
|
$0.000675 |
|
|
|
0.000675 |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Outstanding
as of September 30, 2023 |
|
|
1,022,376,420 |
|
|
|
$0.001
to $0.00205 |
|
|
$ |
0.0012840 |
|
The
following table summarizes information about warrants outstanding at September 30, 2023:
Schedule of assumption
|
|
|
Warrants
outstanding |
|
|
Warrants
exercisable |
|
Exercise
price |
|
|
No.
of shares |
|
|
Weighted
average
remaining years |
|
|
Weighted
average
exercise price |
|
|
No.
of shares |
|
|
Weighted
average
exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$0.001 |
|
|
|
745,810,761 |
|
|
|
3.75 |
|
|
|
|
|
|
|
745,810,761 |
|
|
|
|
|
$0.002050 |
|
|
|
276,565,659 |
|
|
|
2.27 |
|
|
|
|
|
|
|
276,565,659 |
|
|
|
|
|
|
|
|
|
1,022,376,420 |
|
|
|
3.35 |
|
|
$ |
0.001284 |
|
|
|
1,022,376,420 |
|
|
$ |
0.001284 |
|
All
of the warrants outstanding at September 30, 2023 are vested. The warrants outstanding at September 30, 2023 have an intrinsic value
of $0.
|
X |
- References
+ Details
Name: |
us-gaap_EquityAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 16 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (i) -URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 50 -Paragraph 6 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008
+ Details
Name: |
us-gaap_StockholdersEquityNoteDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Segment information
|
9 Months Ended |
Sep. 30, 2023 |
Segment Reporting [Abstract] |
|
Segment information |
16. Segment
information
The
Company had two reportable operating segments:
|
a. |
Rental income
from the property owned by CCH subsidiary located at 3571 Muskoka Road, #169, Bala, on which the operations of the Canadian Rehab
Clinic were located prior to disposal on February 14, 2017 and subsequently leased to the purchasers of the business of the Canadian
Rehab Clinic, for a period of 5 years renewable for a further three five-year periods and with an option to acquire the property
at a fixed price. In terms of an exchange agreement entered into with Leonite Capital effective June 30, 2023, the property owning
subsidiary CCH was exchanged for the Series B preferred shares issued to Leonite Capital. Refer note 4 above. |
|
b. |
Rehabilitation
Services provided to customers, these services were provided to customers at our Evernia, Addiction Recovery Institute of America
and Seastone of Delray operations. |
The
segment operating results of the reportable segments is disclosed as follows:
Schedule of segment information
| |
|
|
|
|
|
|
|
|
|
|
| |
Nine
months ended September 30, 2023 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Revenue | |
$ | 180,522 | | |
$ | 4,039,382 | | |
$ | 4,219,904 | |
Operating expenses | |
| 245,528 | | |
| 3,833,676 | | |
| 4,079,204 | |
| |
| | | |
| | | |
| | |
Operating (loss) income | |
| (65,006 | ) | |
| 205,706 | | |
| 140,700 | |
| |
| | | |
| | | |
| | |
Other (expense)
income | |
| | | |
| | | |
| | |
Forgiveness
of intercompany loan | |
| 3,481,332 | | |
| (3,481,332 | ) | |
| — | |
Other
income | |
| — | | |
| 449 | | |
| 449 | |
Penalty
on convertible notes | |
| — | | |
| (34,688 | ) | |
| (34,688 | ) |
Extension
fee on property purchase | |
| — | | |
| (130,000 | ) | |
| (130,000 | ) |
Gain
on disposal of property | |
| — | | |
| 2,484,172 | | |
| 2,484,172 | |
Loss
on debt extinguishment | |
| — | | |
| (277,175 | ) | |
| (277,175 | ) |
Interest
expense | |
| (95,464 | ) | |
| (286,984 | ) | |
| (382,448 | ) |
Amortization
of debt discount | |
| — | | |
| (238,304 | ) | |
| (238,304 | ) |
Foreign
exchange movements | |
| (81,033 | ) | |
| (3,115 | ) | |
| (84,148 | ) |
Net income
(loss) before taxes | |
| 3,239,829 | | |
| (1,761,271 | ) | |
| 1,478,558 | |
Taxes | |
| — | | |
| 221,107 | | |
| 221,107 | |
Net
income (loss) | |
$ | 3,239,829 | | |
$ | (1,540,164 | ) | |
$ | 1,699,665 | |
The
operating assets and liabilities of the reportable segments is as follows:
| |
|
|
|
|
|
|
|
|
|
|
| |
September
30, 2023 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Purchase
of fixed assets | |
$ | (43,611 | ) | |
$ | 5,287,622 | | |
$ | 5,244,011 | |
Assets | |
| | | |
| | | |
| | |
Current assets | |
| — | | |
| 794,521 | | |
| 794,521 | |
Non-current assets | |
| — | | |
| 11,213,407 | | |
| 11,213,407 | |
Liabilities | |
| | | |
| | | |
| | |
Current liabilities | |
| — | | |
| (7,713,189 | ) | |
| (7,713,189 | ) |
Non-current liabilities | |
| — | | |
| (9,801,769 | ) | |
| (9,801,769 | ) |
Net
liability position | |
$ | — | | |
$ | (5,507,030 | ) | |
$ | (5,507,030 | ) |
The
segment operating results of the reportable segments is disclosed as follows:
| |
|
|
|
|
|
|
|
|
|
|
|
| |
Nine
months ended September 30, 2022 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Revenue | |
$ | 292,303 | | |
$ | 3,297,387 | | |
$ | 3,586,290 | |
Operating expenses | |
| (99,515 | ) | |
| (3,105,091 | ) | |
| (3,204,606 | ) |
| |
| | | |
| | | |
| | |
Operating
income | |
| 192,788 | | |
| 188,896 | | |
| 381,684 | |
| |
| | | |
| | | |
| | |
Other (expense)
income | |
| | | |
| | | |
| | |
Other
income | |
| — | | |
| 10,018 | | |
| 10,018 | |
Forgiveness
of government assistance loan | |
| — | | |
| 104,368 | | |
| 104,368 | |
Interest
expense | |
| (156,297 | ) | |
| (210,880 | ) | |
| (367,177 | ) |
Amortization
of debt discount | |
| — | | |
| (551,738 | ) | |
| (551,738 | ) |
Derivative
liability movement | |
| — | | |
| 175,593 | | |
| 175,593 | |
Foreign
exchange movements | |
| 116,635 | | |
| 385,715 | | |
| 502,350 | |
Net income
before taxes | |
| 153,126 | | |
| 101,972 | | |
| 255,098 | |
Taxes | |
| — | | |
| (87,615 | ) | |
| (87,615 | ) |
Net
Income | |
$ | 153,126 | | |
$ | 14,357 | | |
$ | 167,483 | |
The
operating assets and liabilities of the reportable segments is as follows:
| |
|
|
|
|
|
|
|
|
|
|
| |
September
30, 2022 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Purchase
of fixed assets | |
$ | — | | |
$ | 285,103 | | |
$ | 285,103 | |
Assets | |
| | | |
| | | |
| | |
Current assets | |
| 7,972 | | |
| 952,223 | | |
| 960,195 | |
Non-current assets | |
| 2,469,499 | | |
| 3,299,226 | | |
| 5,768,725 | |
Liabilities | |
| | | |
| | | |
| | |
Current liabilities | |
| (4,974,475 | ) | |
| (9,047,232 | ) | |
| (14,021,707 | ) |
Non-current liabilities | |
| (603,557 | ) | |
| (1,523,795 | ) | |
| (2,127,352 | ) |
Mandatory redeemable preferred
shares | |
| — | | |
| (400,000 | ) | |
| (400,000 | ) |
Intercompany
balances | |
| (1,263,485 | ) | |
| 1,263,485 | | |
| — | |
Net
liability position | |
$ | (4,364,046 | ) | |
$ | (8,131,754 | ) | |
$ | (9,820,139 | ) |
|
X |
- References
+ Details
Name: |
us-gaap_SegmentReportingAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI https://asc.fasb.org/topic&trid=2134510
+ Details
Name: |
us-gaap_SegmentReportingDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Net income per common share
|
9 Months Ended |
Sep. 30, 2023 |
Income per share |
|
Net income per common share |
17. Net
income per common share
For the three months ended September 30, 2023, the computation of basic and diluted earnings per share is calculated as follows:
Schedule of Earnings Per Share, Basic and Diluted
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings per share | |
| | | |
| | | |
| | |
Net income per
share available for common stockholders | |
$ | 2,076,479 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible debt | |
| 50,964 | | |
| 202,325,970 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 2,127,443 | | |
| 3,931,379,775 | | |
$ | 0.00 | |
For
the three months ended September 30, 2022, the computation of basic and diluted earnings per share is calculated as follows:
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings per share | |
| | | |
| | | |
| | |
Net income per
share available for common stockholders | |
$ | 458,713 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible debt | |
| 163,565 | | |
| 547,490,575 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 622,278 | | |
| 4,276,544,380 | | |
$ | 0.00 | |
For
the nine months ended September 30, 2023, the computation of basic and diluted earnings per share is calculated as follows:
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings
per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 1,524,534 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible
debt | |
| 146,395 | | |
| 202,325,970 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 1,670,929 | | |
| 3,931,379,775 | | |
$ | 0.00 | |
For the nine months ended September 30, 2022, the computation of basic and diluted earnings per share is calculated as follows:
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings per share | |
| | | |
| | | |
| | |
Net income per
share available for common stockholders | |
$ | 41,135 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible debt | |
| 230,724 | | |
| 547,490,575 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 271,859 | | |
| 4,244,126,798 | | |
$ | 0.00 | |
|
X |
- References
+ Details
Name: |
us-gaap_EarningsPerShareAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for earnings per share.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI https://asc.fasb.org/topic&trid=2144383
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257
+ Details
Name: |
us-gaap_EarningsPerShareTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Commitments and contingencies
|
9 Months Ended |
Sep. 30, 2023 |
Commitments and Contingencies Disclosure [Abstract] |
|
Commitments and contingencies |
18. Commitments
and contingencies
a. Options
granted to purchase shares in ATHI
On
July 12, 2020, the Company entered into a five year option agreement with Leonite Capital LLC (“Leonite”) and other investors
(collectively the “Transferees”). The Company agreed to sell to Leonite a portion of the total outstanding shares of ATHI
from the shares of ATHI held by the company. The Company provided Leonite an option to purchase 4,000,000 shares of ATHI from the Company
for a purchase consideration of $0.0001 per share (a total consideration of $400), based on the advances that Leonite made to the Company
totaling $396,000. Leonite shall share in all distributions by ATHI to the Company, on an as exercised basis, equal to the advances made
by Leonite to the Company, thereafter the option will be reduced to 50% of the shares exercisable under the option.
On
September 14, 2020, the Company entered into a five year option agreement with Ed Blasiak (“Blasiak”) whereby the Company
agreed to sell to Blasiak a portion of the total outstanding shares of ATHI. The Company provided Blasiak an option to purchase 571,428
shares of ATHI from the Company for a purchase consideration of $0.0001 per share (a total consideration of $57), based on the advances
that Blasiak made to the Company totaling $50,000. Blasiak shall share in all distributions by ATHI to the Company, on an as exercised
basis, equal to the advances made by Blasiak to the Company, thereafter the option will be reduced to 50% of the shares exercisable under
the option.
On
October 29, 2020, the Company entered into a five year option agreement with First Fire whereby the Company agreed to sell to First Fire
a portion of the total outstanding shares of ATHI. The Company provided First Fire an option to purchase 1,428,571 shares of ATHI from
the Company for a purchase consideration of $0.0001 per share (a total consideration of $143), based on the advances that First Fire
made to the Company totaling $120,000. First Fire shall share in all distributions by ATHI to the Company, on an as exercised basis,
equal to the advances made by First Fire to the Company, thereafter the option will be reduced to 50% of the shares exercisable under
the option.
On October
29, 2020, the Company entered into a five year option agreement entered into with Bauman, so that the Company agreed to sell to Bauman
a portion of the total outstanding shares of ATHI. The Company provided Bauman an option to purchase 1,428,571 shares of ATHI from the
Company for a purchase consideration of $0.0001 per share (a total consideration of $143), based on the advances that Bauman made to
the Company totaling $120,000. Bauman shall share in all distributions by ATHI to the Company, on an as exercised basis, equal to the
advances made by Bauman to the Company, thereafter the option will be reduced to 50% of the shares exercisable under the option.
From
time to time, the Company and its subsidiaries enter into legal disputes in the ordinary course of business. The Company believes there
are no material legal or administrative matters pending that are likely to have, individually or in the aggregate, a material adverse
effect on its business or results of operations.
|
X |
- References
+ Details
Name: |
us-gaap_CommitmentsAndContingenciesDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for commitments and contingencies.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -URI https://asc.fasb.org/topic&trid=2144648
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 440 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -URI https://asc.fasb.org/topic&trid=2127136
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308
+ Details
Name: |
us-gaap_CommitmentsAndContingenciesDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Subsequent events
|
9 Months Ended |
Sep. 30, 2023 |
Subsequent Events [Abstract] |
|
Subsequent events |
19. Subsequent
events
On
November 15, 2023, the Company, entered into a senior secured Promissory Note in the aggregate principal amount of $250,000 for net
proceeds of $223,500 after an original issue discount and fees of $26,500. The note earns interest at 10% per annum and matures on March
15, 2024.
Other
than disclosed above, the Company has evaluated subsequent events through the date of the condensed consolidated financial statements
were issued, we did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
|
X |
- References
+ Details
Name: |
us-gaap_SubsequentEventsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 855 -URI https://asc.fasb.org/topic&trid=2122774
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 855 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662
+ Details
Name: |
us-gaap_SubsequentEventsTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Summary of significant accounting policies (Policies)
|
9 Months Ended |
Sep. 30, 2023 |
Accounting Policies [Abstract] |
|
Use of Estimates |
a) Use
of Estimates
The
preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the
date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting
periods. Actual results could differ from those estimates.
|
Principles of consolidation and foreign translation |
b) Principles
of consolidation and foreign translation
The
accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all of its subsidiaries. All
intercompany transactions and balances have been eliminated on consolidation.
Certain
of the Company’s subsidiaries functional currency is the Canadian dollar, while the Company’s reporting currency is the U.S.
dollar. All transactions initiated in Canadian dollars are translated into US dollars in accordance with ASC 830, “Foreign Currency
Translation” as follows:
|
● |
Monetary
assets and liabilities at the rate of exchange in effect at the balance sheet date. |
|
● |
Certain
non-monetary assets and liabilities and equity at historical rates. |
|
● |
Revenue
and expense items and cash flows at the average rate of exchange prevailing during the year. |
Adjustments
arising from such translations are deferred until realization and are included as a separate component of stockholders’ deficit
as a component of accumulated other comprehensive income or loss. Therefore, translation adjustments are not included in determining
net income (loss) but reported as other comprehensive income (loss).
b) Principles
of consolidation and foreign translation (continued)
For
foreign currency transactions, the Company translates these amounts to the Company’s functional currency at the exchange rate effective
on the invoice date. If the exchange rate changes between the time of purchase and the time actual payment is made, a foreign exchange
transaction gain or loss results which is included in determining net income for the year.
On
June 30, 2023, the Company disposed on Cranberry Cove Holdings whose functional currency was Canadian Dollars, all remaining subsidiaries
have the U.S. dollar as a functional currency.
The
relevant translation rates are as follows: The Company disposed of Cranberry cove Holdings on June 30, 2023, the exchange rates used
for the six months in which it had control over Cranberry cove holdings was as follows; for the six months ended June 30, 2023, a closing
rate of CDN$1 equals US$0.7553 and an average exchange rate of CDN$1 equals US$0.7420, and for the year ended December 31, 2022, a closing
rate of CDN$1.0000 equals US$0.7383 and an average exchange rate of CDN$1.0000 equals US$0.7686.
|
Cash and cash equivalents |
c) Cash
and cash equivalents
For
purposes of the statements of cash flows, the Company considers all highly liquid instruments purchased with a maturity of three months
or less and money market accounts to be cash equivalents. The Company maintains cash and cash equivalents with several financial institutions
in the USA and Canada. There were no cash equivalents at September 30, 2023 and December 31, 2022.
The
Company primarily places cash balances in the USA with high-credit quality financial institutions located in the United States which
are insured by the Federal Deposit Insurance Corporation up to a limit of $250,000 per institution, in Canada which are insured
by the Canadian Deposit Insurance Corporation up to a limit of CDN$100,000 per institution.
|
Accounts receivable |
d) Accounts
receivable
Accounts
receivable primarily consists of amounts due from third-party payors (non-governmental) and private pay patients and is recorded net
of allowances for doubtful accounts and contractual discounts. The Company’s ability to collect outstanding receivables is critical
to its results of operations and cash flows. Accordingly, accounts receivable reported in the Company’s unaudited condensed consolidated
financial statements is recorded at the net amount expected to be received. The Company’s primary collection risks are (i) the
risk of overestimating net revenues at the time of billing that may result in the Company receiving less than the recorded receivable,
(ii) the risk of non-payment as a result of commercial insurance companies denying claims, (iii) the risk that patients will
fail to remit insurance payments to the Company when the commercial insurance company pays out-of-network claims directly to the patient,
(iv) resource and capacity constraints that may prevent the Company from handling the volume of billing and collection issues in
a timely manner, (v) the risk that patients do not pay the Company for their self-pay balances (including co-pays, deductibles and
any portion of the claim not covered by insurance) and (vi) the risk of non-payment from uninsured patients.
|
Allowance for Doubtful Accounts, Contractual and Other Discounts |
e) Allowance
for Doubtful Accounts, Contractual and Other Discounts
The
Company derives the majority of its revenues from commercial payors at in-network rates. The Company recognizes revenue based on historical
collections received from healthcare providers, recognizing only a percentage of revenues actually billed. Effectively recognizing revenue
net of any expected billing differentials. Based on the Company’s collection experience, the percentage of revenue recognized is
adjusted on a periodic basis, thereby taking into account expected credit losses in the revenue recognition process. The revenue we recognize
is already net of expected credit losses, therefore management does not maintain a separate allowance for doubtful accounts, contractual
and other discounts.
Management
also takes into consideration the age of accounts, creditworthiness and current economic trends when evaluating the percentage of revenue
to be recognized.
|
Property and equipment |
f) Property
and equipment
Property
and equipment is recorded at cost. Depreciation is calculated on the straight line basis over the estimated life of the asset.
|
Intangible assets |
g) Intangible
assets
Intangible
assets are stated at acquisition cost less accumulated amortization, if applicable, less any adjustments for impairment losses.
Amortization
is charged on a straight-line basis over the estimated remaining useful lives of the individual intangibles. Where intangibles are deemed
to be impaired the Company recognizes an impairment loss measured as the difference between the estimated fair value of the intangible
and its book value.
Licenses
to provide substance abuse rehabilitation services are amortized over the expected life of the contract, including any anticipated renewals.
The Company expects its licenses to remain in operation for a period of five years.
|
Leases |
h) Leases
The
Company accounts for leases in terms of AC 842 whereby leases are classified as either finance or operating leases. Leases that transfer
substantially all of the benefits and inherent risks of ownership of property to the Company are accounted for as finance leases. At
the time a finance lease is entered into, an asset is recorded together with its related long-term obligation to reflect the acquisition
and financing. Property and equipment recorded under finance leases is amortized on the same basis as described above. Operating leases
are recognized on the balance sheet as a lease liability with a corresponding right of use asset for all leases with a term that is more
than twelve months. Payments under operating leases are expensed as incurred.
|
Derivatives |
i) Derivatives
The
Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine
whether the embedded conversion feature should be bifurcated from the host instrument and accounted for as a derivative at fair value
with changes in fair value recorded in earnings. The Company previously used a Black Scholes Option Pricing model to estimate the fair
value of convertible debt conversion features at the end of each applicable reporting period. Changes in the fair value of these derivatives
during each reporting period were included in the statements of operations. Inputs into the Black Scholes Option Pricing model require
estimates, including such items as estimated volatility of the Company’s stock, risk free interest rate and the estimated life
of the financial instruments being fair valued.
|
Financial instruments |
j) Financial
instruments
The
Company initially measures its financial assets and liabilities at fair value. The Company subsequently measures all its financial assets
and financial liabilities at amortized cost.
Financial
assets measured at amortized cost include cash and accounts receivable.
Financial
liabilities measured at amortized cost include bank indebtedness, accounts payable and accrued liabilities, harmonized sales tax payable,
withholding taxes payable, convertible notes payable, loans payable and related party notes.
Financial
assets measured at cost are tested for impairment when there are indicators of impairment. The amount of the write-down is recognized
in net income. The previously recognized impairment loss may be reversed to the extent of the improvement, directly or by adjusting the
allowance account, provided it is no greater than the amount that would have been reported at the date of the reversal had the impairment
not been recognized previously. The amount of the reversal is recognized in net income. The Company recognizes its transaction costs
in net income in the period incurred. However, financial instruments that will not be subsequently measured at fair value are adjusted
by the transaction costs that are directly attributable to their origination, issuance or assumption.
FASB
ASC 820 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles,
and expands disclosures about fair value measurements. ASC 820 establishes a three tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value as follows:
|
· |
Level 1. Observable
inputs such as quoted prices in active markets; |
|
· |
Level 2. Inputs,
other than the quoted prices in active markets, that are observable either directly or indirectly; and |
|
· |
Level 3. Unobservable
inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions. |
The
Company measures its convertible debt and derivative liabilities associated therewith at fair value. These liabilities are revalued periodically
and the resultant gain or loss is realized through the consolidated Statement of Operations and Comprehensive Loss
|
Related parties |
k) Related
parties
Parties
are considered to be related to the Company if the parties directly or indirectly, through one or more intermediaries, control, are controlled
by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members
of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if
one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting
parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All
transactions are recorded at fair value of the goods or services exchanged.
|
Revenue recognition |
l) Revenue
recognition
ASC
606 requires companies to exercise more judgment and recognize revenue using a five-step process.
The
Company’s provision for doubtful accounts are recorded as a direct reduction to revenue instead of being presented as a separate
line item on the consolidated statements of operations and comprehensive loss.
As
our performance obligations relate to contracts with a duration of one year or less, the Company elected the optional exemption in ASC
606-10-50-14(a). Therefore, the Company is not required to disclose the transaction price for the remaining performance obligations at
the end of the reporting period or when the Company expects to recognize the revenue. The Company has minimal unsatisfied performance
obligations at the end of the reporting period as our patients typically are under no obligation to remain admitted in our facilities.
The
Company receives payments from the following sources for services rendered in our U.S. Facility: (i) commercial insurers; and (ii) individual
patients and clients. As the period between the time of service and time of payment is typically one year or less, the Company elected
the practical expedient under ASC 606-10-32-18 and does not adjust for the effects of a significant financing component.
The
Company derives a significant portion of its revenue from other payors that receive discounts from established billing rates. The various
managed care contracts under which these discounts must be calculated are complex, subject to interpretation and adjustment, and may
include multiple reimbursement mechanisms for different types of services provided in the Company’s inpatient facilities and cost
settlement provisions. Management estimates the transaction price on a payor-specific basis given its interpretation of the applicable
regulations or contract terms. The services authorized and provided and related reimbursement are often subject to interpretation that
could result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract renegotiations
occur frequently, necessitating regular review and assessment of the estimation process by management.
Settlements
with third-party payors are estimated and recorded in the period in which the related services are rendered and are adjusted in future
periods as final settlements are determined. In the opinion of management, adequate provision has been made for any adjustments and final
settlements. However, there can be no assurance that any such adjustments and final settlements will not have a material effect on the
Company’s financial condition or results of operations. The Company’s receivables were $681,072, $337,074 and $176,011 at
September 30, 2023, December 31, 2022 and December 31, 2021, respectively. Management believes that these receivables are properly stated
and are not likely to be settled for a significantly different amount.
The
Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that
reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from
the sale of its services. The Company applies the following five steps in order to determine the appropriate amount of revenue to
be recognized as it fulfills its obligations under each of its revenue transactions:
|
i. |
identify the
contract with a customer; |
|
ii. |
identify the
performance obligations in the contract; |
|
iii. |
determine the
transaction price; |
|
iv. |
allocate the
transaction price to performance obligations in the contract; and |
|
v. |
recognize revenue
as the performance obligation is satisfied. |
|
Income taxes |
m) Income
taxes
The
Company accounts for income taxes under the provisions of ASC Topic 740, “Income Taxes”. Under ASC Topic
740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated
financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred income taxes are provided
using the liability method. Under this method, deferred income taxes are recognized for the tax consequences of temporary differences
by applying enacted statutory rates applicable to future years to differences between the financial statement carrying amounts and the
tax bases of existing assets and liabilities. The tax basis of an asset or liability is the amount attributed to that asset or liability
for tax purposes. The effect on deferred taxes of a change in tax rates is recognized in income in the period of change. A valuation
allowance is provided to reduce the amount of deferred tax assets if it is considered more likely than not that some portion of, or all
of, the deferred tax assets will not be realized.
ASC Topic
740 contains a two-step approach to recognizing and measuring uncertain tax positions taken or expected to be taken in a tax return.
The first step is to determine if the weight of available evidence indicates that it is more likely than not that the tax position will
be sustained in an audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax
benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company recognizes interest and
penalties accrued on unrecognized tax benefits within general and administrative expense. To the extent that accrued interest and penalties
do not ultimately become payable, amounts accrued will be reduced and reflected as a reduction in general and administrative expenses
in the period that such determination is made. The tax returns for fiscal 2019, through 2022 are subject to audit or review by the US
tax authorities, whereas fiscal 2011 through 2022 are subject to audit or review by the Canadian tax authority.
|
Net income per Share |
n) Net
income per Share
Basic
net income per share is computed on the basis of the weighted average number of common stock outstanding during the year.
Diluted
net income per share is computed on the basis of the weighted average number of common stock and common stock equivalents outstanding.
Dilutive securities having an anti-dilutive effect on diluted net income per share are excluded from the calculation.
Dilution
is computed by applying the treasury stock method for options and warrants. Under this method, “in-the money” options and
warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained
thereby were used to purchase common stock at the average market price during the period. Dilution is computed by applying the if-converted
method for convertible preferred stocks. Under this method, convertible preferred stock is assumed to be converted at the beginning of
the period (or at the time of issuance, if later), and preferred dividends (if any) will be added back to determine income applicable
to common stock. The shares issuable upon conversion will be added to weighted average number of common stock outstanding. Conversion
will be assumed only if it reduces earnings per share (or increases loss per share).
|
Stock based compensation |
o) Stock
based compensation
Stock
based compensation cost is measured at the grant date, based on the estimated fair value of the award and is recognized as expense over
the employee’s requisite service period or vesting period on a straight-line basis. Share-based compensation expense recognized
in the consolidated statements of operations for the nine months ended September 30, 2023 and 2022 is based on awards ultimately expected
to vest and has been reduced for estimated forfeitures. This estimate will be revised in subsequent periods if actual forfeitures differ
from those estimates. We have no awards with performance conditions and no awards dependent on market conditions.
There
were no stock -based compensation awards that vested during the nine months ended September 30, 2023 and 2022 and there was no stock based
compensation recorded in the unaudited condensed consolidated financial statements.
|
Financial instruments risks |
p) Financial
instruments risks
The
Company is exposed to various risks through its financial instruments. The following analysis provides a measure of the Company’s
risk exposure and concentrations at the balance sheet dates, September 30, 2023 and December 31, 2022.
Credit
risk is the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an
obligation. Financial instruments that subject the Company to credit risk consist primarily of accounts receivable.
Credit
risk associated with accounts receivable is mitigated as only a percentage of the revenue billed to health insurance companies is recognized
as income until such time as the actual funds are collected. The revenue is concentrated amongst several health insurance companies located
in the US.
In
the opinion of management, credit risk with respect to accounts receivable is assessed as low.
Liquidity
risk is the risk the Company will not be able to meet its financial obligations as they fall due. The Company is exposed to liquidity
risk through its working capital deficiency of approximately $6.9 million, and an accumulated deficit of approximately $42.0 million.
The Company is dependent upon the raising of additional capital in order to implement its business plan. There is no assurance that the
Company will be successful with future financing ventures, and the inability to secure such financing may have a material adverse effect
on the Company’s financial condition. In the opinion of management, liquidity risk is assessed as high, material and remains unchanged
from that of the prior year.
Market
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices.
Market risk comprises of three types of risk: interest rate risk, currency risk, and other price risk. The Company is exposed to interest
rate risk.
Interest
rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
interest rates. The Company is exposed to interest rate risk on its convertible debt, short term loans, third party loans and government
assistance loans as of September 30, 2023. In the opinion of management, interest rate risk is assessed as moderate.
Currency
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange
rates. The Company is no longer subject to currency risk as it has disposed of its subsidiaries that operated in Canada.
Other
price risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
prices (other than those arising from interest rate risk or currency risk), whether those changes are caused by factors specific to the
individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market. In the opinion
of management, the Company is not exposed to this risk and remains unchanged from the prior year.
|
Allowance for credit losses |
q) Allowance
for credit losses
The
Company recognizes revenue based on historical collections received from healthcare providers, recognizing only a percentage of revenues
actually billed. Effectively recognizing revenue net of any expected billing differentials. Based on the Company’s collection experience,
the percentage of revenue recognized is adjusted on a periodic basis, thereby taking into account expected credit losses in the revenue
recognition process. The revenue we recognize is already net of expected credit losses.
We
constantly evaluate our collections experience and consider the market conditions and current economic developments facing the Company’s
operations . We have not experienced significantly different collections to revenues we have recognized and we have not seen any deterioration
in the payment patterns from the healthcare providers that the Company works with, we cannot predict with any certainty that the payment
patterns the Company experiences may change and we may be required to adjust the percentage of revenue recognized.
|
Recent accounting pronouncements |
r) Recent
accounting pronouncements
The
Financial Accounting Standards Board (“FASB”) issued additional updates during the nine months ended September 30, 2023.
None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material
impact on the Company’s consolidated financial statements upon adoption.
|
X |
- References
+ Details
Name: |
grst_AllowanceForCreditLossesPolicyTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_AllowanceForDoubtfulAccountsContractualAndOtherDiscountsPolicyTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_FinancialnstrumentsRisksPolicyTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_RelatedPartiesPolicyTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586
+ Details
Name: |
us-gaap_CashAndCashEquivalentsPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for its derivative instruments and hedging activities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(n)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959
+ Details
Name: |
us-gaap_DerivativesPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257
+ Details
Name: |
us-gaap_EarningsPerSharePolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for determining the fair value of financial instruments.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 60 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611
+ Details
Name: |
us-gaap_FairValueOfFinancialInstrumentsPolicy |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -URI https://asc.fasb.org/topic&trid=2175825
+ Details
Name: |
us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 20 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 19 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 28 -URI https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 17 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319
+ Details
Name: |
us-gaap_IncomeTaxPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 926 -SubTopic 20 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 920 -SubTopic 350 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783
Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 920 -SubTopic 350 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 920 -SubTopic 350 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783
+ Details
Name: |
us-gaap_IntangibleAssetsFiniteLivedPolicy |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for leasing arrangement entered into by lessee.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980
+ Details
Name: |
us-gaap_LesseeLeasesPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
+ Details
Name: |
us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 958 -SubTopic 360 -Section 50 -Paragraph 1 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 958 -SubTopic 360 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534
+ Details
Name: |
us-gaap_ReceivablesPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790
+ Details
Name: |
us-gaap_RevenueRecognitionPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI https://asc.fasb.org/topic&trid=2208762
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI https://asc.fasb.org/topic&trid=2228938
+ Details
Name: |
us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 12 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 11 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592
+ Details
Name: |
us-gaap_UseOfEstimates |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Disposal of subsidiary (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
Discontinued Operations and Disposal Groups [Abstract] |
|
Schedule of Other Assets and Liabilities Disposed |
Schedule of Other Assets and Liabilities Disposed
| |
Net
book value |
Assets | |
| | |
Other
receivable | |
$ | 12,015 | |
Property
and equipment | |
| 2,420,499 | |
| |
| 2,432,514 | |
Liabilities | |
| | |
Accounts
payable and accrued liabilities | |
| (196,859 | ) |
Government
assistance loans | |
| (45,317 | ) |
Mortgage
loan | |
| (3,525,223 | ) |
| |
| (3,767,399 | ) |
| |
| | |
Disposal
of subsidiary to related party – recorded as additional paid in capital | |
$ | (1,334,885 | ) |
|
X |
- References
+ Details
Name: |
grst_ScheduleOfOtherAssetsAndOtherLiabilitiesDisposedTableTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Property and equipment (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
Property, Plant and Equipment [Abstract] |
|
Property purchase and subsequent |
Property purchase and subsequent
| |
Amount |
Purchase
of 950 Evernia Street property | |
| | |
Purchase
price | |
$ | 5,500,000 | |
Fees
and expenses related to property purchase | |
| 109,276 | |
Total
acquisition cost | |
| 5,609,276 | |
| |
| | |
Proceeds
on sale | |
| 8,500,000 | |
Fees
and expenses related to disposal of the property | |
| (406,552 | ) |
Net
proceeds on disposal of property | |
| 8,093,448 | |
| |
| | |
Gain
on sale of property | |
$ | 2,484,172 | |
|
Schedule of sale of property |
Schedule of sale of property
| |
| |
September
30, 2023 | |
December
31, 2022 |
| |
Useful lives | |
Cost | |
Accumulated
depreciation | |
Net
book value | |
Net
book value |
Land | |
Indefinite | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | 158,742 | |
Property | |
25 years | |
| — | | |
| — | | |
| — | | |
| 2,310,448 | |
Leasehold
improvements | |
Life of
lease | |
| 456,547 | | |
| (76,676 | ) | |
| 379,871 | | |
| 373,320 | |
Furniture
and fittings | |
6 years | |
| 149,260 | | |
| (41,234 | ) | |
| 108,026 | | |
| 92,941 | |
Vehicles | |
5 years | |
| 55,949 | | |
| (26,263 | ) | |
| 29,686 | | |
| 38,079 | |
Computer
equipment | |
3
years | |
| 7,525 | | |
| (1,409 | ) | |
| 6,116 | | |
| 865 | |
| |
| |
$ | 669,281 | | |
$ | (145,582 | ) | |
$ | 523,699 | | |
$ | 2,974,395 | |
|
X |
- DefinitionTabular disclosure of key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.
+ References
+ Details
Name: |
us-gaap_LongTermPurchaseCommitmentTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
X |
- References
+ Details
Name: |
us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details
Name: |
us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Leases (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
Leases |
|
Schedule of Right of use assets |
Schedule of Right of use assets
| |
September
30, 2023 | |
December
31, 2022 |
Non-current
assets | |
| | | |
| | |
Right-of-use
assets – finance leases, net of depreciation, included in Property and equipment | |
$ | 26,937 | | |
$ | 38,079 | |
Right-of-use
assets - operating leases, net of amortization | |
$ | 9,331,261 | | |
$ | 1,393,071 | |
|
Schedule of finance and operating lease |
Schedule of finance and operating lease
| |
| |
|
| |
Nine
months ended September 30, |
| |
2023 | |
2022 |
Finance lease cost: | |
| | | |
| | |
Amortization of
right-of-use assets | |
$ | 8,392 | | |
$ | 8,392 | |
Interest
expense on finance lease liabilities | |
| 1,504 | | |
| 1,880 | |
| |
| 9,896 | | |
| 10,272 | |
| |
| | | |
| | |
Operating
lease cost | |
$ | 446,189 | | |
$ | 194,086 | |
Lease
cost | |
$ | 456,085 | | |
$ | 204,358 | |
|
Schedule of Other lease |
Schedule of Other lease
| |
|
|
|
|
|
|
| |
Nine
months ended September 30, |
| |
2023 | |
2022 |
Cash paid for amounts included
in the measurement of lease liabilities | |
| |
|
Operating cash
flows from finance leases | |
$ | (1,504 | ) | |
$ | (1,880 | ) |
Operating cash flows from
operating leases | |
| (446,189 | ) | |
| (199,539 | ) |
Financing
cash flows from finance leases | |
| (5,868 | ) | |
| (5,492 | ) |
Cash
paid for amounts included in the measurement of lease liabilities | |
$ | (453,361 | ) | |
$ | (204,479 | ) |
| |
| | | |
| | |
Weighted average lease term
– finance leases | |
| 3
years and 2 months | | |
| 4
years and 1 months | |
Weighted average remaining
lease term – operating leases | |
| 19
years and 11 months | | |
| 4
years and 4 months | |
| |
| | | |
| | |
Discount rate – finance
leases | |
| 6.60 | % | |
| 6.61 | % |
Discount rate – operating
leases | |
| 7.70 | % | |
| 4.64 | % |
|
Schedule of Finance lease liability |
Schedule of Finance lease liability
| |
Amount |
Remainder of 2023 | |
$ | 2,457 | |
2024 | |
| 9,829 | |
2025 | |
| 9,829 | |
2026 | |
| 6,195 | |
2027 | |
| 1,707 | |
| |
| 30,017 | |
Imputed interest | |
| (3,080 | ) |
Total finance lease liability | |
$ | 26,937 | |
Disclosed as: | |
| | |
Current portion | |
$ | 8,289 | |
Non-Current portion | |
| 18,648 | |
Lease liability | |
$ | 26,937 | |
|
Schedule of Operating lease liability |
Schedule of Operating lease liability
| |
Amount |
| |
|
Remainder of 2023 | |
$ | 249,333 | |
2024 | |
| 754,857 | |
2025 | |
| 775,615 | |
2026 | |
| 796,945 | |
2027 | |
| 818,861 | |
| |
| 16,200,042 | |
Total undiscounted minimum future lease payments | |
| 19,595,653 | |
Imputed interest | |
| (10,223,673 | ) |
Total operating lease liability | |
$ | 9,371,980 | |
| |
| | |
Disclosed as: | |
| | |
Current portion | |
$ | 32,753 | |
Non-Current portion | |
| 9,339,227 | |
Lease liability | |
$ | 9,371,980 | |
|
X |
- References
+ Details
Name: |
grst_DisclosureLeasesAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_OtherLeaseTableTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ScheduleoOfFinanceAndOperatingLeaseTableTextBlock |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 30 -Section 50 -Paragraph 13 -URI https://asc.fasb.org/extlink&oid=124258985&loc=SL77919398-209981
+ Details
Name: |
us-gaap_ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Short-term Convertible Notes (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
Debt Disclosure [Abstract] |
|
Schedule of short-term convertible notes |
Schedule of short-term convertible notes
|
|
Interest
rate |
|
Maturity
Date |
|
Principal |
|
Interest |
|
September
30, 2023 |
|
December
31, 2022 |
Leonite Capital, LLC |
|
|
12.0 |
% |
|
On Demand |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
184,749 |
|
Leonite Fund I, LP |
|
|
Variable |
|
|
On Demand |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
720,830 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Auctus Fund, LLC |
|
|
0.0 |
% |
|
On Demand |
|
|
70,000 |
|
|
|
— |
|
|
|
70,000 |
|
|
|
80,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Labrys Fund, LP |
|
|
12.0 |
% |
|
On Demand |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
8,826 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ed Blasiak |
|
|
6.5 |
% |
|
On Demand |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
63,322 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joshua Bauman |
|
|
11.0 |
% |
|
October 21, 2022 |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
169,710 |
|
|
|
|
10.0 |
% |
|
August 9, 2023 |
|
|
150,000 |
|
|
|
2,131 |
|
|
|
152,131 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series N convertible notes |
|
|
6.0 |
% |
|
On Demand |
|
|
3,229,000 |
|
|
|
957,078 |
|
|
|
4,186,078 |
|
|
|
4,041,813 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
3,449,000 |
|
|
$ |
959,209 |
|
|
$ |
4,408,209 |
|
|
$ |
5,269,250 |
|
|
X |
- References
+ Details
Name: |
us-gaap_DebtDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_ScheduleOfShortTermDebtTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Mortgage loans (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
Mortgage Loans |
|
Schedule of mortgage loans |
Schedule of mortgage loans
|
|
Interest
rate |
|
|
Maturity
date |
|
Principal
Outstanding |
|
|
Accrued
interest |
|
|
September
30,
2023 |
|
|
December
31,
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cranberry Cove Holdings, Ltd. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pace Mortgage |
|
|
4.2 |
% |
|
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,504,605 |
Disclosed as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term portion |
|
|
|
|
|
|
|
|
|
|
|
|
$ |
— |
|
|
$ |
3,504,605 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X |
- References
+ Details
Name: |
grst_DisclosureMortgageLoansAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.
+ References
+ Details
Name: |
us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Related party payables (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
Related Party Transactions [Abstract] |
|
Schedule of Related party payable |
Schedule
of Related party payable
| |
September
30, | |
December
31, |
| |
2023 | |
2022 |
Due
to related parties | |
| | | |
| | |
Shawn
E. Leon | |
$ | 124,445 | | |
$ | 411,611 | |
Leon
Developments Ltd. | |
| 1,092,701 | | |
| 850,657 | |
Eileen
Greene | |
| 1,452,862 | | |
| 1,451,610 | |
Total
related party payables | |
$ | 2,670,008 | | |
$ | 2,713,878 | |
|
X |
- DefinitionTabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.
+ References
+ Details
Name: |
us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Stockholder’s deficit (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
Equity [Abstract] |
|
Share-Based Payment Arrangement, Performance Shares, Activity |
Share-Based
Payment Arrangement, Performance Shares, Activity
|
|
Nine
months ended
September 30,
2023 |
Exercise price |
|
$ |
0.001 |
|
Risk free interest rate |
|
|
4.31 to 4.87 |
% |
Expected life of options |
|
|
2 to 4 years |
Expected volatility of underlying stock |
|
|
205.5 to 243.0 |
% |
Expected dividend rate |
|
|
0 |
% |
|
Schedule of warrants outstanding |
Schedule of warrants outstanding
|
|
No.
of shares |
|
Exercise
price
per share |
|
Weighted
average exercise
price |
|
|
|
|
|
|
|
Outstanding
as of January 1, 2022 |
|
|
623,777,506 |
|
|
|
$0.000675
to $0.12 |
|
|
$ |
0.0052875 |
|
Granted |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Forfeited/cancelled |
|
|
(20,925,000 |
) |
|
|
$0.12 |
|
|
|
0.12 |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Outstanding
as of December 31, 2022 |
|
|
602,852,506 |
|
|
|
$0.000675 to $0.00205 |
|
|
$ |
0.001306 |
|
Granted |
|
|
745,810,761 |
|
|
|
$0.001 |
|
|
|
0.001 |
|
Forfeited/cancelled |
|
|
(326,286,847 |
) |
|
|
$0.000675 |
|
|
|
0.000675 |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Outstanding
as of September 30, 2023 |
|
|
1,022,376,420 |
|
|
|
$0.001
to $0.00205 |
|
|
$ |
0.0012840 |
|
|
Schedule of assumption |
Schedule of assumption
|
|
|
Warrants
outstanding |
|
|
Warrants
exercisable |
|
Exercise
price |
|
|
No.
of shares |
|
|
Weighted
average
remaining years |
|
|
Weighted
average
exercise price |
|
|
No.
of shares |
|
|
Weighted
average
exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$0.001 |
|
|
|
745,810,761 |
|
|
|
3.75 |
|
|
|
|
|
|
|
745,810,761 |
|
|
|
|
|
$0.002050 |
|
|
|
276,565,659 |
|
|
|
2.27 |
|
|
|
|
|
|
|
276,565,659 |
|
|
|
|
|
|
|
|
|
1,022,376,420 |
|
|
|
3.35 |
|
|
$ |
0.001284 |
|
|
|
1,022,376,420 |
|
|
$ |
0.001284 |
|
|
X |
- References
+ Details
Name: |
us-gaap_EquityAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775
+ Details
Name: |
us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Segment information (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
Segment Reporting [Abstract] |
|
Schedule of segment information |
Schedule of segment information
| |
|
|
|
|
|
|
|
|
|
|
| |
Nine
months ended September 30, 2023 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Revenue | |
$ | 180,522 | | |
$ | 4,039,382 | | |
$ | 4,219,904 | |
Operating expenses | |
| 245,528 | | |
| 3,833,676 | | |
| 4,079,204 | |
| |
| | | |
| | | |
| | |
Operating (loss) income | |
| (65,006 | ) | |
| 205,706 | | |
| 140,700 | |
| |
| | | |
| | | |
| | |
Other (expense)
income | |
| | | |
| | | |
| | |
Forgiveness
of intercompany loan | |
| 3,481,332 | | |
| (3,481,332 | ) | |
| — | |
Other
income | |
| — | | |
| 449 | | |
| 449 | |
Penalty
on convertible notes | |
| — | | |
| (34,688 | ) | |
| (34,688 | ) |
Extension
fee on property purchase | |
| — | | |
| (130,000 | ) | |
| (130,000 | ) |
Gain
on disposal of property | |
| — | | |
| 2,484,172 | | |
| 2,484,172 | |
Loss
on debt extinguishment | |
| — | | |
| (277,175 | ) | |
| (277,175 | ) |
Interest
expense | |
| (95,464 | ) | |
| (286,984 | ) | |
| (382,448 | ) |
Amortization
of debt discount | |
| — | | |
| (238,304 | ) | |
| (238,304 | ) |
Foreign
exchange movements | |
| (81,033 | ) | |
| (3,115 | ) | |
| (84,148 | ) |
Net income
(loss) before taxes | |
| 3,239,829 | | |
| (1,761,271 | ) | |
| 1,478,558 | |
Taxes | |
| — | | |
| 221,107 | | |
| 221,107 | |
Net
income (loss) | |
$ | 3,239,829 | | |
$ | (1,540,164 | ) | |
$ | 1,699,665 | |
The
operating assets and liabilities of the reportable segments is as follows:
| |
|
|
|
|
|
|
|
|
|
|
| |
September
30, 2023 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Purchase
of fixed assets | |
$ | (43,611 | ) | |
$ | 5,287,622 | | |
$ | 5,244,011 | |
Assets | |
| | | |
| | | |
| | |
Current assets | |
| — | | |
| 794,521 | | |
| 794,521 | |
Non-current assets | |
| — | | |
| 11,213,407 | | |
| 11,213,407 | |
Liabilities | |
| | | |
| | | |
| | |
Current liabilities | |
| — | | |
| (7,713,189 | ) | |
| (7,713,189 | ) |
Non-current liabilities | |
| — | | |
| (9,801,769 | ) | |
| (9,801,769 | ) |
Net
liability position | |
$ | — | | |
$ | (5,507,030 | ) | |
$ | (5,507,030 | ) |
The
segment operating results of the reportable segments is disclosed as follows:
| |
|
|
|
|
|
|
|
|
|
|
|
| |
Nine
months ended September 30, 2022 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Revenue | |
$ | 292,303 | | |
$ | 3,297,387 | | |
$ | 3,586,290 | |
Operating expenses | |
| (99,515 | ) | |
| (3,105,091 | ) | |
| (3,204,606 | ) |
| |
| | | |
| | | |
| | |
Operating
income | |
| 192,788 | | |
| 188,896 | | |
| 381,684 | |
| |
| | | |
| | | |
| | |
Other (expense)
income | |
| | | |
| | | |
| | |
Other
income | |
| — | | |
| 10,018 | | |
| 10,018 | |
Forgiveness
of government assistance loan | |
| — | | |
| 104,368 | | |
| 104,368 | |
Interest
expense | |
| (156,297 | ) | |
| (210,880 | ) | |
| (367,177 | ) |
Amortization
of debt discount | |
| — | | |
| (551,738 | ) | |
| (551,738 | ) |
Derivative
liability movement | |
| — | | |
| 175,593 | | |
| 175,593 | |
Foreign
exchange movements | |
| 116,635 | | |
| 385,715 | | |
| 502,350 | |
Net income
before taxes | |
| 153,126 | | |
| 101,972 | | |
| 255,098 | |
Taxes | |
| — | | |
| (87,615 | ) | |
| (87,615 | ) |
Net
Income | |
$ | 153,126 | | |
$ | 14,357 | | |
$ | 167,483 | |
The
operating assets and liabilities of the reportable segments is as follows:
| |
|
|
|
|
|
|
|
|
|
|
| |
September
30, 2022 |
| |
Rental
Operations | |
In-Patient
services | |
Total |
| |
| |
| |
|
Purchase
of fixed assets | |
$ | — | | |
$ | 285,103 | | |
$ | 285,103 | |
Assets | |
| | | |
| | | |
| | |
Current assets | |
| 7,972 | | |
| 952,223 | | |
| 960,195 | |
Non-current assets | |
| 2,469,499 | | |
| 3,299,226 | | |
| 5,768,725 | |
Liabilities | |
| | | |
| | | |
| | |
Current liabilities | |
| (4,974,475 | ) | |
| (9,047,232 | ) | |
| (14,021,707 | ) |
Non-current liabilities | |
| (603,557 | ) | |
| (1,523,795 | ) | |
| (2,127,352 | ) |
Mandatory redeemable preferred
shares | |
| — | | |
| (400,000 | ) | |
| (400,000 | ) |
Intercompany
balances | |
| (1,263,485 | ) | |
| 1,263,485 | | |
| — | |
Net
liability position | |
$ | (4,364,046 | ) | |
$ | (8,131,754 | ) | |
$ | (9,820,139 | ) |
|
X |
- DefinitionTabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599
+ Details
Name: |
us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_SegmentReportingAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Net income per common share (Tables)
|
9 Months Ended |
Sep. 30, 2023 |
Income per share |
|
Schedule of Earnings Per Share, Basic and Diluted |
Schedule of Earnings Per Share, Basic and Diluted
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings per share | |
| | | |
| | | |
| | |
Net income per
share available for common stockholders | |
$ | 2,076,479 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible debt | |
| 50,964 | | |
| 202,325,970 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 2,127,443 | | |
| 3,931,379,775 | | |
$ | 0.00 | |
For
the three months ended September 30, 2022, the computation of basic and diluted earnings per share is calculated as follows:
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings per share | |
| | | |
| | | |
| | |
Net income per
share available for common stockholders | |
$ | 458,713 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible debt | |
| 163,565 | | |
| 547,490,575 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 622,278 | | |
| 4,276,544,380 | | |
$ | 0.00 | |
For
the nine months ended September 30, 2023, the computation of basic and diluted earnings per share is calculated as follows:
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings
per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 1,524,534 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible
debt | |
| 146,395 | | |
| 202,325,970 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 1,670,929 | | |
| 3,931,379,775 | | |
$ | 0.00 | |
For the nine months ended September 30, 2022, the computation of basic and diluted earnings per share is calculated as follows:
| |
| |
Number
of | |
Per
share |
| |
Amount | |
shares | |
amount |
| |
| |
| |
|
Basic earnings per share | |
| | | |
| | | |
| | |
Net income per
share available for common stockholders | |
$ | 41,135 | | |
| | |
$ | 0.00 | |
| |
| | | |
| | | |
| | |
Effect
of dilutive securities | |
| | | |
| | | |
| | |
Convertible debt | |
| 230,724 | | |
| 547,490,575 | | |
| | |
| |
| | | |
| | | |
| | |
Diluted
earnings per share | |
| | | |
| | | |
| | |
Net
income per share available for common stockholders | |
$ | 271,859 | | |
| 4,244,126,798 | | |
$ | 0.00 | |
|
X |
- References
+ Details
Name: |
us-gaap_EarningsPerShareAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257
+ Details
Name: |
us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.
+ References
+ Details
Name: |
us-gaap_CashFDICInsuredAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
v3.23.3
Property and equipment (Details) - USD ($)
|
9 Months Ended |
Sep. 30, 2023 |
Sep. 30, 2022 |
Purchase of 950 Evernia Street property |
|
|
Purchase price |
$ 5,500,000
|
|
Fees and expenses related to property purchase |
109,276
|
|
Total acquisition cost |
5,609,276
|
|
Proceeds on sale |
8,500,000
|
|
Fees and expenses related to disposal of the property |
(406,552)
|
|
Net proceeds on disposal of property |
8,093,448
|
|
Gain on sale of property |
$ 2,484,172
|
|
X |
- DefinitionThe capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 932 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-10(c)(7)(ii)) -URI https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 932 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-10(c)(3)(ii)(A)) -URI https://asc.fasb.org/extlink&oid=126954596&loc=d3e511914-122862
+ Details
Name: |
us-gaap_AcquisitionCosts |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_GainLossOnDispositionOfAssets1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_GainLossOnSaleOfPropertyPlantEquipment |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_GainLossOnSaleOfPropertyPlantEquipmentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentAdditions |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentDisposals |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) of physical assets used in the normal conduct of business and not intended for resale, from reclassification, impairment, donation, or changes classified as other. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentTransfersAndChanges |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
v3.23.3
Property and equipment (Details 1) - USD ($)
|
9 Months Ended |
|
Sep. 30, 2023 |
Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] |
|
|
Property, Plant and Equipment, Gross |
$ 669,281
|
|
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
(145,582)
|
|
Property, Plant and Equipment, Net |
$ 523,699
|
$ 2,974,395
|
[custom:PropertyPlantAndEquipmentNet1-0] |
|
2,974,395
|
Land [Member] |
|
|
Property, Plant and Equipment [Line Items] |
|
|
Useful Lives |
Indefinite
|
|
Property, Plant and Equipment, Gross |
|
|
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
|
|
Property, Plant and Equipment, Net |
|
158,742
|
Property, Plant and Equipment [Member] |
|
|
Property, Plant and Equipment [Line Items] |
|
|
Useful Lives |
25 years
|
|
Property, Plant and Equipment, Gross |
|
|
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
|
|
Property, Plant and Equipment, Net |
|
2,310,448
|
Leasehold Improvements [Member] |
|
|
Property, Plant and Equipment [Line Items] |
|
|
Useful Lives |
Life of
lease
|
|
Property, Plant and Equipment, Gross |
$ 456,547
|
|
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
(76,676)
|
|
Property, Plant and Equipment, Net |
$ 379,871
|
373,320
|
Furniture and Fixtures [Member] |
|
|
Property, Plant and Equipment [Line Items] |
|
|
Useful Lives |
6 years
|
|
Property, Plant and Equipment, Gross |
$ 149,260
|
|
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
(41,234)
|
|
Property, Plant and Equipment, Net |
$ 108,026
|
92,941
|
Vehicles [Member] |
|
|
Property, Plant and Equipment [Line Items] |
|
|
Useful Lives |
5 years
|
|
Property, Plant and Equipment, Gross |
$ 55,949
|
|
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
(26,263)
|
|
Property, Plant and Equipment, Net |
$ 29,686
|
38,079
|
Computer Equipment [Member] |
|
|
Property, Plant and Equipment [Line Items] |
|
|
Useful Lives |
3
years
|
|
Property, Plant and Equipment, Gross |
$ 7,525
|
|
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment |
(1,409)
|
|
Property, Plant and Equipment, Net |
$ 6,116
|
$ 865
|
X |
- References
+ Details
Name: |
grst_PropertyPlantAndEquipmentEstimatedUsefulLive |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_PropertyPlantAndEquipmentNet1 |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(14)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(13)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentGross |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(8)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 360 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630
Reference 4: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- Details
Name: |
us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_PropertyPlantAndEquipmentMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
X |
- DefinitionThe amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_Depreciation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Intangibles (Details) - USD ($)
|
9 Months Ended |
|
Sep. 30, 2023 |
Dec. 31, 2022 |
Goodwill and Intangible Assets Disclosure [Abstract] |
|
|
Intangible assets useful lives |
5
years
|
|
Finite-Lived Intangible Assets, Gross |
$ 1,789,903
|
|
Finite-Lived Intangible Assets, Accumulated Amortization |
(805,456)
|
|
Finite-Lived Intangible Assets, Net |
$ 984,447
|
$ 1,252,932
|
X |
- References
+ Details
Name: |
grst_FiniteLivedIntangibleAssetUsefulLifeOne |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAccumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(16)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 928 -SubTopic 340 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsGross |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 926 -SubTopic 20 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
X |
- DefinitionThe aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274
+ Details
Name: |
us-gaap_AmortizationOfIntangibleAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Leases (Details) - USD ($)
|
Sep. 30, 2023 |
Dec. 31, 2022 |
Leases |
|
|
Right-of-use assets – finance leases, net of depreciation, included in Property and equipment |
$ 26,937
|
$ 38,079
|
Right-of-use assets - operating leases, net of amortization |
$ 9,331,261
|
$ 1,393,071
|
X |
- References
+ Details
Name: |
grst_DisclosureLeasesAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_RightofuseAssetsOperatingLeasesNetOfAmortization |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
v3.23.3
Leases (Details 1) - USD ($)
|
9 Months Ended |
Sep. 30, 2023 |
Sep. 30, 2022 |
Leases |
|
|
Amortization of right-of-use assets |
$ 8,392
|
$ 8,392
|
Interest expense on finance lease liabilities |
1,504
|
1,880
|
|
9,896
|
10,272
|
Operating lease cost |
446,189
|
194,086
|
Lease cost |
$ 456,085
|
$ 204,358
|
X |
- References
+ Details
Name: |
grst_DisclosureLeasesAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_InterestExpenseOnFinanceLeaseLiabilities |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash outflow for principal payment on finance lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 5 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (g)(1) -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980
+ Details
Name: |
us-gaap_FinanceLeasePrincipalPayments |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of amortization expense attributable to right-of-use asset from finance lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 55 -Paragraph 53 -URI https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971
+ Details
Name: |
us-gaap_FinanceLeaseRightOfUseAssetAmortization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of lease cost recognized by lessee for lease contract.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 55 -Paragraph 53 -URI https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971
+ Details
Name: |
us-gaap_LeaseCost |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 55 -Paragraph 53 -URI https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980
+ Details
Name: |
us-gaap_OperatingLeaseCost |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
v3.23.3
Leases (Details 2) - USD ($)
|
9 Months Ended |
Sep. 30, 2023 |
Sep. 30, 2022 |
Leases |
|
|
Operating cash flows from finance leases |
$ (1,504)
|
$ (1,880)
|
Operating cash flows from operating leases |
(446,189)
|
(199,539)
|
Financing cash flows from finance leases |
(5,868)
|
(5,492)
|
Cash paid for amounts included in the measurement of lease liabilities |
$ (453,361)
|
$ (204,479)
|
[custom:WeightedAverageLeaseTermFinanceLeases] |
3
years and 2 months
|
4
years and 1 months
|
[custom:WeightedAverageRemainingLeaseTermOperatingLeases] |
19
years and 11 months
|
4
years and 4 months
|
[custom:DiscountRateFinanceLeases] |
6.60%
|
6.61%
|
[custom:DiscountRateOperatingLeases] |
7.70%
|
4.64%
|
X |
- References
+ Details
Name: |
grst_DisclosureLeasesAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_DiscountRateFinanceLeases |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_DiscountRateOperatingLeases |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_FinancingCashFlowsFromFinanceLeases |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NetChangeLease |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_OperatingCashFlowsFromFinanceLeases |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_OperatingCashFlowsFromOperatingLeases |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_WeightedAverageLeaseTermFinanceLeases |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_WeightedAverageRemainingLeaseTermOperatingLeases |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Leases (Details 3) - USD ($)
|
Sep. 30, 2023 |
Dec. 31, 2022 |
Leases |
|
|
Remainder of 2023 |
$ 2,457
|
|
2024 |
9,829
|
|
2025 |
9,829
|
|
2026 |
6,195
|
|
2027 |
1,707
|
|
|
30,017
|
|
Imputed interest |
(3,080)
|
|
Total finance lease liability |
26,937
|
|
Current portion |
8,289
|
$ 7,891
|
Non-Current portion |
18,648
|
$ 24,952
|
Lease liability |
$ 26,937
|
|
X |
- References
+ Details
Name: |
grst_DisclosureLeasesAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ImputedInterest |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
grst_TotalFinanceLeaseLiability |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from finance lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_FinanceLeaseLiability |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from finance lease, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.23.3
Leases (Details 4) - USD ($)
|
Sep. 30, 2023 |
Dec. 31, 2022 |
Leases |
|
|
Remainder of 2023 |
$ 249,333
|
|
2024 |
754,857
|
|
2025 |
775,615
|
|
2026 |
796,945
|
|
2027 |
818,861
|
|
|
16,200,042
|
|
Total undiscounted minimum future lease payments |
19,595,653
|
|
Imputed interest |
(10,223,673)
|
|
Total operating lease liability |
9,371,980
|
|
Current portion |
32,753
|
$ 287,017
|
Non-Current portion |
9,339,227
|
$ 1,206,413
|
Lease liability |
$ 9,371,980
|
|
X |
- References
+ Details
Name: |
grst_DisclosureLeasesAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_TotalOperatingLeaseLiability |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
grst_TotalUndiscountedMinimumFutureLeasePayments |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980
+ Details
Name: |
us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_OperatingLeaseLiability |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_OperatingLeaseLiabilityCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977
+ Details
Name: |
us-gaap_OperatingLeaseLiabilityNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.23.3
X |
- References
+ Details
Name: |
grst_DisclosureLeasesAbstract |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_FutureMinimumLeasePayments |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.23.3
Short-term Convertible Notes (Details) - USD ($)
|
9 Months Ended |
12 Months Ended |
Sep. 30, 2023 |
Dec. 31, 2022 |
Short-Term Debt [Line Items] |
|
|
Principal Amount |
$ 3,449,000
|
|
Interest Costs Capitalized |
959,209
|
|
Short-term convertible notes |
$ 4,408,209
|
$ 5,269,250
|
Leonite Capital L L C [Member] |
|
|
Short-Term Debt [Line Items] |
|
|
Interest rate |
12.00%
|
|
Long-Term Debt, Maturities, Repayment Terms |
On Demand
|
|
Principal Amount |
|
|
Interest Costs Capitalized |
|
|
Short-term convertible notes |
|
184,749
|
Interest rate |
12.00%
|
|
Leonite Fund I L P [Member] |
|
|
Short-Term Debt [Line Items] |
|
|
Long-Term Debt, Maturities, Repayment Terms |
On Demand
|
|
Principal Amount |
|
|
Interest Costs Capitalized |
|
|
Short-term convertible notes |
|
720,830
|
Auctus Fund L L C [Member] |
|
|
Short-Term Debt [Line Items] |
|
|
Interest rate |
0.00%
|
|
Long-Term Debt, Maturities, Repayment Terms |
On Demand
|
|
Principal Amount |
$ 70,000
|
|
Interest Costs Capitalized |
|
|
Short-term convertible notes |
$ 70,000
|
80,000
|
Interest rate |
0.00%
|
|
Labrys Fund L P [Member] |
|
|
Short-Term Debt [Line Items] |
|
|
Interest rate |
1200.00%
|
|
Long-Term Debt, Maturities, Repayment Terms |
On Demand
|
|
Principal Amount |
|
|
Interest Costs Capitalized |
|
|
Short-term convertible notes |
|
8,826
|
Interest rate |
1200.00%
|
|
Ed Blasiak [Member] |
|
|
Short-Term Debt [Line Items] |
|
|
Interest rate |
6.50%
|
|
Long-Term Debt, Maturities, Repayment Terms |
On Demand
|
|
Principal Amount |
|
|
Interest Costs Capitalized |
|
|
Short-term convertible notes |
|
63,322
|
Interest rate |
6.50%
|
|
Joshua Bauman [Member] |
|
|
Short-Term Debt [Line Items] |
|
|
Interest rate |
11.00%
|
|
Long-Term Debt, Maturities, Repayment Terms |
October 21, 2022
|
|
Principal Amount |
|
|
Interest Costs Capitalized |
|
|
Short-term convertible notes |
|
169,710
|
Interest rate |
11.00%
|
|
Convertible Notes [Member] |
|
|
Short-Term Debt [Line Items] |
|
|
Interest rate |
10.00%
|
|
Long-Term Debt, Maturities, Repayment Terms |
August 9, 2023
|
|
Principal Amount |
$ 150,000
|
|
Interest Costs Capitalized |
2,131
|
|
Short-term convertible notes |
$ 152,131
|
|
Interest rate |
10.00%
|
|
Series N Convertible Notes [Member] |
|
|
Short-Term Debt [Line Items] |
|
|
Interest rate |
6.00%
|
|
Principal Amount |
$ 3,229,000
|
|
Interest Costs Capitalized |
957,078
|
|
Short-term convertible notes |
$ 4,186,078
|
$ 4,041,813
|
Interest rate |
6.00%
|
|
Series N Convertible [Member] |
|
|
Short-Term Debt [Line Items] |
|
|
Long-Term Debt, Maturities, Repayment Terms |
On Demand
|
|
X |
- References
+ Details
Name: |
grst_DebtInstrumentOfPrincipalAmount |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ShorttermConvertible |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of interest capitalized during the period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391
+ Details
Name: |
us-gaap_InterestCostsCapitalized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of timing of required repayments, sinking fund requirements, and other redeemable securities at fixed or determinable prices and dates in the five years immediately following the date of the latest balance sheet presented in the financial statements, and the amount thereafter to fully repay the principal of long-term debt. These disclosures may be made either on an individual debt or security basis, by type of debt or security basis, or on a combined basis.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601
+ Details
Name: |
us-gaap_LongTermDebtMaturitiesRepaymentTerms |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionPercentage increase in the stated interest rate on a short-term debt instrument.
+ References
+ Details
Name: |
us-gaap_ShortTermDebtInterestRateIncrease |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
+ Details
Name: |
us-gaap_ShortTermDebtLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_LeoniteCapitalLLCMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_LeoniteFundILPMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_AuctusFundLLCMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_LabrysFundLPMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_EdBlasiakMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_JoshuaBaumanMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_ConvertibleNotesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_SeriesNConvertibleNotesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_SeriesNConvertibleMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
Mortgage loans (Details) - USD ($)
|
9 Months Ended |
|
Sep. 30, 2023 |
Dec. 31, 2022 |
Short-Term Debt [Line Items] |
|
|
Debt Instrument, Interest Rate, Stated Percentage |
4.20%
|
|
Principal Amount Outstanding on Loans Securitized or Asset-Backed Financing Arrangement |
|
|
Debt Instrument, Increase, Accrued Interest |
|
|
Cranberry Cove Holdings Ltd [Member] |
|
|
Short-Term Debt [Line Items] |
|
|
Loans Payable |
|
$ 3,504,605
|
Loans Payable, Current |
|
$ 3,504,605
|
X |
- DefinitionIncrease for accrued, but unpaid interest on the debt instrument for the period.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(f)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
+ Details
Name: |
us-gaap_DebtInstrumentIncreaseAccruedInterest |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionContractual interest rate for funds borrowed, under the debt agreement.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_DebtInstrumentInterestRateStatedPercentage |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionIncluding the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(16)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(16)(a)(2)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910
+ Details
Name: |
us-gaap_LoansPayable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_LoansPayableCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThis is the principal amount outstanding for securitized loans only (across all types of loans).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 860 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719
+ Details
Name: |
us-gaap_PrincipalAmountOutstandingOnLoansSecuritized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
+ Details
Name: |
us-gaap_ShortTermDebtLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_CranberryCoveHoldingsLtdMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
Related party payables (Details) - USD ($)
|
9 Months Ended |
12 Months Ended |
Sep. 30, 2023 |
Dec. 31, 2022 |
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] |
|
|
Related party disclosure |
$ 2,670,008
|
$ 2,713,878
|
Shawan E Leon [Member] |
|
|
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] |
|
|
Related party disclosure |
124,445
|
411,611
|
Leon Developments Ltd [Member] |
|
|
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] |
|
|
Related party disclosure |
1,092,701
|
850,657
|
Eileen Greene [Member] |
|
|
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] |
|
|
Related party disclosure |
$ 1,452,862
|
$ 1,451,610
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
+ Details
Name: |
us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
srt_TitleOfIndividualAxis=grst_ShawanELeonMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_TitleOfIndividualAxis=grst_LeonDevelopmentsLtdMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_TitleOfIndividualAxis=grst_EileenGreeneMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
Stockholders deficit (Details)
|
9 Months Ended |
Sep. 30, 2023
$ / shares
|
Equity [Abstract] |
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price |
$ 0.001
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum |
4.31%
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum |
4.87%
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term |
2 years
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term 1 |
4 years
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum |
205.50%
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum |
243.00%
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate |
0.00%
|
X |
- References
+ Details
Name: |
grst_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm2 |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_EquityAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAgreed-upon price for the exchange of the underlying asset relating to the share-based payment award.
+ References
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe maximum risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe minimum risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionExpected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Stockholders deficit (Details 1) - $ / shares
|
9 Months Ended |
12 Months Ended |
Sep. 30, 2023 |
Dec. 31, 2022 |
Equity [Abstract] |
|
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Beginning Balance |
602,852,506
|
623,777,506
|
Exercise Price per share upper limit |
|
$ 0.000675
|
Exercise Price per share lower limit |
|
0.12
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Beginning Balance |
$ 0.001306
|
$ 0.0052875
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross |
745,810,761
|
|
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price |
$ 0.001
|
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period |
(326,286,847)
|
(20,925,000)
|
Forfeited per share |
|
$ 0.12
|
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price |
$ 0.000675
|
$ 0.12
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period |
|
|
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price |
|
|
Exercise Price per share upper limit ending balance |
0.000675
|
|
Exercise Price per share Lower limit ending balance |
0.00205
|
|
Forfeited Exercise Price per share |
0.001
|
|
Exercise Price per share upper limit |
$ 0.000675
|
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number, Ending Balance |
1,022,376,420
|
602,852,506
|
Exercise Outstanding Price per share |
$ 0.001
|
|
Exercise Outstanding Price per share |
0.00205
|
|
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price, Ending Balance |
$ 0.0012840
|
$ 0.001306
|
X |
- References
+ Details
Name: |
grst_ExerciseOutstandingPricePerShare |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ExerciseOutstandingPricePerShareUpperlimit |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ExercisePricePerShareLowerLimit |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ExercisePricePerShareLowerLimitEndingBalance |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ExercisePricePerShareUpperLimit |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ExercisePricePerShareUpperLimitEndingBalance |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ExercisePricePerShareUpperLimitOne |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ForfeitedExercisePricePerShare1 |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ForfeitedPerShare |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_EquityAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(03) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionGross number of share options (or share units) granted during the period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of options outstanding, including both vested and non-vested options.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionWeighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionWeighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(04) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionWeighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(03) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionWeighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(01) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of share options (or share units) exercised during the current period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Stockholders deficit (Details 2)
|
9 Months Ended |
Sep. 30, 2023
$ / shares
shares
|
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] |
|
Number of shares |
1,022,376,420
|
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceTerm] |
3 years 9 months
|
[custom:WarrantsExercisable] |
1,022,376,420
|
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceTerm1] |
2 years 3 months 7 days
|
[custom:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceTerm2] |
3 years 4 months 6 days
|
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares |
$ 0.001284
|
[custom:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercisable] | $ / shares |
$ 0.001284
|
Excercise 2 [Member] |
|
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] |
|
[custom:WarrantsExercisable] |
276,565,659
|
Excercise 1 [Member] |
|
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] |
|
Number of shares |
745,810,761
|
[custom:WarrantsExercisable] |
745,810,761
|
Excercise 2 [Member] |
|
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] |
|
Number of shares |
276,565,659
|
X |
- References
+ Details
Name: |
grst_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercisable |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceTerm |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceTerm1 |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceTerm2 |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_WarrantsExercisable |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_WarrantsOutstanding |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionExercise price per share or per unit of warrants or rights outstanding.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644
+ Details
Name: |
us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
+ Details
Name: |
us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_DebtInstrumentAxis=grst_Excercise2Member |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=grst_Excercise1Member |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=grst_Excercise2Member |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
Segment information (Details) - USD ($)
|
3 Months Ended |
9 Months Ended |
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Segment Reporting Information [Line Items] |
|
|
|
|
Revenue |
$ 1,353,899
|
$ 1,424,943
|
$ 4,219,904
|
$ 3,586,290
|
Foreign exchange movements |
$ 6,598
|
$ 404,538
|
(84,148)
|
502,350
|
Rental Operations [Member] |
|
|
|
|
Segment Reporting Information [Line Items] |
|
|
|
|
Revenue |
|
|
180,522
|
292,303
|
Operating expenses |
|
|
245,528
|
(99,515)
|
Operating income |
|
|
(65,006)
|
192,788
|
Forgiveness of government assistance loan |
|
|
3,481,332
|
|
Other income |
|
|
|
|
Penalty on convertible notes |
|
|
|
|
Extension fee on property purchase |
|
|
|
|
Gain on disposal of property |
|
|
|
|
Loss on debt extinguishment |
|
|
|
|
Interest expense |
|
|
(95,464)
|
(156,297)
|
Amortization of debt discount |
|
|
|
|
Foreign exchange movements |
|
|
(81,033)
|
116,635
|
Net income before taxes |
|
|
3,239,829
|
153,126
|
Taxes |
|
|
|
|
Net Income |
|
|
3,239,829
|
153,126
|
Derivative liability movement |
|
|
|
|
In Patient Services [Member] |
|
|
|
|
Segment Reporting Information [Line Items] |
|
|
|
|
Revenue |
|
|
4,039,382
|
3,297,387
|
Operating expenses |
|
|
3,833,676
|
(3,105,091)
|
Operating income |
|
|
205,706
|
188,896
|
Forgiveness of government assistance loan |
|
|
(3,481,332)
|
104,368
|
Other income |
|
|
449
|
10,018
|
Penalty on convertible notes |
|
|
(34,688)
|
|
Extension fee on property purchase |
|
|
(130,000)
|
|
Gain on disposal of property |
|
|
2,484,172
|
|
Loss on debt extinguishment |
|
|
(277,175)
|
|
Interest expense |
|
|
(286,984)
|
(210,880)
|
Amortization of debt discount |
|
|
(238,304)
|
(551,738)
|
Foreign exchange movements |
|
|
(3,115)
|
385,715
|
Net income before taxes |
|
|
(1,761,271)
|
101,972
|
Taxes |
|
|
221,107
|
(87,615)
|
Net Income |
|
|
(1,540,164)
|
14,357
|
Derivative liability movement |
|
|
|
175,593
|
Rental In Patient Services [Member] |
|
|
|
|
Segment Reporting Information [Line Items] |
|
|
|
|
Revenue |
|
|
4,219,904
|
3,586,290
|
Operating expenses |
|
|
4,079,204
|
(3,204,606)
|
Operating income |
|
|
140,700
|
381,684
|
Forgiveness of government assistance loan |
|
|
|
104,368
|
Other income |
|
|
449
|
10,018
|
Penalty on convertible notes |
|
|
(34,688)
|
|
Extension fee on property purchase |
|
|
(130,000)
|
|
Gain on disposal of property |
|
|
2,484,172
|
|
Loss on debt extinguishment |
|
|
(277,175)
|
|
Interest expense |
|
|
(382,448)
|
(367,177)
|
Amortization of debt discount |
|
|
(238,304)
|
(551,738)
|
Foreign exchange movements |
|
|
(84,148)
|
502,350
|
Net income before taxes |
|
|
1,478,558
|
255,098
|
Taxes |
|
|
221,107
|
(87,615)
|
Net Income |
|
|
$ 1,699,665
|
167,483
|
Derivative liability movement |
|
|
|
$ 175,593
|
X |
- References
+ Details
Name: |
grst_DerivativeLiabilityMovement |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ExtensionFeeOnPropertyPurchase1 |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ForeignExchangeMovements |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ForgivenessOfIntercompanyLoan |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_LossOnDebtExtinguishment |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NetIncomeLoss1 |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_OperatingLossIncome |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_PenaltyOnConvertibleNotes1 |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_Taxes |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of amortization expense attributable to debt discount (premium) and debt issuance costs.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 55 -Paragraph 69E -URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1F -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611
Reference 5: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 55 -Paragraph 69F -URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612
+ Details
Name: |
us-gaap_AmortizationOfFinancingCostsAndDiscounts |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionTotal costs of sales and operating expenses for the period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
+ Details
Name: |
us-gaap_CostsAndExpenses |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of gain (loss) on sale or disposal of property with proven oil and gas reserves.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585
+ Details
Name: |
us-gaap_GainLossOnSaleOfProvedProperty |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of the cost of borrowed funds accounted for as interest expense.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (210.5-03(11)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260
+ Details
Name: |
us-gaap_InterestExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount after tax, before reclassification adjustments of other comprehensive income (loss).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 50 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 45 -Paragraph 17 -URI https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 55 -Paragraph 15 -URI https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581
Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 30 -Section 45 -Paragraph 20 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900
+ Details
Name: |
us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of revenue and income classified as other.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.4) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263
+ Details
Name: |
us-gaap_OtherIncome |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 235 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-05(b)(2)) -URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227
+ Details
Name: |
us-gaap_Revenues |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_StatementBusinessSegmentsAxis=grst_RentalOperationsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementBusinessSegmentsAxis=grst_InPatientServicesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementBusinessSegmentsAxis=grst_RentalInPatientServicesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
Segment information (Details 1) - USD ($)
|
Sep. 30, 2023 |
Dec. 31, 2022 |
Sep. 30, 2022 |
Assets |
|
|
|
Current assets |
$ 794,521
|
$ 542,896
|
|
Non-current assets |
11,213,407
|
6,020,398
|
|
Current liabilities |
(7,713,189)
|
(13,289,131)
|
|
Non-current liabilities |
(9,801,769)
|
$ (2,106,706)
|
|
Rental Operations [Member] |
|
|
|
Segment Reporting Information [Line Items] |
|
|
|
Purchase of fixed assets |
(43,611)
|
|
|
Assets |
|
|
|
Current assets |
|
|
$ 7,972
|
Non-current assets |
|
|
2,469,499
|
Current liabilities |
|
|
(4,974,475)
|
Non-current liabilities |
|
|
(603,557)
|
Net liability position |
|
|
(4,364,046)
|
Purchase of fixed assets |
|
|
|
Mandatory redeemable preferred shares |
|
|
|
Intercompany balances |
|
|
(1,263,485)
|
In Patient Services [Member] |
|
|
|
Segment Reporting Information [Line Items] |
|
|
|
Purchase of fixed assets |
5,287,622
|
|
|
Assets |
|
|
|
Current assets |
794,521
|
|
952,223
|
Non-current assets |
11,213,407
|
|
3,299,226
|
Current liabilities |
(7,713,189)
|
|
(9,047,232)
|
Non-current liabilities |
(9,801,769)
|
|
(1,523,795)
|
Net liability position |
(5,507,030)
|
|
(8,131,754)
|
Purchase of fixed assets |
|
|
285,103
|
Mandatory redeemable preferred shares |
|
|
(400,000)
|
Intercompany balances |
|
|
1,263,485
|
Rental In Patient Services [Member] |
|
|
|
Segment Reporting Information [Line Items] |
|
|
|
Purchase of fixed assets |
5,244,011
|
|
|
Assets |
|
|
|
Current assets |
794,521
|
|
960,195
|
Non-current assets |
11,213,407
|
|
5,768,725
|
Current liabilities |
(7,713,189)
|
|
(14,021,707)
|
Non-current liabilities |
(9,801,769)
|
|
(2,127,352)
|
Net liability position |
$ (5,507,030)
|
|
(9,820,139)
|
Purchase of fixed assets |
|
|
285,103
|
Mandatory redeemable preferred shares |
|
|
(400,000)
|
Intercompany balances |
|
|
|
X |
- References
+ Details
Name: |
grst_IntercompanyBalances |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
grst_MandatoryRedeemablePreferredShares |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
grst_NetLiabilityPosition |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
grst_PurchaseOfFixedAssets |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
grst_PurchaseOfFixedAssets1 |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_AssetAcquisitionAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionSum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (bb) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(9)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
+ Details
Name: |
us-gaap_AssetsCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionSum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (bb) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
+ Details
Name: |
us-gaap_AssetsNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 55 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (bb) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 5 -URI https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765
Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
+ Details
Name: |
us-gaap_LiabilitiesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of obligation due after one year or beyond the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 201.5-02(25)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(23)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 201.5-02(26)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 852 -SubTopic 10 -Section 50 -Paragraph 7 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 201.5-02(24)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (bb) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988
+ Details
Name: |
us-gaap_LiabilitiesNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- Details
Name: |
us-gaap_StatementBusinessSegmentsAxis=grst_RentalOperationsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementBusinessSegmentsAxis=grst_InPatientServicesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementBusinessSegmentsAxis=grst_RentalInPatientServicesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
Net income (loss) per common share (Details) - USD ($)
|
3 Months Ended |
9 Months Ended |
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Basic earnings per share |
|
|
|
|
Net income per share available for common stockholders Amount |
$ 2,076,479
|
$ 458,713
|
$ 1,524,534
|
$ 41,135
|
Net income per share available for common stockholders Shares |
3,729,053,805
|
3,729,053,805
|
3,729,053,805
|
3,693,636,223
|
Net income per share available for common stockholders Per share |
$ 0.00
|
$ 0.00
|
$ 0.00
|
$ 0.00
|
Convertible debt Amount |
$ 50,964
|
$ 163,565
|
$ 146,395
|
$ 230,724
|
Convertible debt Shares |
202,325,970
|
547,490,575
|
202,325,970
|
547,490,575
|
Diluted earnings per share |
|
|
|
|
Net income per share available for common stockholders Diluted Amount |
$ 2,127,443
|
$ 622,278
|
$ 1,670,929
|
$ 271,859
|
Net income per share available for common stockholders diluted Shares |
3,931,379,775
|
4,276,544,380
|
3,931,379,775
|
4,244,126,798
|
Net income per share available for common stockholders Diluted Per Shares |
$ 0.00
|
$ 0.00
|
$ 0.00
|
$ 0.00
|
X |
- References
+ Details
Name: |
grst_ConvertibleDebtAmount |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_ConvertibleDebtShares |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NetIncomePerShareAvailableForCommonStockholdersAmount |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NetIncomePerShareAvailableForCommonStockholdersDilutedAmount |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NetIncomePerShareAvailableForCommonStockholdersDilutedPerShares |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NetIncomePerShareAvailableForCommonStockholdersDilutedShares |
Namespace Prefix: |
grst_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
grst_NetIncomePerShareAvailableForCommonStockholdersPerShare |
Namespace Prefix: |
grst_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_EarningsPerShareBasicAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_EarningsPerShareDilutedAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Ethema Health (PK) (USOTC:GRST)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Ethema Health (PK) (USOTC:GRST)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024